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ABSTRACT 
Many chemical products available today provide essential tools that make the 
world economy viable. However, the current reliance on fossil fuels is unsustainable and 
possibly negatively affects the environment. Therefore, a new method of synthesis for 
biorenewable and sustainable chemicals is needed. In this treatise, significant advancement 
in the production of short chain carboxylic acids during bacterial fermentation is described. 
This work offers new insights into carboxylic acid toxicity and methods for improvement 
of microbial tolerance that is important for improving productivity, titer, and yields for 
economical production of biorenewable chemicals. 
The methods described include metabolic engineering techniques for E. coli strain 
construction: gene knockouts, gene overexpression, directed evolution for tolerance and E. 
coli biocatalyst characterization techniques: specific growth rate, membrane fluidity, 
membrane leakage, membrane lipid analysis, hydrophobicity, carboxylic acid production, 
transcriptome analysis, intracellular pH, γ-amino butyric acid determination, proton motive 
force simulation, genome reverse engineering, and biocatalyst zeta potential. These 
methods allow greater insight into the mechanisms of toxicity of carboxylic acids and how 
bacteria cells improve tolerance. 
Hexanoic, octanoic (C8), and decanoic acids are completely inhibitory to 
Escherichia coli MG1655 in minimal medium. This growth inhibition is pH-dependent and 
is accompanied by a significant change in the fluorescence polarization (fluidity) and 
integrity. This inhibition and sensitivity to membrane fluidization, but not to damage of 
membrane integrity, can be at least partially mitigated during short-term adaptation to 
octanoic acid. This short-term adaptation was accompanied by a change in membrane lipid 
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composition and a decrease in cell surface hydrophobicity. Specifically, the 
saturated/unsaturated lipid ratio decreased and the average lipid length increased. A fatty 
acid-producing strain exhibited an increase in membrane leakage as the product titer 
increased, but no change in membrane fluidity. These results highlight the importance of 
the cell membrane as a target for future metabolic engineering efforts for enabling 
resistance and tolerance of desirable biorenewable compounds, such as carboxylic acids. 
Transcriptome analysis of Escherichia coli during exogenous challenge with C8 at 
pH 7.0 suggested that C8 challenge causes intracellular acidification and membrane 
damage. Network component analysis identified transcription factors with altered activity. 
We conclude that the membrane permeability of carboxylic acids enables acidification of 
the cell interior despite maintenance of the media pH at neutral. This acidification was not 
observed in a carboxylic acid producing strain, though this may be due to lower titers than 
those used in our exogenous challenge studies. We developed a framework for predicting 
the proton motive force during adaptation to strong inorganic acids and carboxylic acids. 
This model predicts that inorganic acid challenge is mitigated by cation accumulation, but 
the inverted proton motive force imposed by carboxylic acids requires anion accumulation. 
Utilization of native acid resistance systems was not useful in terms of supporting growth 
or alleviating intracellular acidification. The glutamate-dependent acid resistance system 
was found to be non-functional, possibly due to membrane damage. E. coli strains were 
also engineered for altered cyclopropane fatty acid content in the membrane, which had a 
dramatic effect on membrane properties, though C8 tolerance was not increased. 
The microbial directed evolution method by sequential transfers was utilized to 
engineer an E. coli cell for an enhanced carboxylic acid tolerance phenotype. The C8-
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tolerant LAR1 strain overexpressing a short chain thioesterase specific for C8 more than 
doubled the production titer from 300 mg/L to 650 mg/L. The LAR1 strain displayed an 
altered physiology by a change in the membrane compared to the parent strain ML115. 
LAR1 had a lower saturated:unsaturated lipid ratio (S/U), higher average lipid length, a 
lower membrane fluidity, and a more negative surface charge. LAR1 did not show an 
improvement in the intracellular pH. Both the evolved strains and the parent strain were 
resequenced using Illumina short reads in order to identify the mutations responsible for 
the tolerance phenotype. Two mutations were found: two copies of the essential gene rpoC 
(rpoC-A1256C and rpoC∆(1-305) and basR-G82T. The rpoC mutations may give a 
hypermutability phenotype that allows LAR1 to adapt the stressful environments. The 
basR-G82T mutation increased the surface charge, as measured by zeta potential. These 
findings are quite significant as it may explain fundamental differences of bacterial 
physiology that can relate to changes in behavior.
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CHAPTER 1 
INTRODUCTION 
Background 
Throughout the ages man has made vast technological and scientific advances that 
revolutionize human society. With the discovery of fire that opened up a world of endless 
possibilities, the human race has created industries such as ceramics, metallurgy, paper, 
and chemicals in search of products that improve our daily lives. These products and 
materials have originated in forms that were readily obtainable and transformed into 
something useful. For example, through iron deposits one could harvest the metal and 
smelt it into stronger tools. The chemical industry became the first science-based industry 
in 1856 with the discovery of synthetic mauve by William Henry Perkin. He marketed his 
product successfully and sold it to the dyestuffs industry (1). 
The modern chemical industry has expanded greatly to include a multitude of 
products deriving from coal, petroleum, and natural gas reserves. The far-reaching utility 
of these vast carbon deposits became apparent with the sophistication of energy 
production. The petrochemical industry is closely coupled with the petroleum energy 
sector. Byproducts from crude oil have become value added chemicals along with the 
development of chemical synthesis and refinery techniques in the production of 
commodity chemicals, polymers, lubricants, and specialty chemicals. Greater than 90 % of 
crude oil is used in the production of transportation fuel; however, the value of the 
chemical industry is equivalent to the energy industry. Hence, the importance of value-
added products. The integration and consolidation of the energy and commodity chemicals 
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businesses have led to production of petroleum and large-volume commodity chemicals 
together at a very low cost (1,2). The rise of an efficient infrastructure has been the 
development of platform chemicals that are catalyzed and polymerized to produce a 
plethora of chemical products serving almost every modern industry for a variety of 
applications. The top 30 chemicals by weight produced in the United States all derive from 
three platform chemicals: ethylene, propylene, and benzene (2-4). 
 Coal, petroleum, and natural gas are condensed hydrocarbons that have taken 
millions of years to form through heat and pressure; thereby so-called fossil fuels are 
inherently nonrenewable and non-sustainable in modern society. A sustainable carbon 
source is only possible when the relative rate of generation is equivalent to the rate of 
consumption. Biomass or organic matter comprising of carbon, hydrogen, oxygen, and 
nitrogen is quickly regenerated and the only option as an alternative feedstock to the 
chemical industry. 
The dependency on a nonrenewable carbon feedstock for a modern society has long 
been known, but out of environmental and economic concerns, only in the last few years 
has society expressed a sharp interest in shifting towards alternative, renewable carbon 
sources. There are many examples of successfully commercialized biorenewable chemical 
processes, but each process has been developed painstakingly over decades in order to 
bring a specific product to the market. Commercially available alternative processes 
include the production of ethanol, glycerol, 1,3 propanediol, and lactic acid (2,5). These 
examples have been chosen for their industrial importance, similarity in structure to fatty 
acids, and successfulness in production. 
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Production of ethanol is more geared towards biofuels production; however, it has 
been a major focus in microbial production of chemicals. Ingram’s laboratory has been 
quite successful at producing ethanol by the recombinant Escherichia coli LY168 strain. 
Utilizing mixed sugars and the artificial PET operon from Zymomonas mobilis for pentose 
sugar conversion has yielded a titer of 46 g/L in minimal salts media (5-7). Glycerol has 
many applications in cosmetics, liquid soaps, food, pharmaceuticals, lubricants and others. 
Yeasts are natural producers of glycerol; however, there are natural advantages of using a 
prokaryote for chemical production. Those advantages include comparative simplicity in 
metabolic engineering. Genencor and DuPont have together developed transgenic E. coli 
bearing both GPD1 from Saccharomyces diastaticus and GPP2 from S. cerevisiae; the 
biocatalyst is highly efficient in the production of glycerol. Final titers are over 200 g/L 
(5,8). 1,3-Propanediol is a monomer in the synthesis of polyesters, polyurethanes, and 
cyclic molecules. Its biological production is not a new concept and has been used for over 
100 years; however, there are limitations involving expensive substrates (glycerol), 
availability of reducing agents, and pathway inhibition. Through metabolic engineering, 
optimization of 1,3-propanediol can be achieved by utilizing a two-step process that 
converts glucose to glycerol and glycerol to 1,3-propanediol. This method has improved 
the process in reaching a titer of 150 g/L (5). L-lactic acid is used predominately in the 
food industry as a preservative and flavoring agent. It has been increasingly used in the 
production of biodegradable polymers. The major problem with lactic acid production is 
that the free acid form is preferred in most industrial processes; however, the optimal pH 
for anaerobic lactic acid production is above its pKa of 3.87. Therefore, the salt form is 
predominating, which gives rise to gypsum waste formation. Saitoh and coworkers have 
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engineered S. cerevisiae with six copies of the bovine L-lactate dehydrogenase gene that 
allows fermentation at a low pH giving rise to 122 g/L of 99% pure L-lactate (5,9). 
Other potential synthesis routs of a single product have been demonstrated using 
either biotechnology (bioengineering, metabolic engineering) or mechanical/biochemical 
engineering of biomass digestion. An alternative approach to singular product development 
is the merging of both microbial metabolic engineering and chemical catalysis in order to 
provide an entire foundation for the conversion of a nonrenewable-based industry to a 
sustainable and biorenewable industry. 
The Center for Biorenewable Chemicals (CBiRC) has been established to provide a 
research-based infrastructure in revolutionizing the modern chemical industry. Its vision is 
“to transform the chemical industry by integrating biological and chemical catalysis 
systems to produce biorenewable chemicals (10).” Due to the greatness of the task, nine 
academic and research institutions have partnered together in order to achieve such a lofty 
goal. The center includes three research thrusts: new biocatalysts for metabolic pathway 
engineering (thrust I), microbial metabolic engineering (thrust II), and chemical catalyst 
design (thrust III). The objective of thrust I is to identify and characterize platform 
biocatalytic pathways that can produce either precursory or final commodity molecules. 
Thrust II is to take the technological and scientific discoveries from thrust I and develop 
efficient microorganisms that produce these compounds economically. Thrust III will take 
the molecule produced in thrust I or thrust II and use traditional heterogeneous or 
homogeneous catalysis to make a final product. An additional research area, life cycle 
assessment, is necessarily incorporated to integrate the three research thrusts and determine 
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the sustainability and economic feasibility of a proposed industrial process. This proposal 
highlights the research of thrust II. 
The research of thrust II has two goals: I) develop an efficient biocatalyst for the 
metabolic synthesis of reduced chemicals with specific functional groups and II) shorten 
strain development by creating an extensive knowledge base of microbial production 
platforms. With respect to the first goal, an “efficient” biocatalyst should have the 
following properties: I) easy transformation with new pathways, II) enhanced metabolic 
pathway design that balances cell growth and target molecule production, III) balanced 
carbon and cofactor flow, IV) great stability and performance at high productivity. An 
easily transformative biocatalyst should be compatible with new pathways from thrust I 
that are introduced into the host cell by carrier plasmids, mutagenesis, or transgenic 
recombination. An enhanced pathway will optimize cellular growth necessary for cell 
culturing and product formation to obtain a high substrate conversion yield, production 
rate, and product titer. A balanced carbon and cofactor flow allows for pathway 
optimization. A robust biocatalyst is able to withstand necessary stresses at high 
productivity. The second goal will come from the knowledge obtained by strain 
characterization. Figure 1 describes the steps of biocatalyst design within thrust II. Other 
stepwise protocols for biocatalyst design have been reviewed (11-13). Specifically, the 
research described here contains Escherichia coli that have been engineered for short chain 
fatty acid tolerance by both methods of rational metabolic engineering and reverse 
engineering of evolved strains (Table 1). 
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Thesis Organisation 
The following chapters are a collection of research papers and book chapters that 
are either published, under review, or intended for submission for publication when 
completed. They are organized as follows: Chapters 2-4 are research papers that are the 
bulk of the work presented on the topic of engineering E. coli biocatalysts for carboxylic 
acid tolerance and elucidating the mechanisms of short chain fatty acid toxicity. Chapter 5 
is a summary of the contained work and a description of future work to enhance the field 
of improving carboxylic acid tolerance. Appendix A and B are book chapters. Appendix A 
is a methods chapter intended for an audience with interest an in biocatalyst reverse 
engineering, but who do not have an expertise. Appendix B is a book chapter written for 
scientist and engineers who are interested in learning novel bioprocessing technology. 
Appendix C is a list of additional experiments and data that may be useful for further 
publications.  
Chapter 2: The Damaging Effects of Short Chain Fatty Acids on Escherichia coli 
Membranes. 
Chapter 2 is a research paper discussing the physiological effects of short chain 
fatty acids; it highlights how the cell membrane is damaged. An integral part of this work 
includes the ability of E. coli to adapt to octanoic acid stress in order to survive in extreme 
environments. 
Chapter 3: Transcriptomic Analysis of Carboxylic Acid Challenge: Beyond Membrane 
Damage  
This research paper utilizes transcriptomics in order to gain global information on 
the response network of E. coli during octanoic acid challenge. The activation of acid 
resistance genes was highlighted as the main factor in the response network. This work 
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characterized how intracellular pH affected E. coli cells and how octanoic acid impaired 
the native acid resistance systems. 
Chapter 4: Directed Evolution for and Reverse Engineering of Short Chain Fatty Acid 
Tolerance 
This research paper uses the technique of directed microbial evolution for short 
chain fatty acid tolerance. The genetic mutations as well as the physiological differences 
that give rise to the tolerance phenotype in the evolved strain are identified and analyzed. 
Chapter 5: Summary, future work, and Conclusions 
The final chapter summarizes the important findings of carboxylic acid toxicity and 
E. coli tolerance of carboxylic acids for enhanced production. The future work describes a 
path forward to a greater understanding of carboxylic acid toxicity and bacterial tolerance.  
Appendix A: Identification of Mutations in Evolved Bacterial Genomes 
Reverse engineering is a crucial task in directed microbial evolution projects in 
order to gain the most information on how microorganisms can genetically evolve for 
desirable phenotypes. As such, it is a challenging task, where in this book chapter a 
method of identifying mutations in evolved genomes is described. 
Appendix B: Metabolic Engineering For Biocatalyst Robustness 
This book chapter describes general methods for improving biocatalyst robustness. 
It focuses on the importance of cellular physiology and the cell membrane as an 
engineering target for improving tolerance to inhibitors. 
Appendix C: Additional Experiments 
This is a list of additional experiments that may be suitable for future publications. 
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Tables 
Table 1. Summary of Strains and Plasmids in this Work 
Strain and plasmid Genotype Reference 
MG1655 ATCC#700926 F- lambda- ilvG- rfb-50 rph-1 Wildtype 
E. coli W ATCC#9637 - Wildtype 
E. coli Crooks 
ATCC#8739 - Wildtype 
ML103 MG1655∆fadD (14) 
∆cfa MG1655∆cfa This reference 
cfa++ MG1655+pCA-cfa (15) 
∆lrp MG1655∆lrp This reference 
lrp++ MG1655+pCA-lrp (15) 
ML115 (parent) MG1655 
fadD poxB ackA-pta::cmR 
(14) 
LAR1 (evolved ML115-15-C5) ML115 
… 
This reference 
LAR2 (evolved ML115-15-C2) ML115 
… 
This reference 
pJMY-EEI82564 pTrc-EEI82564 thioesterase 
from Anaerococcus tetradius 
This reference 
pXZ18Z pTrc99a-acyl 
thioesterase R. communis-fabZ 
(17) 
pJDT1 pBad24-TorA-GFPmut3* (18) 
pZS-GFP pZS-TorA-GFPmut3*  (18) and this reference 
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Figures 
Figure 1. Strain Design and Characterization of Biocatalysts for Production of 
Biorenewable Chemicals 
 
  
12 
 
CHAPTER 2 
THE DAMAGING EFFECTS OF SHORT CHAIN FATTY ACIDS ON ESCHERICHIA 
COLI MEMBRANES 
Accepted for publication in Applied Microbiology and Biotechnology 
Liam A. Royce1, Ping Liu2, Matthew J. Stebbins1, Benjamin C. Hanson1, Laura R. 
Jarboe1,2 
1Department of Chemical & Biological Engineering, Iowa State University, Ames, IA 
50011. 
2Interdepartmental Microbiology Program, Iowa State University, Ames, IA 50011. 
This work was supported by the NSF Engineering Research Center for Biorenewable 
Chemicals (CBiRC), NSF award number EEC-0813570. 
Abstract 
Carboxylic acids are an attractive biorenewable chemical. However, like many 
other fermentatively produced compounds, they are inhibitory to the biocatalyst. An 
understanding of the mechanism of toxicity can aid in mitigating this problem.  Here we 
show that hexanoic and octanoic acids are completely inhibitory to Escherichia coli 
MG1655 in minimal media at a concentration of 40 mM, while decanoic acid was 
inhibitory at 20 mM. This growth inhibition is pH-dependent and is accompanied by a 
significant change in the fluorescence polarization (fluidity) and integrity. This inhibition 
and sensitivity to membrane fluidization, but not to damage of membrane integrity, can be 
at least partially mitigated during short-term adaptation to octanoic acid. This short-term 
adaptation was accompanied by a change in membrane lipid composition and a decrease in 
cell surface hydrophobicity. Specifically, the saturated:unsaturated lipid ratio decreased 
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and the average lipid length increased. A fatty acid-producing strain exhibited an increase 
in membrane leakage as the product titer increased, but no change in membrane fluidity. 
These results highlight the importance of the cell membrane as a target for future metabolic 
engineering efforts for enabling resistance and tolerance of desirable biorenewable 
compounds, such as carboxylic acids. Knowledge of these effects can help in the 
engineering of robust biocatalysts for biorenewable chemicals production. 
Introduction 
Biofuels and biorenewable chemicals are an increasingly important area of 
research. Government policies are demanding cleaner, safer, and more sustainable 
processes for production of energy and chemicals (Chambers and Muecke 2010; DOE 
2012). Development of drop-in replacements of petroleum-derived compounds is key to a 
sustainable carbon-based chemicals industry (Bozell and Petersen 2010; Nikolau et al. 
2008). To this end, there is substantial interest in producing biorenewable fuels and 
chemicals from biomass (Centi and van Santen 2007; Erickson et al. 2012; Wackett 2008). 
Carboxylic acids can serve as precursors to many molecules in industrial applications. For 
example, carboxylic acids can be converted into alkanes for diesel fuel applications (Mäki-
Arvela et al. 2007) or into α-olefins for polymer synthesis applications (Alonso et al. 2010; 
Shanks 2010). α-hydroxyalkanoates, another molecule of interest in biorenewables 
research, can be made into a polymer from carboxylic acids as a monomer (Guo-Qiang et 
al. 2001). Short chain fatty acids (SFCAs) may be more desirable for polymer synthesis in 
order to control the number of carbons in the polymer backbone, whereas the larger 
molecules are applicable for biodiesel.  
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Fatty acids or carboxylic acids with 12 - 18 carbons are common in biology as the 
main components of bacterial cell membranes. The fatty acid biosynthesis pathway is an 
iterative way to modulate the carbon chain length of molecules as desired (Nikolau et al. 
2008; Zhang et al. 2011) and thus there is extensive interest in exploiting this system to 
make a broad range of biorenewable chemicals.  
In addition to their potential as biorenewable chemicals, fatty acids are used in a 
number of industries ranging from soap to preservatives. For example, the food industry 
uses free fatty acids as a preservative to increase shelf life (Kabara 1984, 2005; Makkar 
and Cameotra 2002). Therefore, it is known that SCFAs are inhibitory to microbial growth, 
as reported by a number of sources (Desbois and Smith 2010; Kabara and Marshall 2005; 
Liu et al. 2013; Yang et al. 2010). This usefulness as a preservative could in turn be a 
problem in the fermentative production of SCFAs as biorenewable chemicals. Small 
organic acids (i.e., formic, acetic, propanoic and butyric acids) are a natural byproduct of 
fermentation, especially in the human intestine, where concentrations can range from 20 to 
120 mM (Cummings and Macfarlane 1991). Therefore, many enteric bacteria have natural 
pathways and mechanisms for mitigating toxicity of small organic acids, including 
transport, altered metabolism, acid resistance, and stress proteins (Diez-Gonzalez and 
Russell 1999; Polen et al. 2003). Individual response mechanisms are reported in literature, 
but as a whole, the entire response network is not clear. Moreover, the mechanisms can be 
molecule-dependent and even have opposing effects in some cases, confounding analysis 
(Kirkpatrick et al. 2001; Russell 1991).  
Inhibition of the biocatalyst by the desired product is a common problem in the 
fermentative production of biorenewable fuels and chemicals, but knowledge of the 
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mechanism of inhibition can aid in the design of strategies for engineering tolerance 
(Jarboe et al. 2011). Much work has been done to address microbial inhibition by biofuels 
such as ethanol and butanol (Huffer et al. 2011; Jarboe et al. 2007; Minty et al. 2011; 
Reyes et al. 2011); however, the mechanisms of short chain fatty acid (SCFA) toxicity in 
E. coli are not well understood. Specifically, our knowledge of the mechanism of 
inhibition by hexanoic (C6), octanoic (C8), and decanoic acids (C10) remains incomplete 
(Carpenter and Broadbent 2009; Ricke 2003). Recently, Hyldgaard and coworkers 
(Hyldgaard et al. 2012) showed the mechanisms of inhibition of monocaprylate, a 
monoester containing octanoate. Their work addressed the cellular physiology as described 
by atomic force microscopy, dye leakage, and the lamellar phase of model membranes. 
While their study is an excellent qualitative analysis, more work is needed for a 
quantitative assessment of the mechanisms of inhibition. 
Lennen et al. (2011, 2013) indicated that toxicity may adversely affect yields of 
free fatty acid production. Their transcriptome analysis led to the proposition that the 
SCFAs damage the cell membrane; similar effects were proposed in Brynildsen’s (2009) 
transcriptome analysis of butanol challenge. Here we confirm and quantify the potentially 
damaging effects of SCFAs on the E. coli cell membrane and possible mechanism E. coli 
uses to increase tolerance to SCFAs. In addition to observing this damage to the membrane 
during exogenous challenge with SCFAs, we also observe similar damage during 
carboxylic acid production. 
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Materials and Methods   
Strains and Growth Conditions 
Escherichia coli strains were obtained from ATCC (Manassas, VA, USA) (Table 1) 
and were grown with 1 mL MOPS minimal media (Wanner 1994) with 2 % dextrose in a 5 
mL sterile culture tube shaking horizontally at 100 rpm at 37 °C for 24 h. Overnight 
cultures were diluted to an optical density of 0.05 at 550 nm (OD550) for specific growth 
measurements and diluted to 0.1 for cell viability, fluidity, leakage, lipid composition, and 
hydrophobicity measurements. Adapted E. coli were grown to midlog (OD550 ~0.8), 
centrifuged (Fisher Scientific Marathon 21000R, Thermo IEC 6555C rotor, Hampton, NH, 
USA) at 5,000 g for 15 min., resuspended in MOPS media with 2 % dextrose containing 
C8 and incubated for 3 hours at 37 °C without shaking. Strain ML103+pXZ18Z 
(Ranganathan et al. 2012) (obtained from Dr. Ka-Yiu San, Rice University, Houston, TX, 
USA) was grown in a 500 mL bioreactor in MOPS + 2 % dextrose + 100 µM IPTG at 30 
°C, 300 rpm. The bioreactor was pH and temperature controlled. Foam was controlled with 
automated addition of 50 % solution of antifoam B silicone emulsion (J.T. Baker, 
Phillipsburg, NJ, USA).  
Determination of the Specific Growth Rate 
The specific growth rate was determined by the OD550 measurements in the 
exponential phase of cultures in 25 mL MOPS media with 2 % dextrose with various 
concentrations of fatty acid solutions (4 M stock in 100 % ethanol) in 250 mL baffled 
shake flasks shaking at 150 rpm in a rotary shaker. Adding the same volume amount of 
100 % ethanol as a control did not affect the growth rate. The initial media pH was 
adjusted to 7.0 in all cases except when modulating the pH from 5 to 7. The media pH 
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during fermentation maintained a pH between 6.5 and 7.0 when estimating the specific 
growth rate. The line of fit when estimating the specific growth rate had a R2 value ≥ 0.9.   
Viability Assays 
E. coli cell viability was assessed by colony counting and propidium iodide (PI) 
using flow cytometry assays. The samples were prepared as follows: cells were centrifuged 
at 5,000 g, 4 °C for 15 min., washed twice with phosphate buffer saline diluted to the 
working concentration (PBS, 10X powder concentrate, Thermo Fisher Scientific, Vista, 
CA) pH=7.0 and resuspended in PBS. The cells were treated with 30 mM  C8 and 
incubated at 37 °C for 30 min. The colony counting assay was performed as follows: the 
samples were diluted serially using sterile water and plated out on MOPS + 2 % glucose 
plates. Two replicates were conducted. The PI assay was performed as follows: the OD550 
of each sample was diluted to 1 x 106 cells/ml (OD550=0.005). 200 µl diluted cell culture 
with 100 µg/ml PI was used for flow cytometry. Cells without PI was also included. 
Fitting Specific Growth Rate Data as a Function of pH and Protonated Octanoic Acid 
After determination of the specific growth rate by OD550 measurements, the 
specific growth rate data was fitted using the following equations derived from the 
Henderson-Hasselbach equation: 
    𝐶8! = 𝐶8𝑂! + 𝐶8𝑂𝐻    (1)	  
	   	   	   	   𝐶8𝑂𝐻 = !!!!!!"(!"!!!!) ,𝑝𝐾! = 4.89	   	   	   (2)	  
where C8t is the total concentration of C8, C8O- is the undissociated form, and C8OH is 
the protonated form. 
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Determination of Membrane Fluidity 
Membrane fluidity can be measured as a fluorescence polarization or anisotropy 
value, which corresponds to how a fluorescent probe inside the membrane reacts to 
polarized light (Mykytczuk et al. 2007). Harvested cells were treated according to the 
protocol described by Beney et al. 2004. Briefly, the samples were washed twice in PBS, 
pH=7.0, resuspended (1x108 cells/mL), and incubated at 37 °C for 30 min. with 1,6-
diphenyl-1,3,5-hexatriene (DPH, supplied by Life Technologies, Carlsbad, CA, USA) at a 
concentration of 0.2 µM (0.2 mM stock solution in tetrahydrofuran). Fluorescence 
polarization values were determined by using a Synergy 2 Multi-Mode microplate reader 
from BioTek using sterile black-bottom Nunclon delta surface 96-well plates. The filters 
were 360/40 nm fluorescence excitation and 460/40 nm fluorescence emission filters from 
BioTek. The excitation polarized filter was set in the vertical position. The emission 
polarized filter was set either in the vertical (IVV) or horizontal (IVH) position. The 
polarization value is calculated by the following formula: 
    𝑃 = !!!!!!"!!!!!!!"!      (3)	  
,where G is the grating factor, assumed to be 1. The cells were treated with octanoic acid at 
pH 7.0 just before measurements. 
Membrane Leakage 
E. coli cells were grown in the same condition as the fluidity measurements and 
processed at the same time. The leakage test was performed according to Osman et al. 
(Osman and Ingram 1985). Cells were centrifuged at 5,000 g, 4 °C for 15 min., washed 
twice with PBS pH=7.0 and resuspended in PBS at a final OD550=10 (1.69x109 cells/mL). 
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The cells were then treated with octanoic acid at pH 7.0, mixed well by pipetting and 
incubated at 37 °C for 30 min. The cells were then centrifuged at 16,873 g (14,000 rpm) 4 
°C for 5 min. and magnesium in the supernatant was measured by infinity magnesium 
reagent (Thermo Fisher Scientific, Vista, CA) and spectrophotometer with temperature 
control at 30 °C (Varian Cary 50 Series, Agilent Technologies, Santa Clara, CA). The 
leakage values of magnesium were expressed as a percentage of magnesium released by 
chloroform with vortexing for 30 s. (0.2 ml chloroform per 2 ml of suspension). 
Membrane Lipid Composition 
MG1655 cells were harvested at midlog, resuspended in 25 mL media with 0-30 
mM C8 pH 7.0 and incubated for 3 hours. The cells were washed twice in cold sterile 
water and split into four tubes. 50 µL of 0.4 mg/mL C13/C19 (tridecanoic 
acid/nonadecanoic acid) in chloroform was added as internal standards. The Bligh and 
Dyer method was adapted for membrane lipid extraction (Bligh and Dyer 1959). Briefly, 
the cells were resuspended in 1.4 mL methanol, sonicated for three, 20 s bursts, and 
incubated at 70 °C for 15 min. The cells were then centrifuged at 5,000 g for 10 min. and 
the supernatant was collected. The cell pellet was further treated with 750 µL chloroform 
and incubated at 37 °C for 5 min. shaking in a horizontal shaker at 150 rpm. A 
methanol:water:chloroform (1.9:1.9:1) ternary mixture was used to phase-separate the 
extracted lipids in the chloroform layer. The free fatty acids were concentrated with a N-
Evap nitrogen tree evaporator (Organomation Associates). The lipids were methylated into 
fatty acid methyl esters (FAMEs) at 80 °C for 30 min. by adding 2 mL 1N hydrochloric 
acid in methanol to samples concentrated under nitrogen, then 1 mL 0.9 % sodium chloride 
solution was added. The FAMEs were extracted with hexane, filtered with a 0.2 µm 
20 
 
polytetrafluoroethylene (PTFE) filter, and analyzed by gas chromatograph-flame ionization 
detector/mass spectrometer (GC-FID/MS) using the following instruments: an Agilent 
7890 gas chromatography, an Agilent 5975 mass spectroscopy, and a Agilent 190915-433 
30m x 0.25mm x 0.25mm column (Agilent Technologies, Santa Clara, CA). The initial 
temperature was set at 50 °C, holding for 1 min., with the following temperature ramp: 20 
°C/min. to 140 °C, 4 °C/min. to 220 °C, and 5 °C/min. to 280 °C with 1 mL/min. helium 
carrier gas. The relative retention factor of C19 was used to adjust the relative amounts of 
the individual fatty acids analyzed (Tvrzická et al. 2002). 
 The saturated:unsaturated ratio (S/U) and weighted-average lipid length 
were calculated as follows: 
    𝑆:𝑈 = !!":!!!!":!!!!":!!!!":!!!":!!!!"!"!!!!":!!!!"!"!	  	   	   	   (4)	  
	   𝐿 = !"∗!!":!!!"∗!!":!!!"∗(!!":!!!!":!!!!"!"!)!!"∗ !!":!!!!":!!!!"!"!!!":!!!!":!!!!":!!!!":!!!!"!"!!!!":!!!!":!!!!"!"! 	  	   (5)	  
Hydrophobicity Test 
Unadapted and 30 mM C8 adapted cells were harvested at midlog, centrifuged at 
5,000 g for 20 min. and resuspended in PBS buffer to OD550= 0.591 (1x108 cells/mL). 1.2 
mL cells were added to 2.4 mL hexane as previously described (Zhang et al. 2007). The 
microbial adhesion to hydrocarbons (MATH) value was calculated as previously described 
(Aono and Kobayashi 1997). 
Statistical Analysis 
P-values were obtained by using oneway ANOVA and Tukey-Kramer pairs 
analysis with the JMP v/8.02. statistical program (SAS Institute, Cary, NC). The statistical 
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significance of the linear regression estimates of the weight-average lipid length was 
performed in JMP using the t-test on the intercept and the slope (concentration). 
Results 
Strain Comparison 
It is known that short chain fatty acids are toxic to E. coli (Desbois and Smith 2010; 
Kabara and Marshall 2005; Yang et al. 2010). Here we performed a side-by-side 
comparison of three E. coli strains frequently used for metabolic engineering projects. 
Specifically, we tested and compared for their octanoic acid tolerance (Figure 1a). The C8 
sensitivity was similar for all strains and substrain MG1655 was selected for subsequent 
experiments, given that it is the most well-characterized substrain. 
Specific Growth Rate of MG1655 
The specific growth rate of MG1655 under SCFA stress was determined at a 
variety of concentrations and three chain lengths (Figure 1b). All carbon chain lengths (C6, 
C8, C10) were completely inhibitory by 40 mM, with C10 being completely inhibitory at 
20 mM. While C6 and C8 imposed roughly the same degree of inhibition, C10 was more 
inhibitory than C6 or C8. Thus, there is a slight association between SCFA toxicity and 
SCFA chain length, though not to the degree observed with yeast (Liu et al. 2013).  
It is known that the inhibitory action of free fatty acids on microorganisms is pH-
dependent (Yang et al. 2010). Therefore, the media pH was modulated to quantitatively 
describe the inhibitory behavior on the specific growth rate. In the absence of octanoic 
acid, media pH has a roughly linear impact on the E. coli specific growth rate (Figure 1c). 
However, in the presence of 10 mM C8, the relationship between media pH and E. coli 
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growth changed to a logarithmic decay. Comparing the growth rate to the concentration of 
protonated C8 instead of bulk media pH restores the linear relationship with specific 
growth rate (Figure 1d). This result is consistent with previous reports that the protonated 
form has a greater permeability of the membrane and is therefore more toxic to 
microorganisms. SCFAs are known to cause cell death (Desbois and Smith 2010). 
Therefore, we assessed the cell viability using colony counting and propidium iodide (flow 
cytometry) assays. With the addition of 30 mM C8, 54  ± 26 % of cells remained viable 
based on colony counting assays and 49  ± 12 % remained viable based on propidium 
iodide assays. 
Short-term Adaptation 
The results described above provide insight into the sensitivity of E. coli to SCFA. 
In order to gain insight into the E. coli response to this inhibition, short-term adaptation 
was performed. MG1655 cells were adapted to octanoic acid during three hours of growth 
in the presence of 30 mM C8 at pH 7.0 before inoculation into fresh media and re-
assessing the specific growth rate. The adapted cells had significantly increased C8 
tolerance, as evidenced by their ability to grow faster than the un-adapted cells in the 
presence of 30 and 40 mM C8 and demonstration of slight growth in the presence of 50 
mM C8 (Figure 1e).  
 These results demonstrate that changes that occur during SCFA adaptation 
increase the tolerance of E. coli to the stresses imposed by SCFAs. Identification of these 
changes can provide insight into the mechanism of SCFA toxicity. 
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Membrane Fluidity and Leakage 
Previous studies have concluded that SCFA toxicity is imposed by membrane 
damage (Desbois and Smith 2010; Lennen et al. 2011). We quantified this damage in terms 
of the impact on both membrane fluidity and membrane integrity. Measurements of the 
membrane fluidity and membrane leakage confirm that SCFAs damage the cell membrane 
(Figure 2). As the concentration of octanoic acid increased, the fluorescence polarization 
significantly decreased in unadapted E. coli, corresponding to increased fluidity (Figure 
2a). 
Another indication of a damaged membrane is the membrane porosity, as reflected 
by the amount of intracellular magnesium released. Challenge with 30 mM octanoic acid 
resulted in the release of 46 % more magnesium than the control sample (Figure 2b). 
These results confirm that exogenous SCFA challenge has a significant impact on 
both the fluidity and integrity of E. coli that was grown in the absence of SCFA. However, 
these results do not indicate which of these two effects is the most detrimental to growth or 
if either of these can be mitigated through the adaptive response. Given the fact that a short 
period of adaptation is sufficient to increase the resistance to growth inhibition by SCFAs, 
we repeated the quantification of membrane fluidity and integrity using cells that had 
undergone three hours of SCFA adaptation. 
In contrast to the results seen for the unadapted cells, C8-adapted E. coli were 
significantly more resistant to the fluidizing effects of octanoic acid under the 
concentrations tested (Figure 2a). However, there was not a significant difference in the 
C8-mediated leakage between the adapted and unadapted cells (Figure 2b). 
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These results suggest that during SCFA adaptation, the cell membrane is changed 
in a way that makes it resistant to the fluidizing effects of SCFAs, but not to the type of 
damage that induces a loss of integrity. An understanding of these changes could provide 
insight into both the mechanism of SCFA toxicity and means for increasing tolerance. 
Membrane Lipids 
In order to better understand the changes in the membrane that occur during 
adaptation and lead to maintenance of fluidity, we first quantified the membrane lipid 
composition for E. coli cells either grown in the control condition or adapted for 3 hours to 
a variety of C8 concentrations (Figure 3). As previously observed for bacteria, the 
membrane lipids can change upon environmental perturbations (Di Pasqua et al. 2007; 
Zhang and Rock 2008). 
Interestingly, there was a sharp decrease in C16:1 and an increase C17cyc upon 
addition of 10 mM C8; however, upon further addition of C8, the affect was reversed to 
the control value. The shorter lipids (C12:0 and C14:0) decreased whereas the longer lipids 
increased. The degree of change is apparent in the ratio of saturated to unsaturated lipids 
(S/U ratio) and the weight-averaged lipid length (Figure 3b). The S/U ratio significantly 
decreased and the lipid length significantly increased upon C8 adaptation. This combined 
change of the S/U ratio and the lipid length may be the mechanism behind the maintenance 
of the membrane fluidity.  
Surface Hydrophobicity 
The bacterial cell membrane consists of lipids, proteins, peptidoglycans, and 
lipopolysaccharides (Raetz et al. 2007). In an effort to query the changes occurring during 
SCFA adaptation, we measured the effect of C8 on the surface hydrophobicity of outer 
25 
 
membrane (Figure S1 in the Supplementary Material). The 30 mM C8-adapted E. coli had 
a %MATH value of 5.0 %, which was much lower than unadapted E. coli at 22 %. The 
%MATH value quantifies adhesion to hydrocarbons and thus indicates cell surface 
hydrophobicity. Unadapted E. coli adhered significantly to hydrocarbons, but the 30 mM 
C8-adapted E. coli did not significantly adhere to hydrocarbons. Therefore, C8-adaptation 
can change the surface properties of the E. coli cell. 
Effect of Free Fatty Acid Production on Membrane Integrity 
The work described above analyzes the effect of free fatty acids on the wildtype E. 
coli. Through exogenous supplementation of SCFAs, we have observed that these 
compounds impact the membrane fluidity and leakage of unadapted cells; however, during 
adaptation changes in the membrane composition and hydrophobicity are accompanied by 
increased resistance to the fluidizing effect of these compounds, but not a change in the 
resistance to fatty acid-induced leakiness. However, our ultimate goal is to apply this 
knowledge to fatty acid producing strains, not just strains challenged with exogenous fatty 
acids. Therefore, we tested a recently described fatty acid production strain (San et al. 
2011) for evidence of damaged cell membranes via changes in membrane fluidity and 
integrity (Figure 4). 
Specifically, we studied free fatty acid producing strain, ML103+pXZ18Z 
(Ranganathan et al. 2012). This strain produced a final total fatty acid titer of 0.6 g/L after 
36 h fermentation in MOPS glucose minimal media. The majority of the free fatty acids 
were produced during stationary phase and these were predominantly C14:0 and C16:0. 
Our measurement of membrane fluidity and leakage over the course of the 
fermentation demonstrated that fatty acid production was associated with a dramatic 
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increase the membrane leakage, but not a significant change in membrane fluidity (Figure 
4). Considering that fatty acid production can be considered analogous to adaptation, these 
results are consistent with our exogenous supplementation results. As the E. coli is 
producing free fatty acids in the stationary phase, it is also adapting to its environment by 
changing its membrane. Therefore, the same trends exist between the producer strain and 
the adaptation studies. Specifically, the fluidizing effects of fatty acids can be resisted by 
adaptation, but the fatty acid-induced leakage cannot. Additionally, the fatty acid-induced 
leakage is a problem with fatty acids longer than the model 8-carbon compound that we 
focused on in this study. 
Discussion 
There is not much of a difference in the specific growth rate as the chain length of 
the fatty acid increases from six to eight carbons. The lower solubility of C10 in the media 
may be an exception to the trends shown by C6 and C8 and was not studied further. In our 
system, C10 does not make micelles since it is above the melting temperature (32 °C), 
below the critical micelles concentration (100 mM), and at neutral pH (Cistola et al. 1988). 
Therefore, it is assumed that the protonated C10 has a higher solubility within the 
membrane. The inhibition of C8 was further characterized by adjusting the media pH 
(Figure 1c). Upon addition of C8, the growth inhibition exhibited an exponential decay due 
to a shift in the concentration of the protonated form (Figure 1d).  Our results are in 
agreement with previous reports (Carpenter and Broadbent 2009; Kamp and Hamilton 
2006; Ricke 2003; Russell 1991) that the protonated form is toxic to bacteria cells via 
permeation of the membrane to neutral lipophilic molecules and subsequent accumulation 
within the cell. Additionally, cell viability was measured by colony counting and 
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propidium iodide assays, indicating that some cell death does occur upon addition of 
SCFAs. 
It is known that E. coli cells are dynamic and are able to adapt in stressful 
environments in order to survive. Therefore, we used short-term adaptation to study how 
E. coli can change under SCFA stress. We have shown that adaptation can allow E. coli to 
be more tolerant of SCFAs (Figure 1e) by maintenance of the optimal membrane fluidity 
and possibly by restructuring of the membrane composition and surface properties, such as 
hydrophobicity. 
We have shown that addition of octanoic acid decreases fluorescence polarization, 
which indicates an increase in fluidity (Figure 2a). Our measurements of membrane 
fluidity are in the range previously reported, between 0.28-0.37 (Mykytczuk 2007). 
Membrane disruption is often a cause for toxicity of organic compounds, such as essential 
oils, cellulosic hydolysates, and cyclic hydrocarbons (Di Pasqua et al. 2007; Mills et al. 
2009; Sikkema et al. 1994). Membrane fluidity is one physiological element that can be 
used to quantify membrane damage and study membrane dynamics. Presumably, SCFAs, 
such as octanoic acid, impact the membrane fluidity and integrity due to their partial 
solubility within the membrane (Kamp and Hamilton 2006; Walter and Gutknecht 1984). 
Integration of octanoic acid into the cellular membrane may have an effect of increasing 
fluidity by reducing the hydrophobic interactions of the fatty acid tails as they flow 
laterally and transiently within the lipid bilayer. 
It is known that bacteria are capable of changing their membrane composition in 
response to environmental conditions (Epand and Epand 2009). For example, the fatty acid 
profile of the membrane changes at different growth stages (De Siervo 1969). C8-adapted 
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E. coli changed the membrane lipid composition (Figure 3a), which possibly allows the 
cell to resist the fluidizing effects of SCFAs (Figure 2a). The change in membrane lipid 
composition is characterized by a decrease in the S/U ratio and a significant increase in the 
average lipid length (Figure 3b). Although the change in the average lipid length is small, 
it is significant overall (Table S1 in the Supplementary Material). The lipid profile is 
dominated by C16:0, which accounts for ~50 % of the total lipids. It appears that C8-
adapted E. coli increased C17cyc at the expense of its precursor C16:1 upon the addition of 
10 mM C8. While there was no change in the S/U ratio at 10mM C8 adaptation, the lipid 
length increased. Cyclopropane lipids are often included in S/U ratio calculations as it is 
believed to act similarly to unsaturated lipids (Zhang and Rock 2008). While there are 
many reports of E. coli changing the S/U ratio in response to biofuels or solvents (Huffer et 
al. 2011; Luo et al. 2009), there are few reports of a change in lipid length. Increasing the 
lipid length may increase the membrane lipid bilayer thickness (Lewis and Engelman 
1983; Veld et al. 1991), which was not measured here. Alterations in the membrane 
thickness may also distort curvature and protein conformation, which may disrupt 
membrane protein functions (Engelman 2005; Veld et al. 1991). E. coli can use both the 
S/U ratio and the average lipid length to retain the optimum membrane fluidity. Both an 
increase in the average lipid length and an increase in the S/U ratio can increase the 
packing efficiency of the lipids within the membrane, thereby decreasing the membrane 
fluidity (Mykytczuk et al. 2007). Therefore, an increase in the average lipid length could 
counter-balance the decrease in the S/U ratio to maintain the appropriate membrane 
fluidity. Bacteria cells have an elegant way of dynamically changing the lipid distribution 
in the membrane as a way of controlling the membrane properties. 
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Membrane leakage is a useful indicator of the porosity of the cellular membrane. 
While E. coli naturally uses passive transport for important nutrients, a leaky membrane is 
a costly burden. One of the most important functions of the cell membrane is to selectively 
exclude harmful compounds and retain valuable metabolites. We have shown here that 
octanoic acid significantly disrupts the cellular membrane, allowing intracellular 
metabolites to leak out. Interestingly, leakage caused by octanoic acid addition was 
unaffected by C8-adaptation (Figure 2b), unlike adaptation in yeast as recently reported 
(Liu et al. 2013). Therefore, the E. coli cells do not have an adaptive mechanism to reduce 
membrane leakage. 
If the membrane thickness has increased as an adaptive response to C8 stress, 
presumably there are more opportunities for increasing the membrane porosity by 
changing the natural lipid order.  The extent of what passes through the membrane is 
unknown; another method may be useful for detection of larger biomolecules such as 
nucleotide leakage (Osman and Ingram 1985). Note that magnesium is critical for cellular 
function, including stabilization of the lipopolysacharide layer in the outer membrane, 
folding of nucleic acids, binding of tRNA to amino acids, and participating in more than 
300 enzymatic reactions (Walker 1994). 
Finally, the surface hydrophobicity of unadapted and C8-adapted E. coli was 
studied (Figure S1 in the Supplementary Material). While unadapted E. coli had a 
%MATH value of 22 %, C8-adapted E. coli had a value of only 5.0 %, indicating a 
decrease in cell surface hydrophobicity during adaptation. It is known that changes in the 
lipopolysacharide (LPS) layer of the outer membrane affect the cellular surface 
hydrophobicity (Aono and Kobayashi 1997; Li et al. 2012b). E. coli synthesizing more 
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LPS develop an additional barrier to toxic hydrophobic chemicals. A change in the outer 
membrane permeability is known to aid cellular antibiotic resistance (Delcour 2009); 
therefore, it was not surprising that E. coli modified the cell surface properties in order to 
improve tolerance to SCFAs. 
Monocaprylate inhibition is about four times greater than octanoic acid inhibition 
(Hyldgaard et al. 2012). The difference is possibly due to the chemical structure, where the 
fatty acid is bonded to a glycerol molecule, allowing greater incorporation into the 
membrane bilayer. We suspect that monocaprylate may be acting much the same as free 
fatty acids. Our study of the membrane and how inhibitors such as C8 affect it are in 
agreement with previous studies (Huffer et al. 2011; Hyldgaard et al. 2012). Our study has 
taken further steps to quantify the degree of inhibition, the mode of action, and subsequent 
membrane alterations in a comprehensive report. 
Hyldgaard et al. 2012 showed a morphological change when adding monocaprylate 
antibiotic to E. coli cells. Due to the similar nature of monocaprylate and octanoic acid, C8 
may be changing the cellular morphology. Taken altogether, a change in the membrane 
lipid composition affects the membrane fluidity (Figure 2a), porosity (Figure 2b), transport 
(inferred from (Veld et al. 1991)), surface chemistry (Figure S1 in the Supplementary 
Material), and cellular morphology (inferred from (Hyldgaard et al. 2012; Mykytczuk et al. 
2007)). 
Future studies to address SCFA toxicity could look at ways to alter the membrane 
composition of lipids as well as the surface hydrophobicity in an attempt to mitigate the 
perturbation of membrane properties. It may be that a design strategy for the production of 
SCFAs includes the production of long chain and unsaturated fatty acids for optimal 
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membrane stability. It is possible to engineer the membrane; for example, it has been 
shown that an increase in saturated fatty acids in membrane composition can increase 
ethanol tolerance (Luo et al. 2009). Altering the membrane proteins may be also useful to 
reduce membrane permeability, neutralize fluidizing effects of membrane-soluble 
compounds, or restore protein functions. 
SCFAs are desirable biorenewable chemicals; however, like many interesting 
biorenewable fuels and chemicals, these compounds are inhibitory to E. coli. A current 
challenge in strain engineering is a fast and reliable method for rationally engineering 
biocatalysts for the production of target molecules at industrially relevant yields, titers, and 
productivities. Our framework for studying inhibition and membrane damage may be 
helpful in the engineering design of biocatalysts for production of biorenewable chemicals, 
particularly those with partial solubility in the cell membrane. While this work is aimed at 
SCFAs, it can be applicable to a broad range of potential target biorenewable compounds.  
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Tables 
Table 1: Strains and Plasmids used in this Study 
Strain and plasmid Genotype Reference 
MG1655 ATCC#700926 F- lambda- ilvG- rfb-50 rph-1 Wildtype 
E. coli W ATCC#9637 - Wildtype 
E. coli Crooks 
ATCC#8739 - Wildtype 
ML103 MG1655∆fadD Li et al. (2012a) 
pXZ18Z pTrc99a-acyl thioesterase R. communis-fabZ San et al. (2011) 
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Figures 
Figure 1. SCFAs inhibit the Growth of E. coli, though Adaptation can increase Tolerance 
 
Optical density at 24 h of three E. coli laboratory strains in the presence of octanoic acid.  
 
Specific growth rate of MG1655 as a function of SCFA concentration and chain length. 
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Figure 1 Continued
 
Specific growth rate of MG1655 upon addition of 10 mM C8 as a function of media pH. 
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Figure 1 Continued 
The specific growth rate modeled as a function of the concentration of protonated C8. 
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Figure 1 Continued 
 
Specific growth rate of MG1655 in media of increasing C8 concentrations of MG1655 
after short-term (3 h) adaptation to 30 mM C8. An asterisk indicates a significant 
difference (p-value <0.05, 2-tail t-test) in the growth rate of adapted E. coli from its 
corresponding unadapted E. coli growth rate value at that concentration. All data is the 
average of at least three biological replicates, with error bars indicating standard deviation 
values. 
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Figure 2. Increasing the Concentration of Octanoic Acid increases the membrane Fluidity 
and membrane Leakage; adapted Cells can resist the fluidizing Effect, but not Leakage. 
 
Fluorescence polarization of unadapted MG1655 and 30 mM C8 adapted MG1655 during 
log phase with C8 challenge. The polarization values are unitless. Eight technical replicates 
were averaged. An asterisk indicates significantly different values from the 0 mM control 
and a † indicates significantly different values between adapted cells and unadapted cells 
(p-value <0.05). 
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Figure 2 Continued 
 
Membrane leakage of E. coli in log phase with C8 challenge. The membrane leakage is 
reported as percent relative to the magnesium released during chloroform treatment. Three 
technical replicates were averaged for each treatment for the leakage test. All data is the 
average of at least three biological replicates, with error bars indicating standard deviation 
values. An asterisk indicates significantly different values from the 0 mM control (p-value 
<0.05). The significance test in fluidity and leakage experiments used an all-pairs Tukey-
Kramer HSD comparison. 
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Figure 3. During Adaptation E. coli decreases the saturated/unsaturated Ratio and increases 
the average lipid Length. 
 
Membrane lipid composition of log-phase E. coli cells adapted for 3 h to various 
concentrations of C8. The significance test used an all-pairs Tukey-Kramer HSD 
comparison. C12:0- lauric acid, C14:0- myristic acid, C16:1- palmitoleic acid, C16:0- 
palmitic acid, C17cyc- cyclopropane C17:0, C18:1- vaccenic acid, C18:0- stearic acid. 
  
 
Fig. 3 
a) 
   
b)   
   
0 
10 
20 
30 
40 
50 
60 
C12:0 C14:0 C16:1 C16:0 C17cyc C18:1 C18:0 C19cyc 
M
ol
 %
 m
em
br
an
e 
lip
id
s 
0 mM C8 
10 mM C8 
20 mM C8 
30 mM C8 
*  
* 
* 
* * 
)LJXUH
46 
 
Figure 3 Continued 
 
Mol ratio of saturated to unsaturated fatty acids and the weight-average lipid length after 
adaptation. An asterisk indicates a significant difference from the control (0 mM) point   
(p-value <0.05). The statistical significance of the linear regression estimates of the 
weight-average lipid length and S/U ratio is available in Table S1 in the Supplementary 
Material.  
 
Fig. 3 
a) 
   
b)   
   
0 
10 
20 
30 
40 
50 
60 
C12:0 C14:0 C16:1 C16:0 C17cyc C18:1 C18:0 C19cyc 
M
ol
 %
 m
em
br
an
e 
lip
id
s 
0 mM C8 
10 mM C8 
20 mM C8 
30 mM C8 
*  
* 
* 
* * 
)LJXUH
47 
 
Figure 4. Fatty Acid Production in Strain ML103+pXZ18Z is accompanied by increased 
membrane Leakage but not a Change in membrane Fluidity. 
 
Membrane fluidity as measured by fluorescence polarization and membrane leakage as a 
function of the total fatty acid titer. The data represents the average of two simultaneously-
run fermenters. The error bars indicate the standard deviation. 
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Supplementary Material 
Figure S1. E. coli cells adapted to Octanoic Acid have a less hydrophobic Surface 
compared to unadapted E. coli Cells. 
 
% E. coli cells in the aqueous phase after addition of hexane. An asterisk indicates 
significantly different values from the 0 mM control and a † indicates significantly 
different values between adapted cells and unadapted cells (p-value <0.05). The %MATH 
values are calculated using the % cells in the aqueous phase after the addition of 2.4 mL 
hexane. 
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Table S1. Statistical parameter Estimates on the Line of Fit of the weight-average lipid 
Length and the S/U Ratio as a function of C8 concentration. 
Variable Term Estimate Standard error t ratio Probability > |t| 
Length Intercept 16.072 0.0384 419 < 0.0001* 
Slope 
(concentration) 
0.0064 0.0019 3.38 0.0033* 
S/U Ratio Intercept 1.604 0.0911 17.60 < 0.0001* 
Slope 
(concentration) 
-0.0112 0.0045 -2.49 0.0226* 
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CHAPTER 3 
TRANSCRIPTOMIC ANALYSIS OF CARBOXYLIC ACID CHALLENGE IN 
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Abstract 
Carboxylic acids are an attractive biorenewable chemical. Enormous progress has 
been made in engineering microbes for production of these compounds though titers 
remain lower than desired. Here we used transcriptome analysis of Escherichia coli during 
exogenous challenge with octanoic acid (C8) at pH 7.0. This analysis suggests that C8 
challenge causes intracellular acidification and membrane damage. Network component 
analysis identified transcription factors with altered activity including GadE, the activator 
of the glutamate-dependent acid resistance system (AR2) and Lrp, the amino acid 
biosynthesis regulator. The intracellular acidification was confirmed. We conclude that the 
membrane permeability of carboxylic acids enables acidification of the cell interior despite 
maintenance of the media pH at neutral. This is distinct from the action of inorganic acids. 
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This acidification was not observed in a carboxylic acid producing strain, though this may 
be due to lower titers than those used in our exogenous challenge studies. We developed a 
framework for predicting the proton motive force during adaptation to strong inorganic 
acids and carboxylic acids. This model predicts that inorganic acid challenge is mitigated 
by cation accumulation, but the inverted proton motive force imposed by carboxylic acids 
requires anion accumulation. Utilization of native acid resistance systems was not useful in 
terms of supporting growth or alleviating intracellular acidification. AR2 was found to be 
non-functional, possibly due to membrane damage. We proposed that interaction of Lrp 
and C8 resulted in repression of amino acid biosynthesis. However, this hypothesis was not 
supported by perturbation of lrp expression or amino acid supplementation. E. coli strains 
were also engineered for altered cyclopropane fatty acid content in the membrane, which 
had a dramatic effect on membrane properties, though C8 tolerance was not increased. We 
conclude that achieving higher production titers requires circumventing the membrane 
damage. As higher titers are achieved, acidification may become problematic. 
Introduction 
There has been a substantial interest in using microbial fatty acid biosynthesis as a 
platform for a variety of biorenewable chemicals [1-4]. However, there are challenges 
associated with harnessing the fatty acid biosynthesis pathway for producing chemicals at 
industrially relevant titers, productivities, and yields. For example, it has been noted by 
multiple researchers that product toxicity is a major problem for the microbial production 
of carboxylic acids [5-9].  
 Microbial tolerance of inhibitors, either present in the plant-derived feedstock or a 
toxic desired product, is a common problem in the fermentative production of 
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biorenewable fuels and chemicals [10-12]. Knowing the mechanism of inhibition can 
enable rational design strategies for addressing tolerance. Transcriptome analysis is one 
method for identifying these mechanisms [7,10,13,14]. It is relatively well-established that 
one of the major effects of short chain carboxylic acid toxicity is membrane damage, 
largely due to the hydrophobic nature of the carbon chain [15]. It is also well-accepted that 
exogenous challenge with carboxylic acids can cause intracellular acidification, interfering 
with cellular function and imposing an ATP burden [16-19]. Our previous work quantified 
the effect of octanoic acid (C8) on membrane integrity, fluidity, hydrophobicity and 
composition [5] and we concluded that octanoic acid diffuses into the membrane and 
impairs its function. Here we used transcriptomic analysis of exogenous octanoic acid 
challenge to identify and quantify other mechanisms of inhibition, as well as exploring 
strategies for improving tolerance. 
Materials and Methods 
Strains and Growth Conditions 
Escherichia coli strain K-12 MG1655 was obtained from ATCC (Manassas, VA, 
USA) (Table 1). All strains were grown in 25 mL MOPS minimal media [20] with 2 % 
dextrose in 250 mL baffled flasks at 37°C. Overnight cultures were diluted to an optical 
density of 0.05 at 550 nm (OD550) for specific growth measurements and RNA extraction, 
and diluted to 0.1 for intracellular pH, γ-amino butyric acid, and membrane lipid 
composition measurements. 4 M C8 stock solutions were prepared in 100 % ethanol. The 
concentration of ethanol used in these experiments had no significant impact on growth. 
Media with octanoic acid were pH-adjusted to 7.0 with 2 M potassium hydroxide. The 
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specific growth rate was determined by measuring the OD550 during the exponential phase 
as previously described [5]. 
The carboxylic acid production strain, ML103 [21], was obtained by Ka-Yiu San 
(Rice University). This strain was grown in 25mL M9 with 1.5 % dextrose in 250mL 
baffled flasks at 30°C and the appropriate antibiotics and inducers as described below. 
Plasmids 
pJDT1 [22], obtained from Anja Nenninger (University of London), was induced 
by 200 µM L-arabinose and 100 µg/mL ampicillin was used for maintenance. pCA-cfa  
and pCA-lrp [23], obtained from Ramon Gonzalez (Rice University), was induced by 0.5 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 25 µg/mL chloramphenicol was 
used for maintenence. pZS-GFP was cloning using the Gibson Assembly Cloning kit (New 
England Biolabs, Ipswich, MA, USA), with pZS [24] as the backbone and the GFP gene 
from pJDT1. pZS-GFP was induced by using 50 ng/mL anhydrotetracycline (Fisher 
Scientific, Hampton, NH, USA) and 25 µg/mL chloramphenicol was used for maintenance. 
pXZ18Z [25], obtained by Ka-Yiu San (Rice University), was induced by 100 µM IPTG 
and 100 µg/mL ampicillin was used for maintenance (Table 1). 
Transcriptomics Sample Preparation 
E. coli MG1655 was grown to midlog (OD550 ~0.8) with or without 10 mM 
octanoic acid and the RNA was harvested. Three biological replicates were analyzed for 
each condition. Briefly, cells were centrifuged at 5,000 g, 20 min. at 4 ºC and the cell 
pellets were stored in RNA Later solution (Life Technologies, Carlsbad, CA) at -80ºC. 
RNase AWAY solution (Life Technologies) was used to remove contaminating RNase. 
The RNeasy Mini Kit (Qiagen, Venlo, Netherlands) was used to isolate total RNA. The 
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samples were then incubated at 37ºC with RNaseOut (New England Biolabs) and DNaseI 
(New England Biolabs) according to the manufacture’s protocol for 1 hour. The samples 
were mixed with saturated phenol/chloroform (pH=4.5) (Life Technologies) and 
precipitated with ethanol and 30 µL, 3 M sodium acetate (pH=5.5) (Fisher Scientific), 
overnight at -80ºC. After precipitation, the tubes were centrifuged at 16,873 g, 30 min. at 4 
ºC. The RNA pellet was washed twice with 70 % ethanol and dried under vacuum for 30 
min. RNA quality was confirmed on a 1 % TAE gel. The RNA was hybridized to an 
Affymetrix GeneChip E. coli Genome 2.0 Array, from which the sample was prepared 
with the Affymetrix protocols (Affymetrix, Santa Clara, CA) and analyzed on a 
ProScanArray HT Microarray Scanner (Perkin Elmer, Waltham, MA) at the DNA facility 
of Iowa State University Office of Biotechnology. The Affymetrix GeneChip E. coli 
Genome 2.0 Array contains 10,208 probes for genes in four strains of E. coli. The data is 
available in the Gene Expression Omnibus database, accession number:(will be provided). 
Transcriptomic Data Normalization and Analysis 
Background adjustment, normalization, and summarization calculations were 
performed in MATLAB v. R2012b (MathWorks, Natick, MA, USA) using GCRMA [26]. 
Using pooled data, permutation t-tests (10,000 permutations) were performed to identify 
transcripts with statistically significant changes in abundance (q-value < 0.05). 
Additionally, a fold change (log2(treatment/control)) cutoff of ±1 was applied to identify 
genes that demonstrated a significant magnitude of variation between experimental 
conditions. Probes not annotated as MG1655, but orthologous to E. coli strain MG1655 
were included. Probes relating to other species were excluded from analysis. Additionally, 
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overrepresentation of Gene Ontology terms associated with significant transcripts was 
examined and visualized using the Cytoscape tool [27] and BiNGO [28]. 
Transcription Factor Analysis 
The transcription factor analysis was performed using NCA algorithm, and based 
on reconstructed regulatory networks using RegulonDB [29] and the predicted TFA 
information as previously described [30]. 
Intracellular pH Measurements 
E. coli MG1655 carrying the pBad24-TorA-GFPmut3* (pJDT1) plasmid [22] was 
grown in 100mL potassium-modified Luria broth (LBK) [31] media in a 250mL baffled 
flask from OD550 0.05 to midlog (OD550 ~0.8) with 100 µg/mL ampicillin and 200µM L-
arabinose at 37ºC in an orbital incubator shaker at 150rpm. The cells were harvested at 
5,000 g, 4 ºC for 20 min. and resuspended in phosphate buffered saline (pH=7.0) diluted to 
the working concentration (PBS, 10X powder concentrate, Thermo Fisher Scientific, 
Waltham, MA) without a carbon source to an OD500 =0.4. A calibration curve was 
generated using sodium benzoate, according to [32]. E. coli cell suspensions were 
challenged with C8 or HCl and pH-adjusted to 7.0 before measurement. The intracellular 
pH was measured by fluorescence intensity using a Synergy 2 Multi-Mode microplate 
reader from BioTek with sterile black-bottom Nunclon delta surface 96-well plates in the 
W.M. Keck Metabolomics Research Laboratory at Iowa State University. The plates were 
analyzed at 30ºC in 100µL aliquots, using the following filters: excitation filter= 485/20 
nm., emission filter=528/20 nm. 
For the amino acid supplementation studies, MG1655+pJDT1 was grown overnight 
in MOPS media as described above. The cells were harvested at 5,000 g, 4 ºC for 20 min. 
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and resuspended in MOPS with 0.2 mM L-arabinose and incubated at 37 ºC for 3 h with or 
without amino acids (arginine and/or glutamate) and C8 at equimolar concentrations of 10 
mM. The cells were harvested as treated as above to measure the intracellular pH. 
γ-amino Butyric Acid Measurements 
MG1655 was grown to midlog (OD550 ~0.8) as described above with 10 mM C8 
and/or 10 mM glutamate added to the growth media. Measurement of γ-amino butyric acid 
was performed according established protocols [33,34]. All chemicals for this assay were 
purchased from Sigma-Aldrich, St. Louis, MO. Clear UV-transparent microplates were 
purchased from Corning (Corning, NY). 
Membrane Lipids Analysis 
The protocol was performed according to [5]. Briefly, cells were grown to midlog 
(OD550 ~0.8) as described above, harvested at 5,000 g, 4 ºC for 20 min, and then 
challenged with different concentrations of C8 for 3h in MOPS pH 7.0 with 2% dextrose. 
After challenge, the cells were harvested for membrane lipid analysis. 
Proton Motive Force Simulations 
The total electrochemical force was used to calculate the proton motive force 
(PMF): 
ψΔΔ += FFPMF pH      (1) 
and the Nernst potential was used to calculate the contributing forces: 
)(3.2 eipH pHpHzF
RTF −=Δ     (2) 
)log(3.2
i
e
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ions
zF
RTF =Δψ     (3) 
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where FΔpH is the electrochemical force-associated pH-gradient, FΔψ is the electrochemical 
force-associated ion-gradient, R is the gas constant, T is the temperature, z is the molar ion 
charge, and F is Faraday’s constant. Intracellular and extracellular ion abundances are 
represented by ionsi and ionse, respectively. Use of these equations have been previously 
reviewed [35,36]. 
Statistical Analysis 
The p-values were obtained using one-way ANOVA and Tukey-Kramer pairs 
analysis with the JMP v/8.02 statistical program (SAS Institute, Cary, NC, USA). We used 
a p-value cutoff of 0.05 to determine significance. In the amino acid supplementation 
survey, we applied the Bonferroni correction factor and adjusted the p-value cutoff to 
0.0025. 
Results and Discussion 
Transcriptome Analysis highlights the Activation of Acid Resistance Systems 
The information gained by transcriptome analysis is valuable in many applications, 
especially in the area of tolerance for biorenewable chemicals production. Tolerance is a 
complex phenotype that covers a diverse space in the bacterial genome [37]. For this 
reason, transcriptomics is a critical tool that allows for a global measurement of the cellular 
response network of stressors, such as challenge with carboxylic acids. Therefore, we 
performed transcriptome analysis of E. coli MG1655 during mid-log growth in MOPS 
minimal media with and without 10 mM octanoic acid, where octanoic acid serves as a 
representative carboxylic acid. Both cultures had an initial pH of 7.0; 10 mM C8 is 
sufficient to inhibit growth in this condition by 23% [5]. 
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Table 2 lists all significantly perturbed genes (q< 0.05) with at least a 2-fold change 
in response to C8 challenge. The data is also presented graphically in Figure S1 with log2 
fold changes. Similarly, Table 3 lists all transcription factors with significantly perturbed 
(p <0.05) regulatory activity, as determined by network component analysis (NCA). 
Many of the genes with increased expression in response to C8 challenge are 
related to acid response, response to and regulation of pH, and biofilm formation. Genes 
with decreased expression are predominantly attributed to chemotaxis, reduced motility, 
and flagellum assembly. Several genes associated with membrane function and integrity, 
such as bhsA and cpxP were also perturbed, where some had increased expression in 
response to C8 (e.g., cfa) and some had decreased expression (e.g., ompF).  
Similarly, many of the perturbed regulators are also associated with acid response 
and membrane damage. Most notably, GadE regulates various acid response systems and 
is primarily controlled at the transcriptional level in response to pH, as previously 
reviewed [35]. RcsB is known for both association with capsule biosynthesis [38] and acid 
resistance [39,40]. It is known that RcsB activity is regulated by membrane-associated 
partner proteins in response to a variety of extracellular signals [38] and is required for 
maintaining the appropriate cell shape [41]. RcsB also regulates motility in an H-NS-
dependent manner, which could possibly explain the decrease in motility [40]. SoxS 
activation, while not a direct response to acids or membrane integrity, is most likely due to 
superoxide production as an effect of membrane damage, as previously reviewed [9].  
Activation of Lrp in response to carboxylic acid challenge has been previously 
described [42]. Specifically, it was reported that the 4-carbon carboxylic acid butyrate 
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binds to Lrp in a manner that mimics leucine. Therefore, it is possible that a similar 
interaction occurs with octanoic acid, resulting in activation of Lrp during C8 challenge. 
The PutA protein shifts between a cytosolic, DNA-binding form and a membrane-
associated metabolic enzyme [43,44]. The switch to the membrane form is dependent upon 
the availability of proline and FAD; the membrane-associated form then converts proline 
into glutamate [43]. The abundance of the putA transcript is not changed in our dataset. 
The observed decrease in PutA TFA therefore suggests that the pool of PutA enzymes 
shifted from the cytosolic form to the membrane-associated form, suggesting an increase in 
proline and/or FAD availability. This potential effect is discussed further below. The putA 
gene is also transcriptionally activated by the multiple antibiotic resistance regulator MarA, 
which is also activated in our transcriptome data [45].  
FruR and MalT are both responsive to metabolites in the early steps of glycolysis. 
FruR DNA-binding activity is decreased by the metabolites fructose-1-phosphate and 
fructose-1,6-phosphate [46]; decreasing FruR activity suggests increased abundance of one 
or both of these metabolites. MalT is the regulator specific to catabolism of maltose, 
maltotriose, and starch containing maltose sugars [47]. Several factors may be involved in 
the activation of MalT. Intriguingly, MalT activity can be stimulated by increased 
intracellular maltotriose [48]. This maltotriose can be produced from unphosphorylated 
intracellular glucose [48]. This unphosphorylated glucose could come from glycogen or 
possibly enter through the damaged cellular membrane; we have previously quantified this 
membrane “leakiness” using Mg2+ as a reporter molecule [5]. There are other potential 
sources of unphosphorylated glucose, such as the galactose transporter [48]. 
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Two of the most often cited means of carboxylic acid toxicity are intracellular 
acidification and membrane damage [18], and many of the genes and regulators perturbed 
in our dataset can be attributed to these two effects. Membrane damage in this condition 
has recently been quantified [5]. However, the acidification effect remains relatively 
under-characterized. 
Octanoic Acid lowers the Intracellular pH 
We used a pH-dependent modified green fluorescent protein [32] to verify and 
quantify the acidification effect of carboxylic acid challenge at neutral pH. We used the 
familiar example of HCl challenge as a positive control for this system. Addition of 20mM 
HCl without readjusting media pH leads to a severe decrease in intracellular pH to 5.32 
(Figure 2). As expected, adjustment of media pH back to neutral after addition of HCl is 
associated with the appropriate near-neutral intracellular pH. Contrastingly, addition of 10 
or 20 mM C8, even with adjustment of media pH to 7.0, results in a significant (p<0.05) 
and dose-dependent drop in intracellular pH (Figure 2). This data not only confirms the 
acidification effect of C8 challenge in neutral media, but also quantifies this effect.  
This acidification is consistent with the known permeability of the cell membrane 
by the neutral protonated form of octanoic acid. Once this neutral form permeates the cell 
membrane, it is able to deprotonate inside the cell and thereby decrease the intracellular pH 
[5]. Normally, the intracellular pH is slightly basic in order to maintain proper membrane 
transport properties in a neutral pH environment. E. coli uses this pH gradient as a means 
of nutrient transport into and waste transport out of the cell. The pKa of C8 is 4.89 [49]; at 
pH 7.0; the unprotonated form is dominant in the bulk media. The protonated C8 is able to 
permeate the cell membrane [16,18,50] and release the proton into the cell, disrupting the 
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pH gradient. In contrast, HCl is a strong inorganic acid lacking the membrane permeability 
displayed by the largely hydrophobic carboxylic acid. Thus, HCl is able to pass through 
the cell membrane only via membrane channels (i.e., ion exchange porins) and proton 
pumps (e.g., ATPase) [51]. Given these differences, it is unclear if the acid resistance 
strategies thoroughly described in the literature [35] will also apply to carboxylic acids.  
These results highlight the challenge of working with carboxylic acids, as opposed 
to strong inorganic acids. The membrane permeability of these carboxylic acids interferes 
with the ability to control intracellular pH within the appropriate range of 6.0-7.5 [52]. 
Traditional fermentation systems enable maintenance of appropriate media pH, but it is the 
intracellular pH that impacts productivity. Thus, strategies are needed to combat this 
acidification effect in order to maintain biocatalyst functionality. 
Native Acid Resistance Systems are Ineffective in Combatting Carboxylic Acid Stress 
Bacterial acid resistance systems have been previously characterized [35]. 
Specifically there are four known acid resistance systems in E. coli. Two of these, acid 
resistance system 1 (AR1 - hdeAB operon and hdeD) and acid resistance system 2 (AR2 - 
gad system) all have significantly increased expression in our C8 challenge dataset. Since 
AR2 is the better characterized [53,54] of the two, we chose this system as the basis for our 
attempts to enable increased carboxylic acid tolerance. 
AR2 functions by using glutamate as a sink for excess protons, resulting in 
production of γ-amino butyric acid (GABA) [35,54]. The fact that the genes encoding this 
system had increased expression during C8 challenge suggests that E. coli is trying to use 
this system in our condition. This drive to use the glutamate-dependent acid resistance 
system could explain the observed perturbation of the PutA regulator. AR2 relies on 
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extracellular glutamate for full functionality and thus may have limited effectiveness in our 
minimal media condition. For this reason, we tested the effectiveness of glutamate 
supplementation in mitigating both the inhibition of growth and intracellular acidification 
mediated by octanoic acid. 
Supplementation with 10, 20 or 30 mM glutamate was not effective in increasing 
tolerance to 10, 20 or 30 mM C8 at neutral pH respectively (unpublished data). Glutamate 
supplementation was also not effective at mitigating the acidification effect (Figure 3). 
Note that the acidification effect presented in Figure 3 is more severe than that shown in 
Figure 2; this is due to the fact that cells queried in Figure 2 were characterized 
immediately after C8 addition while cells queried in Figure 3 were incubated in the 
presence of C8 for 3 hours giving the opportunity to use the AR2 system. Note that a pH of 
5.5 is the limit of detection using the GFP method and therefore the actual intracellular pH 
may actually be less than 5.5. We also attempted to utilize acid resistance system 3 (AR3), 
which relies on arginine as a proton sink. However, supplemental arginine was also 
ineffective in combating growth inhibition or acidification (Figure 2). 
The Glutamate-dependent Acid Resistance System is Impaired during Carboxylic Acid 
Challenge 
The lack of protection conferred by the arginine- and glutamate-dependent acid 
resistance systems is surprising, especially considering the fact that the expression of the 
genes encoding the glutamate-dependent system is increased in our dataset. According to 
the current understanding of the AR2 system, one glutamate molecule can be used as a 
sink for one intracellular proton. The arginine-dependent system functions similarly. 
However, neither of these amino acids was able to provide protection in terms of growth or 
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intracellular acidification (Figure 3). To gain insight into this surprising result, we further 
characterized the activity of the AR2 system. 
The product of the proton-dependent glutamate decarboxylation by GadB (GABA), 
was measured as a reporter of the activity of the AR2 system (Figure 4). GABA is 
typically released outside of the cell in order to buffer the intracellular pH to physiological 
levels (~7.4). This export occurs via the GadC antiport in concert with glutamate import. 
Note that cells are also capable of transforming GABA into succinate [54]. Therefore, both 
the internal and external GABA abundance values are meaningful. Internal abundance 
values reflect GadB activity, internal glutamate availability and the relative abundance of 
excess protons. External GABA abundance reflects functionality of the GadC antiporter 
and external glutamate availability. 
We observed that in the control condition, the amounts of intracellular and 
extracellular GABA are relatively equal. While previous studies have measured GABA 
abundance in Listeria [55], Corynebacterium [56], Lactobacillus [34] and E. coli [57], to 
the best of our knowledge, ours are the first reported measurements for E. coli that 
document steady-state log-phase intracellular and extracellular GABA concentrations. 
When supplemental glutamate is added to the control condition, secretion of GABA 
is increased, though the total amount of GABA remains unchanged relative to the 
unsupplemented control. This lack of change in the total GABA amount is consistent with 
the lack of excess protons that need to be removed from the cell interior. 
We have already described the fact that addition of 10mM C8 to the media while 
maintaining a neutral media pH both impedes growth [5] and severely acidifies the cell 
interior, with or without provision of 10mM supplemental glutamate (Figure 3). For the 
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cells challenged with C8 in the absence of glutamate, there was a decrease in intracellular, 
extracellular and total GABA. For the cells provided with supplemental glutamate during 
C8 challenge, there was also a decrease in all types of GABA relative to the 
unsupplemented control. This lack of perturbation to the GABA pools is surprising, given 
the known excess of intracellular protons in the +C8 condition. Under appropriate 
functioning, the GadB/GadC system should be producing and exporting GABA as a proton 
sink. However, this system is apparently not functioning during carboxylic acid challenge. 
This lack of function could possibly be attributed to another well-accepted 
mechanism of carboxylic acid toxicity: membrane damage. Both GadB and GadC have 
some degree of membrane-associated function [53]. The damage caused to the cell 
membrane by carboxylic acids can result in impaired function of this system, even when 
the enzymes and the system precursors, glutamate and excess protons, are abundant. This 
again highlights the differences in mitigating tolerance to carboxylic acids and strong 
acids. 
Intracellular Acidification is less severe during Carboxylic Acid Production 
Many of the studies of carboxylic acid tolerance are motivated by a desire to 
produce carboxylic acids at a high titer [9]. Note that some studies are instead motivated by 
the use of carboxylic acids as food preservatives [58]. The data described above quantifies 
the intracellular acidification of E. coli during exogenous challenge with octanoic acid. 
However, this response to exogenous challenge does not necessarily correlate to the 
physiological effects of carboxylic acid production. Therefore, we quantified the 
intracellular pH during production of carboxylic acids, using a strain that produces a 
mixture of C14:0 and C16:0 to a titer of roughly 4 mM in minimal media (Figure 5) [21]. 
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Note that this is the same strain for which we observed decreased membrane integrity as 
product titers increased [5]. 
While intracellular pH values were observed at or below our reliable detection limit 
of 5.5 during long-term challenge with octanoic acid (Figure 3), intracellular pH values 
during carboxylic acid production were above 6.5 (Figure 5). E. coli K-12 is generally able 
to maintain an intracellular pH of 7.6+0.2 when grown in media with a pH between 6.0 and 
7.5, as controlled by the addition of ionic buffering agents [59]. Outside of this range, 
growth is still observed at pH values between 4.5 and 9.0 [59], though growth is inhibited 
if intracellular pH falls below 7.1 [52]. It has been noted that E. coli does not grow if the 
intracellular pH falls below 6.0 [52]. It is also worth noting that similar intracellular pH 
values were observed in our control strain, in which transcription of the thioesterase 
responsible for cleaving the elongating fatty acids was not induced. 
This data suggests that unlike carboxylic acid challenge, carboxylic acid production 
does not result in intracellular acidification. However, the difference in concentration of 
carboxylic acids may be the main factor responsible for this difference. Our exogenous 
challenge studies were performed with 10 or 20 mM C8, but the carboxylic acid 
production strain does not exceed titers of 5 mM. The lack of intracellular acidification 
during carboxylic acid production could also be due to metabolic effects, as discussed 
below.  
Cyclopropane Fatty Acids as a Protectant to low pH 
As described above, membrane damage has been previously cited and quantified as 
a mechanism of biocatalyst inhibition by carboxylic acids [5,6]. Genes and regulators 
related to membrane damage were perturbed in our transcriptome data. We have also 
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proposed that membrane damage is the reason for poor functioning of the glutamate-
dependent acid resistance system. Previous engineering efforts for increasing carboxylic 
acid tolerance in E. coli have focused on increasing the relative content of saturated lipids 
in the cell membrane [60]. These efforts were successful in increasing tolerance to 
carboxylic acids, but not increasing carboxylic acid production.  
Given that increased membrane permeability (leakage) is a likely mechanism of 
carboxylic toxicity, it is appealing to implement genetic modifications that increase 
membrane integrity. Cyclopropane fatty acids are known to have increased bulk in the cell 
membrane relative to saturated fatty acids [61]. Additionally, cyclopropane fatty acids 
have been well-documented in the role in conferring resistance in acidic environments 
[62]. Considering the fact that E. coli inhibition by carboxylic acids is associated with both 
membrane damage and induction of the acid response, we proposed that increasing the 
abundance of these cyclopropane fatty acids in the cell membrane could serve as a method 
of increasing carboxylic acid tolerance.  
The role of cyclopropane fatty acids in carboxylic acid tolerance was investigated 
using mutants either completely deficient in cyclopropane fatty acid production (Δcfa) or 
engineered for increased expression of the Cfa enzyme (cfa++). Note that Cfa is 
responsible for the S-adenosyl-L-methionine (SAM)-dependent methylation of unsaturated 
membrane lipids [63]. No cyclopropane fatty acids were observed in our Δcfa mutant 
(Figure 6a). Strains with increased cfa expression contained more than 32 mol % 
cyclopropane fatty acids while less than 11 mol % were observed during growth in the 
wildtype strain in the control condition (Figure 6a).  
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Despite this substantial change in cyclopropane fatty acid content in the cell 
membrane, there was not an observed increase in C8 tolerance (Figure 6a inset) and no 
change in leakage or fluidity (unpublished data). In fact, strains with the highest 
cyclopropane fatty acid content actually showed significantly (p < 0.05) increased 
sensitivity to C8 (Figure 6a inset).  
Despite the lack of impact on carboxylic acid tolerance, the data obtained in these 
experiments provides interesting trends in control of membrane composition. We observed 
previously that when challenged with C8, E. coli undergoes a dose-dependent, statistically 
significant decrease in the molar ratio of saturated (i.e,. C16:0) and unsaturated (i.e. C16:1 
and C17cyc) membrane lipids (S/U ratio) [5]. Cells deficient in cyclopropane fatty acid 
production have a saturated:unsaturated ratio in the control condition that is significantly 
lower than the wildtype strain (Figure 6b). However, as the C8 concentration increases, the 
S/U ratio in the Δcfa strain approaches the S/U ratio observed in the wildtype strain. 
Contrastingly, cells with increased cyclopropane fatty acid content (cfa++) show a similar 
S/U ratio as the wildtype strain in the control condition, but when C8 is added at increasing 
concentration, the observed S/U ratio is increased more than 2-fold relative to the wildtype 
(Figure 6b). Similar patterns were observed during growth sensitivity measurements. As 
the C8 concentration increases, the Δcfa strain shows growth rates increasingly similar to 
the wildtype strain, while the cfa++ strain diverges from the wildtype (Figure 6a inset). 
Another metric for assessing membrane composition is average lipid length. We 
previously reported that during growth in the presence of C8, the average lipid length 
increased in a significant, dose-dependent manner [5]. Cells with increased expression of 
cfa are able to maintain the same average lipid length as the wildtype in the control 
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condition, but in the presence of C8 the lipid length decreases (Figure 6c). This decrease in 
average lipid length represents a shift from lipids with an 18-carbon chain (C18:0, C18:1, 
C19cyc) to lipids with a 16-carbon chain (C16:0, C16:1 and C17cyc). Contrastingly, the 
Δcfa strain followed the wildtype trend by significantly increasing the average lipid length. 
This was accomplished by decreasing 16:1 and increasing C18:1 (Figure 6a). 
Thus, separation of cfa expression from the wildtype control circuits impacts not 
only the saturated:unsaturated fatty acid ratio, but also the average lipid length. This 
highlights the potential importance of Cfa and cyclopropane fatty acids in maintaining 
appropriate membrane properties. 
Interaction of Lrp and Octanoic Acid does not contribute to C8-mediated growth Inhibition 
 It has been previously noted that small carboxylic acids can interact with the global 
regulator Lrp in a manner than mimics its standard cofactor, leucine [42]. Thus, it is 
possible that the observed activation of Lrp in our dataset was caused by interaction of Lrp 
and octanoic acid. Lrp is a global regulator, primarily of amino acid biosynthesis [64] and 
its activation by a false signal, such as octanoate, could result in inappropriate repression 
of biosynthesis-associated genes, resulting in growth inhibition. 
We tested the octanoic acid tolerance of both an lrp deletion mutant and a strain 
engineered for increased expression of lrp. However, consistent with previous reports [64], 
the deletion mutant grew poorly in our minimal media growth condition and data regarding 
carboxylic acid sensitivity was ambiguous (Figure 7). Specifically, the overall growth rate 
was decreased relative to the wildtype at all C8 concentrations tested, but the relative 
sensitivity to C8 did not appear to be altered. Similar trends were observed for the strain 
engineered for increased lrp expression (Figure 7). 
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We proposed that this difficulty in establishing the role of the potential C8-Lrp 
interaction in C8 tolerance is due to the global regulatory role of Lrp. If C8 is truly serving 
as a false signal for controlling Lrp activity, this is most likely to impact growth in the 
form of inappropriate repression of amino acid biosynthesis. Therefore, we tested each of 
the individual amino acids, as well as a mixture of biosynthetic building blocks in the form 
of casamino acids, for their ability to confer tolerance to C8. If one or more of these amino 
acids is limiting during growth in the presence of C8, supplementation with these amino 
acids should increase C8 tolerance. However, none of the individual amino acid 
supplements or supplemental casamino acids enabled significantly increased growth in the 
presence of 10 mM C8 relative to the unsupplemented condition (unpublished data). It 
should also be noted that none of these supplements significantly inhibited growth in the 
non-C8 condition. 
Therefore, even if there is a significant interaction between octanoic acid and Lrp, 
this interaction does not appear to be contributing to C8-mediated growth inhibition in our 
condition. 
Octanoic Acid causes Inversion of the pH Gradient leading to Anion Accumulation in 
order to maintain the Proton Motive Force 
 While it does not appear at this point that intracellular acidification is a significant 
challenge for carboxylic acid production, that perspective may change as we attain higher 
carboxylic acid titers. Given the qualitative differences observed between challenge with 
strong inorganic acids and carboxylic acids, we have applied a quantitative modeling 
approach to identifying additional differences between these two types of acids. 
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The proton motive force (PMF, typically expressed in mV) is a function of both the 
difference in intracellular and extracellular pH values (∆pH) and differences in internal and 
external electrochemical charge (membrane potential, Δψ) as shown above in equation (1). 
Figure 8 shows simulations of the pH gradients, membrane potential, and the 
resultant PMF under different environmental conditions. When cells are shocked with an 
inorganic acid, such as HCl, the PMF becomes larger than normal and protons initially 
overwhelm the cell interior. But after a period of adaptation, accumulation of cations can 
enable reversion of the PMF back to the physiological range, even though the intracellular 
pH in the adapted state is decreased relative to the original intracellular pH. Such cation 
accumulation, in the form of potassium, has been previously described for E. coli K-12 
[17]. This cation accumulation will lead to a change in the transmembrane potential (Δψ) 
that contributes to stabilization of the PMF. This stabilization of the PMF creates 
hyperpolarization of the membrane, as evidenced by very large ΔpH and Δψ values. This 
hyperpolarization can be mediated by the release of chloride anions through voltage-gated 
channels as discussed in the literature [35,57,65,66]. This sort of change in Δψ from 
negative to positive during challenge with inorganic acids has been previously described 
[65]. 
Given the ability of our model to accurately describe the E. coli response to 
inorganic acids, here we have applied this model to carboxylic acid challenge. When cells 
are shocked with carboxylic acids while maintaining a neutral extracellular pH, the ΔpH 
value is actually inverted. This inversion of ΔpH results in a transient inversion in PMF. In 
order to return to the viable PMF range and appropriate directionality, cells must 
accumulate intracellular anions, as opposed to the cations accumulated after challenge with 
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inorganic acids. Our model predicts that this anion accumulation will increase the 
intracellular anion pool by 3-fold. This anion accumulation in response to carboxylic acid 
challenge, as opposed to the cation accumulation seen with inorganic acids, is consistent 
with literature reports. For example, when E. coli O157:H7 was treated with sufficient 
external acetate to drop the intracellular pH to below 6.5 while maintaining a constant 
media pH of 5.9, the amount of intracellular acetate increased 3-fold while intracellular 
potassium levels remained relatively constant [17]. 
Thus, physiological changes that enable maintenance of the appropriate PMF differ 
between carboxylic acids and inorganic acids. Specifically, our model predicts that 
challenge with carboxylic acids will result in a transient inversion of the proton motive 
force. Note that E. coli K-12 normally maintains a PMF in the range of -140 to -180 mV 
[35]. 
Conclusions 
While transcriptome analysis is informative about the cellular response network 
(Figure 1 and Table 2) during challenge with an inhibitor such as octanoic acid, here we 
have supported these findings with other data that quantitatively describe the physiological 
state of the cell. We have confirmed that octanoic acid acidifies the cytosol of the E. coli 
cell (Figure 2). Our analysis predicts that this acidification inverts the proton gradient and 
substantially changes the PMF (Figure 8). Such a change alters the physiological state of 
the cell in a way that is fundamentally different from inorganic acids such as HCl. Whereas 
adaptation to HCl includes accumulation of intracellular cations, organic acid stress 
adaptation includes accumulation of anions in order to revert the PMF to the appropriate 
range and directionality. Our simulations could be confirmed in future experiments by 
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measuring the intracellular pH, extracellular pH, the transmembrane potential, and 
intracellular ion concentrations. 
We have previously described the negative effects of octanoic acid on the cellular 
membrane of E. coli [5]. Here we have further explored the effect of octanoic acid on 
membrane proteins such as those associated with acid resistance (Figure 4). While 
supplementing E. coli with glutamate aids in export of the decarboxylation product GABA, 
it does not support the glutamate-dependent acid resistance system under octanoic acid 
stress (Figure 3 and Figure 4). We proposed that this system is defective during octanoic 
acid challenge due to membrane damage. 
It is known that cyclopropane fatty acids aid in tolerance of acid stress, presumably 
by slowing the transport of protons into the cell [62,63]. Here we have noted that Cfa is 
involved with complex control of membrane properties, including the 
saturated:unsaturated lipid ratio and the average lipid length. The effect of Cfa on the 
membrane properties is reflected to the specific growth rate. Our efforts to engineer the 
membrane in order to confer carboxylic acid tolerance suggests that precise control of the 
membrane is required for sufficient growth, similar to the conclusions of other researchers 
[60]. 
It was reported previously that both exogenous addition and intracellular 
production of carboxylic acids causes disruption of the membrane [5]. Here we report the 
differences in how carboxylic acids affect the intracellular pH. While exogenous addition 
of carboxylic acids causes a significant drop in the intracellular pH, intracellular 
production of carboxylic acids do not. However, the production strains achieve a much 
lower titer than the concentrations used in our exogenous challenge studies. It may be that 
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the acidification effect may not become significant in carboxylic acid production strains 
until higher product titers are achieved. Another potentially-important aspect of carboxylic 
acid production relates to the distribution of these acids between the protonated and 
anionic forms within the cell interior. The protonated carboxylic acids can more easily 
diffuse through the cell membrane than the anionic form [67]. 
A buildup of intracellular anionic carboxylic acids will shift the equilibrium to the 
protonated form. The neutral lipophilic fatty acids will then diffuse through the membrane, 
where it can disassociate, assuming that the media pH is greater than the pKa of the fatty 
acid.  
These results highlight the ability of transcriptome analysis to guide quantitative 
experiments in establishing the mechanisms of toxicity of various inhibitory compounds. 
These mechanisms of toxicity can differ depending on whether the inhibitor is provided 
exogenously or produced by the cell. Thus, testing of proposed hypotheses in engineered 
strains is helpful in prioritizing engineering strategies. At this point, it still appears that 
membrane damage is the most pressing issue limiting carboxylic acid production. 
Strategies that enable increased membrane integrity may enable increased carboxylic acid 
production titers, so that intracellular acidification becomes problematic. 
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Tables 
Table 1. Strains and Plasmids used in this Study 
Strain and plasmids Genotype Reference 
MG1655 ATCC#700926 F- lambda- ilvG- rfb-50 rph-1 Wildtype 
ML103 MG1655ΔfadD [21] 
∆cfa MG1655∆cfa This reference 
cfa++ MG1655+pCA-cfa [23] 
∆lrp MG1655∆lrp This reference 
lrp++ MG1655+pCA-lrp [23] 
pJDT1 pBad24-TorA-GFPmut3* [22] 
pXZ18Z pTrc99a-acyl Thioesterase 
R. communis-fabZ 
[25] 
pZS-GFP pZS-TorA-GFPmut3*  [24] and this reference 
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Table 2. Differentially expressed Genes under C8 Stress highlight the Acid Resistance 
Fitness Island. 
Expression ratio for genes significantly perturbed (q < 0.05) at least 2-fold are 
reported as increased abundance (+) or decreased abundance (-). Probes not annotated as 
MG1655, but are homologous to other E. coli strains, are annotated as either CFT073 or 
EDL933, with the corresponding c-number or Z-number, respectively. The table is sorted 
by the magnitude of the expression ratio and the function categories are derived from the 
Ecocyc database [68]. Abbreviations: AR1- acid resistance system 1; AR2- glutamate-
dependent acid resistance system 2; OMP- outer membrane protein; IMP- inner membrane 
protein; TA- transcriptional activator; TR- transcriptional regulator; SP- stationary phase; 
SR- stress response. 
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Table 2 Continued 
b # Gene q-value Fold 
change 
Function 
b1493 gadB 0.000 25.3 AR2 decarboxylase 
b3509 hdeB 0.000 21.1 AR1 chaperone protein 
b3238 yhcN 0.002 15.2 Acid response 
b3510 hdeA 0.000 13.7 AR1 chaperone protein 
b4439 micF 0.003 11.9 Antisense RNA regulator of OmpF porin 
b3512 gadE 0.004 10.1 TA of AR2 
b1492 gadC 0.000 9.3 AR2 antiporter 
b3511 hdeD 0.001 8.7 AR1 
b1480 sra 0.001 5.1 SP component of the 30S ribosomal subunit 
b3508 yhiD 0.001 4.5 density-dependent acid resistance 
b0812 dps 0.004 
4.4 
DNA-binding, iron-collecting, oxidative damage 
protection/repair 
b3517 gadA 0.003 4.4 AR2 decarboxylase 
b0485 ybaS 0.007 4.1 Glutaminase- acid shock inducible 
b1531 marA 0.002 
3.9 
Multiple antibiotic resistance TR- organic solvents, 
oxidative stress 
b2013 yeeE 0.009 3.8 Resistance to the DNA-damage 
b0287 yagU 0.003 3.5 IMP- acid resistance 
b1165 ymgA 0.002 3.5 Biofilm formation- rapid acid treatment 
b3516 gadX 0.001 3.5 AR2 TR 
b1112 bhsA 0.002 3.3 Influencing biofilm through hydrophobicity and SR 
b2012 yeeD 0.010 3.0 Uncharacterized 
b1164 ycgZ 0.006 2.9 Cold shock stimulon  
b4554 
(c4419) 
yibT 0.001 
2.8 
Uncharacterized 
b0814 ompX 0.004 2.8 Acid-induced OMP 
b4376 osmY 0.001 2.8 Hyperosmotic stress 
b3405 ompR 0.013 2.7 OMP TR 
b3515 gadW 0.026 2.6 AR2 TR 
b2924 mscS 0.001 
2.4 
IMP mechanosensitive (MS) channel; non-specific 
transporter 
b0850 ybjC 0.003 2.4 marA/SoxS induced 
b3024 ygiW 0.004 2.4 IMP transporter, SR 
b0775 
(c0855) 
bioB 0.018 
2.3 
SAM-dependent biotin synthase 
b2425 cysP 0.020 2.2 IMP Sulfate transporter 
b1661 cfa 0.010 2.1 Cyclopropane fatty acid synthase 
b3160 yhbW 0.000 2.0 Monooxygenase 
b4077 gltP 0.024 2.0 Glutamate and aspartate transporter 
b3458 livK 0.005 -2.0 leucine transporter 
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Table 2 Continued 
b # Gene q-value Fold 
change 
Function 
b1194 ycgR 0.002 -2.0 Flagellar motility 
b1887 cheW 0.003 -2.0 Flagellar motors 
b4484 cpxP 0.038 -2.1 TR, SR of cell envelope 
b1075 flgD 0.009 -2.2 Flagella 
b1941 fliI 0.007 -2.2 Flagellar export 
b0455 ffs 0.035 -2.2 RNA, membrane protein assembly 
b1942 fliJ 0.002 -2.5 Flagellar export 
b1946 fliN 0.012 -2.5 Flagellar motor 
b1921 fliZ 0.005 -2.5 TR flagella 
b1922 fliA 0.000 -2.6 Flagella; sigma F factor 
b1884 cheR 0.001 -2.8 Chemotaxis sensory transduction system 
b1072 flgA 0.002 -3.0 Flagella assembly 
b1742 
(Z2774) 
ves 0.010 
-3.0 
Cold shock stimulon  
b1939 fliG 0.001 -3.2 Flagellar motor 
b1945 fliM 0.000 -3.2 Flagellar motor 
b1881 cheZ 0.012 -3.3 Chemotaxis sensory transduction system 
b1078 flgG 0.024 -3.3 Flagellar motor 
b4355 tsr 0.004 -3.4 Chemotaxis proteins 
b1073 flgB 0.002 -3.4 Flagellar motor 
b1937 fliE 0.005 -3.5 Flagella 
b1076 
(Z1714) 
flgE 0.007 
-3.6 
Flagellar motor 
b0557 
(Z1878) 
borD 0.001 
-3.7 
Magnesium stimulon 
b1938 fliF 0.005 -3.7 Flagella 
b1888 cheA 0.015 -3.7 chemotaxis protein 
b1947 fliO 0.013 -3.8 Flagellar export 
b1925 fliS 0.002 -3.8 Flagellar export 
b1882 cheY 0.003 -3.9 Chemotaxis response regulator 
b1071 flgM 0.001 -3.9 Flagella 
b3525 yhjH 0.003 -3.9 flagellar motility 
b1940 
(c2357) 
fliH 0.001 
-3.9 
flagella ATPase inhibitor 
b1074 flgC 0.001 -4.0 Flagellar motor 
b1944 fliL 0.000 -4.1 Flagella 
b1943 fliK 0.001 -4.3 Flagellar export 
b1886 tar 0.005 -4.3 Aspartate chemoreceptor 
b1924 fliD 0.013 -4.4 Flagella 
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Table 2 Continued 
b # Gene q-value Fold 
change 
Function 
b1889 motB 0.004 -4.5 Flagellar motor 
b1070 flgN 0.000 -5.1 Flagellar export 
b1923 fliC 0.003 -5.4 Flagella 
b1076 flgE 0.004 -5.8 Flagellar motor 
b1890 motA 0.000 -6.0 Flagellar motor 
b1566 flxA 0.000 -6.3 Prophage 
b1083 flgL 0.002 -9.3 Flagella 
b0929 ompF 0.000 
-16.0 
Transport of sugars, ions, and amino acids <600 
daltons 
b0553 nmpC 0.002 -16.3 OMP porin associated with the peptidoglycan 
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Table 3. Transcription Factor Activities significantly changed 
TFA with a significant change (p <0.05) using NCA algorithm with the RegulonDB 
regulatory links [29]. 
 
Transcription factor ∆TFA Sensing signal 
FruR - Fructose 1-phosphate or Fructose 1,6-phosphate 
GadE + Low pH 
Lrp + Leucine 
MalT + Maltodextrin 
PutA - Proline and FAD 
RcsAB + Membrane proteins 
SoxS + Oxidative stress 
 
Table S1. Statistical parameter Estimates on the Line of Fit of the Weight-average lipid 
Length and the S/U Ratio as a function of C8 concentration. 
Strain Variable Term Estimate Standard 
error 
t ratio Probability > |t| 
MG1655 Length Intercept 16.074 0.0495 324.32 <0.0001* 
Slope 
(concentration) 
0.00621 0.00351 1.77 0.1017 
S/U Ratio Intercept 1.588 0.120 13.24 <0.0001* 
Slope 
(concentration) 
-0.00918 0.00849 -1.08 0.3003 
∆cfa Length Intercept 16.098 0.0303 531.87 <0.0001* 
Slope 
(concentration) 
0.00789  3.14 0.0118* 
S/U Ratio Intercept 1.051 0.0262 40.15 <0.0001* 
Slope 
(concentration) 
0.00728 0.00217 3.36 0.0085* 
cfa++ Length Intercept 16.096 0.0345 466.38 <0.0001* 
Slope 
(concentration) 
-0.00594 0.00267 -2.22 0.0616 
S/U Ratio Intercept 1.815 0.0685 26.47 <0.0001* 
Slope 
(concentration) 
0.0556 0.00531 10.47 <0.0001* 
 
  
86 
 
Figures 
Figure 1. Octanoic Acid response Network 
 
MG1655 was challenged with sufficient octanoic acid to inhibit growth by 23% (10 mM) 
in MOPS minimal media at pH 7.0, 37°C, 150 rpm. This diagram shows central 
metabolism and highlights the regulatory effect of regulators with significantly perturbed 
activity during C8 challenge, as identified by network component analysis. Dashed lines 
indicate regulatory connections that were proposed in our previous analysis [30]. 
Mechanisms for changes in transcription factor activity are discussed in the text.  
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Figure 2 Octanoic Acid Challenge decreases the Intracellular pH 
 
E. coli MG1655 + pJTD1 was grown to midlog in minimal media at pH 7.0 and 
resuspended in media containing C8 or hydrochloric acid (HCl). Values are the average of 
4 biological replicates, with error bars indicating the standard deviation. 
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Figure 3. Supplementation with Arginine or Glutamate does not mitigate intracellular 
Acidification. 
 
Measurements of the intracellular pH of E. coli MG1655 + pJTD1 during C8 challenge 
while grown in the presence of supplemental arginine and glutamate. The cells were 
incubated for 3h at 37°C in MOPS media to allow utilization of the amino acid-dependent 
acid resistance systems. All concentrations are 10mM. The error bars indicate the standard 
deviation. 
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Figure 4. Supplementing Glutamate increases GABA export; however, Addition of C8 
reduces GABA accumulation and export. 
 
GABA measurements of MG1655 during log phase growth in MOPS with 2% dextrose at 
37°C, 150rpm. All concentrations are 10mM. GABA: γ-amino butyric acid. 
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Figure 5. Production of Carboxylic Acids in Strain ML103+pXZ18Z+pZS-GFP does not 
significantly change the intracellular pH. 
 
Shake flasks of E. coli producing predominately C14:0 and C16:0 carboxylic acids in M9 
media with 1.5% dextrose at 30°C. IPTG induces the pXZ18Z plasmid carrying a 
thioesterase and a β-hydroxyacyl-ACP dehydratase. The intracellular pH values are the 
average of four biological replicates and four technical replicates. The error bars indicate 
the standard deviation. 
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Figure 6: cfa Mutants with altered membrane lipid Profile, S/U Ratio and the average lipid 
Length 
 
Membrane lipid profile of MG1655 and strains with altered cfa expression. Strains were 
incubated with 0-30 mM C8, pH=7.0. Inset: specific growth rate in the log phase of E. coli 
with varying cfa expression. The error bars indicate the standard deviation and an asterisk 
indicates a significant difference to the control (MG1655 0 mM C8). C16:0- palmitic acid, 
C16:1- palmitoleic acid, C17cyc- cyclopropane C17:0, C18:1- vaccenic acid, C18:0- 
stearic acid, C19cyc- cyclopropane C19:0. The complete lipid profiles are shown in Figure 
S2 of the Supporting Information. 
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Figure 6 Continued 
 
Membrane properties are calculated from S2 to obtain: b: saturated:unsaturated lipid ratio 
and c: average lipid length. The statistical significance of the linear regression estimates of 
the weight-average lipid length and S/U ratio is available in Table S1 in the Supplementary 
Material. 
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Figure 7. lrp Mutations do not improve the E. coli growth Rate upon Addition of Octanoic 
Acid 
 
The specific growth rate of strains with altered lrp expression during the log phase in 
MOPS with 2% dextrose at 37°C, 150 rpm. 
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Figure 8: Simulations of the Effect of the electrochemical Gradients on the Proton Motive 
Force 
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Figure 8 Continued 
The appropriate range for Escherichia coli cells is -140 to -180 mV. pH values are 
measurements from Figure 2 at 20 mM. Assumption 1: An average of -160 mV is used for 
the normal PMF. The target PMF is within the range of -140 to -180 mV. Assumption 2: 
Shock conditions are the instantaneous outcome of the PMF after an extreme change in the 
environment. Assumption 3: The cell can initiate a response that gives time to adjust the 
PMF to the target range. Assumption 4: Rapid addition of a strong mineral acid (e.g., HCl) 
adds an equal amount of anions and protons, which does not change the membrane 
potential. Assumption 5: C8 is at a significant concentration that it rapidly integrates into 
the cell membrane and releases its proton inside the cell, which is not reversible. A 
negative (-) PMF indicates protons diffusing into the cell, whereas a positive (+) PMF 
indicates protons diffusing out of the cell. A negative (-) Δψ indicates an overall negative 
ion gradient due to anions, whereas a positive (+) Δψ indicates an overall positive ion 
gradient due to cations. The mol ions is the molar ratio from the normal condition. pHi- 
intracellular pH; pHe- extracellular pH;  F∆pHF∆!"F∆!"- ΔpH associated electrochemical 
force; F∆ΨF∆!"- membrane potential associated electrochemical force; PMF- proton motive 
force; A- (red) C8 anion; A- (green) another anion; C+ any cation. 
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Figure S1: Transcriptome Data of significantly perturbed Genes during E. coli Challenged 
with Octanoic Acid 
 
The criteria for significantly perturbed genes: q <0.05 with a log2 ratio < -1.0 or > 1.0. 
Positive values are an increase in abundance and negative values are a decrease in 
abundance of transcripts. MG1655 was challenged with 10 mM octanoic acid in MOPS 
with 2% dextrose at 37°C, 150 rpm. 
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Figure S2: The complete lipid Profiles of E. coli strains with engineered Cyclopropane 
Fatty Acid Content 
 
The complete membrane lipid profile of MG1655 and strains with altered cfa expression. 
Strains were incubated with 0-30 mM C8, pH=7.0. C12:0- lauric acid, C14:0- myristic 
acid, C16:0- palmitic acid, C16:1- palmitoleic acid, C17cyc- cyclopropane C17:0, C18:1- 
vaccenic acid, C18:0- stearic acid, C19cyc- cyclopropane C19:0. 
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CHAPTER 4 
DIRECTED EVOLUTION FOR AND REVERSE ENGINEERING OF SHORT CHAIN 
FATTY ACID TOLERANCE 
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Abstract 
Short chain carboxylic acids are attractive molecules as a platform for 
biorenewable chemicals production; however, product inhibition towards the biocatalyst 
has limited the titers. The microbial directed evolution method by sequential transfers was 
utilized to engineer an E. coli cell for an enhanced octanoic acid (C8) tolerance phenotype. 
The tolerance phenotype extended to hexanoic and decanoic carboxylic acids. The C8-
tolerant LAR1 strain overexpressing a short chain thioesterase specific for C8 more than 
doubled the production titer from 300 mg/L to 650 mg/L. The LAR1 strain displayed an 
altered physiology by a change in the membrane compared to the parent strain ML115. 
LAR1 had a lower saturated:unsaturated lipid ratio (S/U), higher average lipid length, a 
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lower membrane fluidity, and a more negative surface charge. The two strains exhibit a 
different behavior for maintenance of the membrane fluidity, possibly due to LAR1 having 
a higher average lipid length. It was hypothesized that the evolved strain may have a higher 
pH buffering capacity, but LAR1 did not show an improvement in the intracellular pH. 
Both the evolved strains and the parent strain were resequenced using Illumina short reads 
in order to identify the mutations responsible for the tolerance phenotype. Two mutations 
were found: two copies of the essential gene rpoC (rpoC-A1256C and rpoC∆(1-305) and 
basR-G82T. The rpoC mutations may give a hypermutability phenotype that allows LAR1 
to adapt the stressful environments. The basR-G82T mutation increased the surface charge, 
as measured by zeta potential, by increasing the amount of modified Lipid A on the outer 
membrane.  The overall more negative surface charge may be the result of another 
mechanism such as modifying the inner core of the lipopolysaccharides. These findings are 
quite significant as it may explain fundamental differences of bacterial physiology that can 
relate to changes in behavior. 
Background  
The chemical industry today relies heavily on single-use carbon. However, there 
are economical, political and environmental incentives to reduce the reliance on fossil 
fuels. The transformation of the chemical industry into a sustainable, renewable carbon-
based industry draws on the development of platform biochemicals (1). One such platform 
biochemical is carboxylic acids, derived from recombinatorial fatty acid and polyketide 
chemistry. 
There has been significant progress in the production of carboxylic acids by 
fermentation (2); however, it has been challenging as titers are low and productivities are 
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less than the theoretical maximum due to product inhibition of the biocatalyst (3). 
Biocatalyst inhibition caused by membrane damage may be the most significant 
mechanism of toxicity and is in need of ways to engineer microbial membranes for 
tolerance. Our previous research explored the mechanisms of short chain carboxylic acid 
inhibition and possible mechanisms of tolerance by using membrane characterization 
techniques such as fluidity, porosity (magnesium leakage), lipid composition, 
hydrophobicity, and membrane protein activity (implicitly quantified by metabolomics) 
(4,5). Additionally, the intracellular pH was measured during octanoic acid challenge; 
however, it was not a significantly inhibitory during carboxylic acid production. 
There are several methods of microbial directed evolution for inhibitor tolerance as 
it applies to acetate, ethanol, butanol (6). Here we have focused on the use of reverse 
engineering of evolved strains obtained from regular intervals of subdilution under 
selective pressure in order to understanding mechanisms of carboxylic acid tolerance. The 
evolved strain membrane and genome was further characterized in order to identify 
mechanisms of carboxylic acid tolerance. 
Materials and Methods 
Strains and growth Conditions 
Escherichia coli strains used in this study are listed in Table 1. All strains were 
grown in 25 mL MOPS minimal media (7) with 2 % dextrose in 250 mL baffled flasks at 
37 °C. Overnight cultures were diluted to an optical density of 0.05 at 550 nm (OD550) for 
specific growth measurements, and diluted to 0.1 for measurements of membrane lipid 
composition, membrane fluidity, intracellular pH, and zeta potential. Octanoic acid stock 
solutions were prepared in 100 % ethanol at 4 M. The concentration of ethanol used in 
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these experiments had no significant impact on growth. Media with octanoic acid were pH-
adjusted to 7.0 with 2 M potassium hydroxide. The specific growth rate was determined by 
measuring the OD550 during the exponential phase as previously described (4). 
The carboxylic acid production strains harbouring the pJMY-EEI82564 plasmid 
was grown in 25 mL LB with 1.5 % dextrose in 250mL baffled flasks at 30 °C, 200 rpm in 
an orbital airbath shaker with the 100 mg/L ampicillin, 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). The thioesterase enzyme EEI82564 was obtained from 
Fuyuan Jing and Basil Nikolau (8). 
Directed Evolution and Strain Selection 
Strain ML115 was serially diluted in 350 mL MOPS 2% dextrose media with 350 
mg/mL chloramphenicol in 500 mL fleakers continually for 714 h. The temperature was 
automatically controlled at 37 °C with a heating bath and magnetic stir plate set at 150 
rpm. The pH was automatically controlled at 7.0 using a pH-controller and gravity-feeding 
2 M potassium hydroxide into the fleaker. The octanoic acid loading was gradually 
increased by 10 mM until there was sufficient growth at 30 mM octanoic acid. Colonies 
were plated and screened by measuring the specific growth rate in MOPS 2 % dextrose 
with 10 mM C8. Strains LAR1 and LAR2 were selected for further analysis. 
Determination of Carboxylic Acid Titers 
Measurement of the carboxylic acid titers have been previously described (9). 
Briefly, 1 mL cell culture was subjected to the Voelker and Davies method (10) and 
analyzed by gas chromatograph-flame ionization detector/mass spectrometer (GC-
FID/MS) using the following instruments: an Agilent 7890 gas chromatography, an 
Agilent 5975 mass spectroscopy, and a Agilent 190915–433 30 m × 0.25 mm × 0.25 mm 
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column (Agilent Technologies). The initial temperature was set at 50 °C, holding for 1 
min, with the following temperature ramp: 20 °C/min to 140 °C, 4 °C/min to 220 °C, and 5 
°C/min to 280 °C with 1 ml/min helium carrier gas. The relative retention factor of 
C13/C17/C19 was used to adjust the relative amounts of the individual fatty acids analyzed 
(11). 
Membrane Lipid Composition and Membrane Fluidity 
The membrane lipid composition was analyzed using a modified Bligh and Dyer 
method. The membrane fluidity was assessed by membrane polarization measurements 
using 1,6-diphenyl-1,3,5-hexatriene (DPH). Both of these methods have been previously 
described (4). 
Intracellular pH Measurements 
The intracellular pH was measured using a pH-dependent green fluorescent protein 
as previously described (5). 
Resequencing of the ML115, LAR1, and LAR2 Strains and obtaining the Set of predicted 
Mutations. 
Preparation of the genomic DNA is described (12). Briefly, E. coli cells were 
grown overnight and the genomic DNA was purified using the Qiagen Blood and Tissue 
kit. The Illumina platform of short reads were used for whole genome sequencing as 
described (12). The computer programs and algorithms used for genome assembly and 
obtaining the set of predicted mutations is previously described (12). 
Determination of the cellular Zeta Potential 
E. coli was grown from OD550=0.1 to OD550=0.8 (midlog) and harvested at 4,000 
rpm, 4°C, 15 min. and resuspended in MOPS 2% dextrose media with and without 0-30 
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mM octanoic acid pH=7.0. The cells were allowed to adapt for 3 h at 37°C without 
shaking. The E. coli cells were washed with sterile nanopure water and resuspended to an 
OD550=0.2. The zeta potential was measured using a U-shaped disposable capillary cell at 
room temperature with a Malvern ZetaSizer NanoZS instrument (Malvern, Worcestershire, 
UK). An average of 12 runs with three measurements were taken. 
Results and Discussion 
An Engineered Strain for Octanoic Acid Tolerance improved Carboxylic Acid Production 
Titers 
Production of carboxylic acids by fermentation has been challenging as titers are 
low and productivities are less than the theoretical maximum (2). In our own previous 
works, we have described the toxicity effects of octanoic acid toward E. coli and shown 
that E. coli have adaptive mechanisms to improve carboxylic acid tolerance by short-term 
adaptation (4, 5). Here, we used microbial directed evolution in order to improve E. coli 
tolerance to octanoic acid. 
An evolved strain exhibiting an octanoic acid tolerance phenotype was engineered 
by using sequential transfers in MOPS minimal media containing octanoic acid (Figure 1). 
The selective pressure of octanoic acid was increased by 10 mM up to 30 mM until 714 h 
of continuous fermentation. End-point colonies were screened for octanoic acid tolerance 
(Table 2). Since evolution experiments naturally contain a high degree of variation and 
randomness, each colony screened exhibited a different growth phenotype under C8 stress. 
Further characterization of LAR1 confirmed a tolerance phenotype. The growth of the 
parent strain ML115 was severely inhibited in octanoic acid media, but the evolved strain, 
LAR1, grew almost as well as the control without octanoic acid (Figure 2). It is also 
important to have a measure of stability in the tolerance phenotype by testing other 
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conditions; in order to speed the strain development process, it is necessary to find 
mutations that give rise to a general carboxylic acid tolerance phenotype. The evolved 
strain exhibited tolerance towards a range of carboxylic acids of different chain lengths 
(hexanoic, octanoic, and decanoic acids) indicating that the tolerance phenotype extends 
broadly. The range of tolerance exhibited by LAR1 makes it a suitable platform for 
enhanced biochemical production.  
In order to test if carboxylic acid tolerance impacted the production of carboxylic 
acids, ML115 and LAR1 habouring the pJMY-EEI82564 plasmid were grown and the 
carboxylic acid products were measured (Figure 3). Not only did the evolved strain LAR1 
grow faster than the parent strain as expected, but the carboxylic acid titer approximately 
doubled. Unlike attempts at improving titers in the production of isobutanol (13,14), it 
appears that carboxylic acid tolerance does enhance carboxylic acid production. 
Biocatalyst Characterization gives Insight to the Mechanisms of Carboxylic Acid 
Tolerance 
Our previous work described methods for biocatalyst characterization to determine 
the mechanisms toxicity of carboxylic acids and adaptive mechanisms arising tolerance 
(4,5). Such methods include membrane fluidity (4), magnesium leakage (4), membrane 
lipid composition (4,5), hydrophobicity (4), transcriptome analysis (5), intracellular pH (5), 
proton motive force simulations (5), and membrane protein activity (5). Here we 
characterize our carboxylic acid tolerant strain LAR1 in order to determine the 
mechanisms of tolerance. 
The membrane lipid composition was measured to determine if the evolved strain 
altered its membrane lipids conferring to carboxylic acid tolerance (Figure 4 and Figure 
S1). Indeed, LAR1 evolved to have a lower saturated:unsaturated lipid ratio (S/U) and a 
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higher average lipid length. Measuring the membrane lipid composition in various stressful 
environmental conditions determined the extent and stability of the altered phenotype. 
Therefore, we chose to assess both strains adapted in octanoic acid, ethanol, decreased 
temperature (30 °C), and elevated temperature (42 °C). 
Allowing the strains to adapt in octanoic acid and ethanol decreased the S/U ratio 
and increased the average lipid length as expected. Because these chemicals are fluidizing 
agents, the cells increase their membrane thickness by increasing the length and decreasing 
the S/U ratio in order to modulate membrane fluidity appropriately as previously described 
(4). Presumably, the lower S/U ratio and greater lipid length allows the LAR1 strain to 
precisely modulate the membrane fluidity under stressful conditions, giving greater 
flexibility in controlling membrane properties. 
It was expected that the membranes adapted at 42 °C would increase the S/U ratio 
and increase the average lipid length since elevated temperatures increase membrane 
fluidity (15). Following this logic, adapted cells at 30 °C should decrease the S/U ratio and 
decrease the average lipid length. Bacteria cells adapted at 42 °C behaved as expected. 
However, cells adapted at 30 °C behaved differently and varied between strains. ML115 
decreased the S/U ratio at lower temperature as expected, but slightly increased the average 
lipid length. Contrastingly, LAR1 increased the S/U ratio and slightly, but not 
significantly, decreased the membrane length at 30 °C. The two strains exhibit a different 
behavior for maintenance of the membrane fluidity, possibly due to LAR1 having a higher 
average lipid length.  
Currently, it is unclear which mechanisms are responsible for this change, whether 
it is genetic differences, or regulation at the transcriptional and/or post-translational level. 
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Fatty acid biosynthesis enzymes may have altered expression or activities as the reduction 
step (FabI) controls the rate of elongation and the dehydration step (FabA/Z) controls the 
level of unsaturated fatty acids during fatty acid biosynthesis (16). Additionally, LAR1 has 
a higher cyclopropane fatty acid content compared to ML115 (Figure S1). Cyclopropane 
fatty acids are important for acid resistance by slowing the mobility of protons across the 
membrane (5,17-18). 
The membrane fluidity of each strain was assessed in order to determine if the 
dramatic differences in the membrane lipid profiles were corresponding to the behavior of 
the membrane (Figure 5). The LAR1 strain has a slightly more rigid membrane compared 
to ML115 as assessed by DPH membrane polarization. This result may indicate how 
LAR1 is able to become more tolerant towards fluidizing agents like carboxylic acids. 
The membrane porosity, as determined by magnesium leakage, and the intracellular 
pH of LAR1 and ML115 were also measured (4,5). There was no difference between 
strains in the membrane porosity (data not shown) or the intracellular pH (Figure 6). After 
characterizing the parent and evolved strain, we sought to identify the genetic mutations 
that may be responsible for the phenotypic change. 
Identification of Mutations in the evolved Strains 
Purified genomic DNA of ML115, LAR1, and LAR2 were sequenced using the 
Illumina whole genome sequencing platform and assembled using different short-read 
genome assembly softwares (12) (Table 3). The SAMtools software (19) was used to 
predict mutations or sequence variations (Table 4) and the predictions were verified by 
Sanger sequencing of PCR products. Additional mutations that were found in all strains 
(parent and evolved strains) are in Table 5 and are not further discussed. Only mutations 
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found the in evolved strain, but not the parent strain, were further characterized as these 
mutations must have come from the directed evolution process. Two genes verified in 
LAR1 had mutations in the rpoC and basR genes. 
One gene that is common to both LAR1 and LAR2 evolved strains is a single 
nucleotide polymorphism (SNP) in rpoC, the β' subunit of RNA polymerase σ70 factor 
(aka. rpoD gene product), which is a sigma factor promoting the transcription of genes 
during cellular logarithmic growth (Figure 7 a). LAR1 has a rpoC-A1256C(H419P) 
mutation. Figure S2 a describes the genome topology of rpoC and the annotated SNP. A 
surfactant-resistance E. coli mutant was previously isolated and sequenced in order to 
identify the genetic mutations conferring resistance (20). Among 7 mutated regions, three 
of the mutations were located within RNA polymerase subunits, including rpoN, rpoB, and 
rpoC. However, their mutation was rpoC-G2011A(G671S). Due to the difficulty in 
engineering essential genes like rpoC, Nakata and coworkers could not make the allel 
replacement and had limited cloning success. 
Another copy of a truncated version of rpoC, designated as rpoC∆(1-305), was 
found to be located in the insF-gatD locus of the genome (Figure 7b). This is possibly due 
to a duplication/rearrangement event during the directed evolution process. Transposon 
Insertion sequences (IS) sequences prefer to transpose into AT-rich DNA sequences and 
therefore may give clues as to how the rearrangement might have occurred. 
The implications of a partial deletion of rpoC could theoretically be vast- affecting 
any gene with a σ70 promoter. There are approximately 599 genes with a σ70 promoter in 
the E. coli K-12 genome (21). Interestingly, RpoC chelates Mg2+ ions, which are required 
by RNA polymerase activity. As previously described (4), C8 increases the porosity of the 
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membrane, which can be measured by the release of Mg2+ ions into the media. Therefore, 
any changes in the metal-binding domain of RpoC may have an effect in its ability to 
chelate Mg2+ ions. The rpoC protein also chelates Zn2+ ions, which are required for the 
correct conformation of the RNA polymerase complex. The 305bp deletion results in a 
deletion of the first 102 amino acids, including the zinc finger and coiled-coil domains in 
the β’ subunit (22). The N-terminus of the β’ subunit is part of the core of the RNA 
polymerase complex (23); this mutation may also have a negative impact on the cellular 
growth rate by destabilizing the RNA polymerase complex. It is known that destabilizing 
RNA polymerase can cause a growth defect such as elevated temperatures (23). The may 
be a contributing factor in the temperature differences in the membrane lipid profiles 
discussed above (Figure 4). 
LAR1 strain also has a basR-G82T mutation for which the mutation is in the 
response regulatory domain (Figure 7c). The BasS-BasR (PmrA-PmrB) two-component 
phosphorelay system is one of several signal transduction pathways for remodeling the cell 
envelope in response to environmental signals (24). Apart from BasS-BasR, these systems 
include PhoP-PhoQ, baeS-baeR (25), cpxP-cpxA-cpxR (26,27), RcsCDB (27,28), envZ-
ompR (27), PhoB-PhoR(29). One of the main functions of the BasS-basR system is to 
modify Lipid A in the outer leaflet of the outer membrane to have surface charges as 
discussed below (30). 
Remodeling of the cell Envelope is critical for Carboxylic Acid Tolerance 
Lipid A is an important component of the outer membrane, serving as a barrier to 
keep important intracellular metabolites inside the cell and toxic chemicals from entering. 
Lipid A also serves as the anchor to which Lipopolysaccharides (LPS) may covalently 
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bond to the cell surface as shown in Figure 8. There are variations in the antigens E. coli 
can have on the cellular surface; however, E. coli K-12 is unable to properly synthesize the 
O-antigen (31,32). BasS senses an environmental signal such as low pH or iron and 
phosphorylates BasR (BasR•P). BasR•P, in its active state, will bind to its recognized 
genomic sequences and upregulate several genes involved in modification of Lipid A. 
PhoP-PhoQ performs a similar function; however, the genes it regulates and its 
environmental signals are different from the BasS-BasR system. Note that in E. coli the 
gene pmrD is defective unlike in Salmonella enterica (33). 
Lipid A can be modified by binding a phosphate group (P-), L-4-aminoarabinose 
(L-Ara4N+) or a phosphoethanolamine (pEtN+) to either the 1’ or 4’ position of the 
glucosamine moiety (34). The gene products performing this modification are in Figure 8. 
pEtN+ can also bind to the 3-deoxy-d-manno-octulosonic acid residue in Lipid A via the 
eptB gene (35). Modified Lipid A with a charge will change the surface charge of the E. 
coli cell. Cellular surface charge is important for protein and membrane functionality (36). 
It has been demonstrated that increasing the number of positive surface charges causes 
resistance to cationic antimicrobial agents such as polymyxin B (37). Therefore, we 
investigated the bacterial cell surface charge by measuring the zeta potential (Figure 9). 
The evolved strain LAR1 had a more negative zeta potential or surface charge 
compared to the parent strain ML115. Upon addition of octanoic acid at different 
concentrations, the zeta potential increased. The overall higher negative charges may 
possibly be due to a greater coverage of the cellular surface with LPS or greater charges on 
the inner core of the LPS. A higher negative surface charge may be able to slow the 
transport of unprotonated octanoic acid into the membrane by creating a higher 
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electronegative density (i.e. electrostatic repulsion). The two-component phosphorelay 
system PhoB-PhoR regulates the LPS core modifications, which is distinct from Lipid A 
(35). The increase in surface charge (more positive) as the concentration of C8 increased 
can be attributed to an increase in modified Lipid A, with either addition of L-Ara4N+ or 
pEtN+ in the 1’ and/or 4’ position. It was previously described that the protonated octanoic 
acid diffuses into the cellular membrane (4) and releases its proton into the cell (5); 
however, the pKa of the organic acid is dependent on the local milieu (38). Therefore, the 
pKa of C8 increases from approximately 4.89 to 7.3 upon dissolution into the cellular 
membrane, allowing the unprotonated C8 to become protonated and diffuse through the 
membrane according to Overton’s rule (39). An increase in the cellular surface charge 
changes the pKa of the carboxylic acid by acid-base chemistry as discussed in (38): 
   𝐴𝐻 ⇌ 𝐴! + 𝐻!     (1) 
   𝐵𝐻! ⇌ 𝐵 + 𝐻!     (2) 
If the media pH is near neutral, L-Ara4N or pEtN on Lipid A may be in the uncharged 
state and act as a base. Therefore, the protonated C8 can donate a proton to the modified 
Lipid A; the unprotonated C8 cannot diffuse through the membrane. This mechanism is 
enough to reduce the pKa of C8 by approximately 3 units. On a logarthimic scale, the 
decrease in pKa can change the equilibrium of ~67% protonated C8 to ~0.35%. Note that 
pEtN is zwitter ionic and can be positively charged in low pH or negatively charged in 
high pH. 
The surface charge can have an effect on the proton motive force (PMF). A high 
negatively charged surface attracts more cations in solution, creating a larger 
electrochemical potential gradient (40). As previously described (5), octanoic acid can 
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invert the PMF. The E. coli cells in return must accumulate anions in order to revert the 
PMF back to the appropriate range to allow for energy production and growth. However, 
instead of accumulation of anions, it may increase the surface charge, which creates the 
same effect on the PMF. This effect can result in a higher localized concentration of 
cationic salts as well as protons surrounding the cellular surface, undoubtedly stimulating 
signal transduction systems like BasS-BasR and PhoP-PhoQ.  
Conclusions 
Microbial directed evolution is a powerful technique that has been used in the 
development of tolerant strains for alcohols and other toxic chemicals (13-14, 41). While it 
is not always the case, we have shown here that a carboxylic acid tolerance strain 
significantly improves the production titer (Figure 3). The characterization techniques used 
here have been instrumental in identifying the underlying mechanisms giving carboxylic 
acid tolerance (Figures 4-6). LAR1 had a lower saturated:unsaturated lipid ratio (S/U), 
higher average lipid length, a lower membrane fluidity, and a more negative surface 
charge. The two strains exhibited a different behavior for maintenance of the membrane 
fluidity, most likely due to LAR1 having a much higher average lipid length. These 
findings are quite significant as they may explain fundamental differences of bacterial 
physiology that can relate to changes in behavior. It may even give greater insight into the 
environmental effects of speciation in bacteria. 
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Tables 
Table 1. List of Strains and Plasmids used in this study. 
Strain Genotype Reference 
MG1655 (ATCC #700926) F- lambda- ilvG- rfb-50 rph-1 ATCC 
ML115 (parent) MG1655 
fadD poxB ackA-pta::cmR 
(9) 
LAR1 (evolved ML115-15-C5) ML115 
… 
This reference 
LAR2 (evolved ML115-15-C2) ML115 
… 
This reference 
pJMY-EEI82564 pTrc-EEI82564 thioesterase 
from Anaerococcus tetradius 
(8) and this reference 
 
Table 2. Specific growth Rate of isolated Mutants from directed Evolution.  
Colony isolates exhibit a different growth behavior, which requires a comparative method 
for choosing colonies for further analysis. Abbreviations: SG- specific growth; τd- 
doubling time. The base condition is normalized to 0%.  
SG (h-1) Experiment τd % difference 
0.646 C1-5 1.07 0.00 
0.637 C6-10 1.09 -1.44 
0.538 C11-15 1.29 -16.8 
0.644 C16-20 1.08 -0.337 
0.629 C21-26 1.10 -2.58 
0.602 C1 1.15 0 
0.673 C2 (LAR2) 1.03 11.7 
0.670 C3 1.03 11.2 
0.689 C5 (LAR1) 1.01 14.3 
Table 3. Assembly of resequenced Genomes 
Strain Total reads Aligned reads Unaligned reads 
ML115 13,885,631 13,666,268 (98.4 %) 219,363 (1.6 %) 
LAR1 (ML115-15-C5) 27,537,361 26,712,156 (97.0 %) 825,205 (3.0 %) 
LAR2 (ML115-15-C2) 25,565,697 25,177,062 (98.5 %) 388,635 (1.5 %) 
 
  
117 
 
Table 4. The Number of Mutations as predicted by the SAMtools Program and verified by 
Sanger Sequencing. 
E. coli 
strain 
Predicted 
mutations 
Tested 
mutations 
Predicted unique 
mutations 
Verified unique 
mutations 
ML115 35 13 8 - 
LAR1 36 50 3 1 
LAR2 43 - 7 - 
Total 114 - 18 - 
 
Table 5. Additional Mutations found in all Strains (ML115, LAR1, and LAR2). 
Additional mutations may be the result of the triple knockout strain (ML115) that is very 
weak, causing random mutations. 
Mutation Function Comments 
yadi- 
G210T(A70) 
Enzyme IIA domain of a predicted 
N-acetylgalactosamine-transporting 
PEP-dependent 
phosphotransferase system 
A silent mutation that does not change 
the amino acid sequence 
ydgJ- 
A308C(Q103P) 
Putative D-galactose 1-
dehydrogenase 
- 
yebB::IS1 Uncharacterized IS1 has flanking promoters that may 
increase expression of neighboring 
genes, including ruvAB and yobi. 
yeaJ::IS1 Putative diguanylate cyclase 
(stress response) 
A ∆yeaJ strain displays a higher motility 
(42) 
hyfH- 
G82A(G28S) 
Hydrogenase-4 Part of a larger operon that converts 
formate to hydrogen. It is silent under 
normal conditions (43). 
glpR- 
C203- 
sn-Glycerol-3-phosphate repressor Mutation in MG1655 is described (44). 
crl::IS1 RNA polymerase regulator Mutation in MG1655 is described (44). 
RNA0-359::IS5 Miscellaneous RNA Mutation in MG1655 is described (44). 
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Figures 
Figure 1. Microbial directed Evolution of a Carboxylic Acid-tolerant E. coli Strain 
 
E. coli were grown in MOPS media with constant pH-adjustment to 7.0. After 15 transfers, 
LAR1 was isolated under increasing selective pressure from 10 mM – 30 mM octanoic 
acid. 
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Figure 2. The evolved Strain has a Carboxylic Acid tolerance Phenotype that extends to C6 
and C10 Carboxylic Acids 
 
The specific growth rate of a) parent strain ML115 and b) evolved strain LAR1 with c) 
different carboxylic acids at 10 mM. C6- hexanoic acid; C8- octanoic acid; C10- decanoic 
acid. 
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Figure 3. The Carboxylic Acid tolerant Strain doubles the Carboxylic Acid production 
Titer 
 
a) The growth curves of strains harbouring the pJMY-EEI82564 plasmid. b) The 
carboxylic acid production titers after 48h fermentation. Error bars indicate standard 
deviation values. C8:0- octanoic acid; C10-OH- hydroxyl decanoic acid; C14:0- myristic 
acid, C16:1- palmitoleic acid, C16:0- palmitic acid, C18:1- vaccenic acid, C18:0- stearic 
acid. 
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Figure 4. LAR1 has an overall lower S/U lipid Ratio and a greater lipid Length 
 
 
The membrane a) S/U lipid ratio and b) average lipid length in different environmental 
stresses. The control and conditions are compared (*) and the two strains are compared (†) 
using p-values 0.1 (* and †) and 0.05 (** and ††). Error bars indicate standard deviation 
values. The significance test used an all-pairs Tukey-Kramer HSD comparison. 
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Figure 4 Continued 
 
Averages of the S/U ratio and the average length for all conditions highlight the 
differences in behavior  of LAR1 and ML115. Bars indicate the maximum and minimum 
and are not error bars. 
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Figure 5. LAR1 has a more rigid Membrane than ML115 
 
The membrane fluidity of ML115 and LAR1 logarithmic-growing E. coli cells in MOPS 
media as assessed by DPH membrane polarization. A * indicates a p-value <0.1. Error bars 
indicate standard deviation values. The significance test used an all-pairs Tukey-Kramer 
HSD comparison. 
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Figure 6. The intracellular pH is the same for both LAR1 and ML115. 
 
The intracellular pH as a function of C8 concentration in LAR1 and ML115 strains. a) 
intracellular pH (ipH) and b) relative difference from the control (0 mM C8) (∆ipH). Error 
bars indicate standard deviation values. 
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Figure 7. Mutations in LAR1 strain.
 
Protein sequence of a predicted and verified rpoC-A1256C mutation in LAR1. 
  
>LAR1_rpoC 
MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDG
LFCARIFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASP
TAHIWFLKSLPSRIGLLLDMPLRDIERVLYFESYVVIEGGMTNLERQQILTEEQY
LDALEEFGDEFDAKMGAEAIQALLKSMDLEQECEQLREELNETNSETKRKKLTKR
IKLLEAFVQSGNKPEWMILTVLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINR
NNRLKRLLDLAAPDIIVRNEKRMLQEAVDALLDNGRRGRAITGSNKRPLKSLADM
IKGKQGRFRQNLLGKRVDYSGRSVITVGPYLRLHQCGLPKKMALELFKPFIYGKL
ELRGLATTIKAAKKMVEREEAVVWDILDEVIREPPVLLNRAPTLHRLGIQAFEPV
LIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEARALMMSTNNILSPAN
GEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAERLYRSGLASLHARVKV
RITEYEKDANGELVAKTSLKDTTVGRAILWMIVPKGLPYSIVNQALGKKAISKML
NTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPEKKHEIISEAEAE
VAEIQEQFQSGLVTAGERYNKVIDIWAAANDRVSKAMMDNLQTETVINRDGQEEK
QVSFNSIYMMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVL
QYFISTHGARKGLADTALKTANSGYLTRRLVDVAQDLVVTEDDCGTHEGIMMTPV
IEGGDVKEPLRDRVLGRVTAEDVLKPGTADILVPRNTLLHEQWCDLLEENSVDAV
KVRSVVSCDTDFGVCAHCYGRDLARGHIINKGEAIGVIAAQSIGEPGTQLTMRTF
HIGGAASRAAAESSIQVKNKGSIKLSNVKSVVNSSGKLVITSRNTELKLIDEFGR
TKESYKVPYGAVLAKGDGEQVAGGETVANWDPHTMPVITEVSGFVRFTDMIDGQT
ITRQTDELTGLSSLVVLDSAERTAGGKDLRPALKIVDAQGNDVLIPGTDMPAQYF
LPGKAIVQLEDGVQISSGDTLARIPQESGGTKDITGGLPRVADLFEARRPKEPAI
LAEISGIVSFGKETKGKRRLVITPVDGSDPYEEMIPKWRQLNVFEGERVERGDVI
SDGPEAPHDILRLRGVHAVTRYIVNEVQDVYRLQGVKINDKHIEVIVRQMLRKAT
IVNAGSSDFLEGEQVEYSRVKIANRELEANGKVGATYSRDLLGITKASLATESFI
SAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRRRAA
GEAPAAPQVTAEDASASLAELLNAGLGGSDNE 
 
Mutation at H419P (Histidine to proline!
a) 
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Figure 7 Continued  
 
 
b) Possible duplication and/or rearrangement of rpoC identified by Sanger sequencing. A 
truncated copy of rpoC is in the insF-5(IS3)-gatD locus. c) Protein sequence of a predicted 
and verified basR-G83T mutation in LAR1. The protein domains are predicted by Prosite. 
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EN 
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Figure 8. BasS-basR and PhoP-PhoQ regulate the Lipid A modification Regulon 
 
BasR•P upregulates the arn operon, eptA, and pmrR. ArnT adds a L-4-aminoarabinose (L-
Ara4N+) and EptA adds a phosphoethanolamine (pEtN+) to lipid A. PmrR down-regulates 
lpxT, the gene product that adds a negatively charged phosphate group to lipid A. PhoP•P 
up-regulates pmrD, which is defective in E. coli K-12 and down-regulate eptB, the gene 
product that adds a pEtN+ to lipid A. Modified lipid A can then enter into the outer 
membrane. Red: up-regulation; green: down-regulation. 
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Figure 9. LAR1 has an overall more negative surface Charge compared to ML115 and 
raises the surface Charge in order to confer Octanoic Acid Tolerance. 
 
Logarithmic growing E. coli cells were incubated in MOPS 2% dextrose media with 0-10 
mM C8 and allowed to adapt for three hours. 
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Supplemental Material 
Figure S1. The complete lipid Profiles of LAR1 and ML115. 
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Figure S1 Continued  
 
 
Logarithmic growing E. coli cells were incubated in MOPS 2% dextrose media with 
different environmental stresses and allowed to adapt for three hours. a: 30 mM C8, b: 2% 
ethanol, c: 30 °C, d: 42°C. 
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Figure S2. AT-rich Gene Topology Analysis in LAR1. 
 
 
 
AT-rich gene topology analysis may give clues to the mechanisms of recombination 
leading to duplications/rearrangements, insertions/deletions (indels), and single nucleotides 
polymorphisms (SNPs). Insertion sequences prefer to recombine in AT-rich regions. 
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CHAPTER 5 
SUMMARY, FUTURE WORK, AND CONCLUSIONS 
The combinatorial nature of the fatty acid biosynthesis and/or polyketide pathway 
in microorganisms has spurred interest in developing a platform for the transformation of 
the chemical industry into a sustainable and biorenewable industry. Intermediates derived 
from fermentation of biomass by microbes can be chemically converted into value-added 
commodity chemicals. However, the toxicity of these intermediates towards microbial 
biocatalysts has made efficient production quite challenging. 
Two methods have been described in order to enhance the tolerance of E. coli to 
carboxylic acids for greater yields, titers, and productivities. One method is to use rational 
engineering by directly modifying the organism to improve tolerance. This requires prior 
knowledge of the mechanisms of inhibition by the toxic product, which can be gained from 
global analysis tools (omics analysis) or previously published literature. The other method 
is the use of continuous fermentation under selective pressure or microbial directed 
evolution in order to obtain tolerant strains. Genetic reverse engineering can be used to 
identify and confirm mutations that arise the tolerance phenotype. This will allow the 
engineer to define the inhibition-tolerance relationship towards a particular inhibitor (or 
class of inhibitor molecules) that can be used to translate the tolerance phenotype to any 
strain of interest- particularly the producer strain. 
Several characterization methods of biocatalysts have been compiled together and 
developed into a framework for defining the inhibitor-tolerance relationship. The majority 
of these techniques describe the cellular membrane. Therefore, other methods such as 
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determination of intracellular pH may be necessary if the inhibitor mode of action is 
intracellular. The specific growth rate measurements are very basic in the sense that it 
defines toxicity or tolerance in actively growing cells. Often times in industry the 
biocatalysts are grown to a particular cell density and used as non-growing biocatalysts. 
Therefore, additional techniques to define toxicity or tolerance in the stationary phase is 
needed. One method may be to add the inhibitor to stationary phase cells and generate a 
specific death rate. In this case, it is desirable to have a low specific death rate instead of a 
high specific growth rate. Additionally, the growth media needs to be well established. 
Media conditions such as pH can have a drastic effect on the actual chemical species or its 
concentration in solution. For example, carboxylic acids are soluble depending on the pH 
or temperature and the neutral form is permeable to the cellular membrane. Other factors 
such as complex media components, ionic strength, trace metals and salts composition may 
alter the degree of toxicity. 
Membrane permeabilization is extremely important in biocatalyst tolerance 
applications. Therefore, when designing platform chemicals, the Meyer-Overton rule 
should be in consideration. Even if the use of transporter proteins is the method of choice 
for transportation across the membrane (possibly to excrete the desired product), proper 
control of the membrane permeability and function is essential. Therefore, in tolerance 
applications, it may be useful to use membrane characterization techniques such as 
fluidity, porosity (magnesium leakage), lipid composition, hydrophobicity, membrane 
protein activity (implicitly quantified by metabolomics), and surface charge. Additional 
characterization methods may aid in indentifying modes of action or mechanisms of 
tolerance. 
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Microbial directed evolution is a powerful technique to select for mutated strains 
with the desired tolerance phenotype. Despite the time and labour costs involved, this 
“black box” approach allows efficient development of inhibitor-resistant biocatalysts. 
Instead of a mundane human-led trial-and-error method, directed evolution lets nature do 
strain engineering for them. A fully automated system of controlling the dilution rate in 
order to keep the cell density and media components constant is the best method, assuming 
that it is with the research budget. Since cell cultures from serial dilutions are 
heterogeneous, this system should also include high throughput screening in order to select 
strains with the greatest tolerance phenotype. The selection method needs to consider 
controls in order to counter-select against unspecific or unwanted mutations. For example, 
if the specific growth rate in the inhibitor challenge condition is greater than the control 
condition, it may contain unnecessary mutations that in the end create strain instability, 
including the ability to metabolize the product. For platform biorenewable chemicals 
production, it is desirable to obtain a tolerance phenotype that is broadly associated to the 
class of molecules in consideration. For example, in the case of LAR1 it was tolerant 
towards hexanoic and decanoic acids as well as octanoic acid. 
While obtaining tolerant-mutant strains is desirable, it is advantageous to identify 
the mutations in the evolved genomes and confirm the mechanism of tolerance. However, 
reverse engineering the tolerant strain is a challenging task. Inconsistencies with the 
genomic assembler programs and algorithms make it difficult to identify exactly what and 
where the mutations are within the genome. Complex genomic sequences, including large 
insertions, deletions, rearrangements, duplications, and palindromes make it an especially 
formidable hurdle. Obtaining the full genome sequence by optical mapping and gap 
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sequencing is extremely time-consuming, but gives confidence in the absolute linear DNA 
sequence of the chromosome. Once the mutations are identified and experimentally 
verified, nature has given you the keys to the tolerance phenotype. From there, it is 
possible to systematically reconstruct the tolerance phenotype from the parent strain and 
deconstruct the tolerance phenotoype from the evolved strain. This is how the inhibition-
tolerance phenotype is defined. Finally, the tolerance phenotype can be translated into the 
producer strain in order to enhance production of the desired biorenewable chemical. 
A good experiment always leads to another experiment. Specifically for the 
carboxylic acid system, there are a number of future directions to take. The evolved strains 
can be analyzed further for know-how to rationally engineer a biocatalyst cell with a lower 
saturated/unsaturated ratio, a higher average lipid length, greater surface charges (more 
lipopolysaccharides and more modified lipid A), modify the lipopolysaccharide core and 
polysaccharides (antigens), exopolysaccharides, biofilms, and peptidoglycans. 
Additionally, there is a lot of opportunity for engineering of membrane proteins for added 
functionality or stability in compromised membranes. The evolved strain genomes can be 
further analyzed in order to map phenotypic differences to changes in the genome. This 
information can be used to systematically reconstruct the tolerance phenotype from the 
parent strain, deconstruct the tolerance phenotoype from the evolved strain, and translate 
the tolerance phenotoype into the producer strain in order to enhance production of the 
desired biorenewable chemical. Finally, sequencing the cellular transcriptome (RNA-seq) 
can describe the whole transcriptome compared to the parent strain. This is necessary in 
order to capture epigenetic differences in gene expression. 
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This work has focused primarily on the characterization of microbial biocatalysts 
with the goal of improving biocatalytic performance by increasing inhibitor tolerance. This 
is a general characterization platform that can be used for any microorganism producing 
any product. Traditionally, one uses “metabolic functional engineering” by use of genetic 
engineering in order to produce the desired product by adding functionality to the 
biocatalytic cell. For example, one can add a new thioesterase from Anaerococcus 
tetradius into Escherichia coli to produce free carboxylic acids. However, here the focus 
has been on enhancing the biocatalytic and productivity properties of the cell with the use 
of genetic engineering. While modification of cell properties doesn’t directly increase 
titers, it is important for cellular physiology, viability, and operativity. For example, the 
use of the basR-G82T mutation in order to increase the cell surface charge for enhanced 
carboxylic acid tolerance does not directly produce the product, but aids in the overall 
biocatalysis. There are still many challenges today in this area of metabolic engineering; 
however, as biologists and engineers come together to understand cellular physiology we 
can holistically utilize biocatalysis most effectively for biochemicals production. As it is 
developed further we can start to understand biocatalysis on a whole new level. Where 
previous technologies were only at the proof of concept level, these techniques in 
bioprocessing can improve the biocatalyst and may carry it into an economical process. 
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APPENDIX A 
IDENTIFICATION OF MUTATIONS IN EVOLVED BACTERIAL GENOMES 
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Summary 
Directed laboratory evolution is a common technique to obtain an evolved bacteria 
strain with a desired phenotype. This technique is especially useful as a supplement to 
rational engineering for complex phenotypes such as increased biocatalyst tolerance to 
toxic compounds. However, reverse engineering efforts are required in order to identify the 
mutations that occurred, including single polymorphisms (SNPs), insertions/deletions 
(indels), duplications, and rearrangements. In this protocol, we describe the steps to 1) 
obtain and sequence the genomic DNA 2) process and analyze the genomic DNA sequence 
data, and 3) verify the mutations by Sanger resequencing. 
Introduction 
Bacteria acting as biocatalysts for production of biorenewable fuels and chemicals 
are often faced with product-mediated inhibition. For example, ethanol was shown to 
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negatively impact growth and structure of E. coli and yeast (1, 2); the effects of succinate 
were revealed on the membrane and enzymes of yeast (3, 4); butanol was shown to inhibit 
the growth and sugar uptake rate of Clostridium acetobutylicum (5, 6).  
Lignocellulosic biomass has been extensively utilized as a source of carbon and 
energy for the fermentative production of ethanol and other biorenewable fuels (7-9). 
However, the sugar streams released from this biomass frequently contain inhibitory 
contaminants that inhibit the growth and substrate utilization of microorganism (10-12).  
Thus, the fermentative production of biorenewable fuels and chemicals is 
associated with both inhibitory contaminants in the feedstock and inhibitory products; in 
these cases, it can be sometimes useful to increase the tolerance of the biocatalyst to these 
inhibitory compounds. Metabolic evolution is frequently used to increase the tolerance of 
bacteria to inhibitory compounds. Directed evolution is when researchers can enhance 
desired features, such as increased tolerance of inhibitory compounds, by selecting for 
random mutations under appropriate selective pressure. While metabolic evolution is 
sufficient to acquire a strain with the desired phenotype, it is often of interest to identify 
the mutations acquired during the evolutionary process. 
Reverse engineering can yield a roadmap for reproducing the desired phenotype or 
behavior in other biocatalysts. This method begins with whole-genome sequencing using 
high-throughput sequencing technology, such as Illumina's sequencing by synthesis 
technique. Bioinformatics methods known as de novo assembly and mapping (or 
alignment) are used to analyze the short read data and reconstruct the genome (13-15). By 
obtaining DNA sequences of the parent and evolved organism genomes, it is possible to 
perform a comparative analysis and identify variations in the evolved strain. Isolation of 
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bacteria genomes is a standard procedure. Sequencing platforms are changing rapidly in 
their throughput and chemistry to increase availability and fidelity of sequence data (16). 
As sequencing data becomes more readily available, there are many challenges to the 
processing and analysis of sequence data, which is costly and time consuming. Thus, 
automation by programs alleviates the burden of manual analysis. The finishing step and 
gap filling in DNA sequence analysis is the bottleneck in automation (17). In the recent 
decade, there has been a great amount of improvement in automating the process with 
computer programs; however, this step still requires human intervention. 
As the genotype of the evolved strain is defined, hypotheses are formed regarding 
the roles of mutations in the context of the phenotype. As researchers elucidate which 
mutations improve fitness, the intent is to infer the mechanisms that lead to the increased 
tolerance to toxicity and then proceed with rational engineering techniques (12, 18). This 
can also enable to identify the function of the undercharacterized enzymes and pathways 
(19). However, the focus of this chapter is to describe the use of genome sequence analysis 
to identify the mutations acquired in an evolved strain. Determination of which of these 
mutations impact the phenotype and understanding the mechanism of the mutation’s 
function is outside the scope of this chapter. 
Materials 
All materials used are standard kits and reagents. Software for high throughput 
sequence analysis generally requires UNIX/Linux operating systems with a large amount 
of memory and storage. Both free and commercial software packages are available for 
analyzing high-throughput sequencing data. All software included in this protocol is open 
source unless otherwise noted. 
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Genomic DNA Purification and Sequencing 
1. Lauria Broth (LB) for growing bacteria cells: dissolve at 25 g/L in nanopure water 
and filter-sterilize using a 0.22 CA bottle top filter. 
2. 1.5mL microfuge tubes and 50mL centrifuge tubes for sample processing. 
3. QIAGEN DNeasy® Blood & Tissue kit for genomic DNA isolation and 
purification. Buy RNase A and 100 % ethanol separately. 
4. Accublock Digital Dry Bath for temperature-controlled incubation. 
5. NanoDrop Spectrophotometer for genomic DNA quantification and quality control. 
6. Illumina cBot System and Illumina TruSeq PE Cluster Kit -GA for cluster 
generation, Illumina GAII sequencing instrument for short-read whole genome 
sequencing (available at a university core facility, prices vary). 
Bioinformatics Software for High-Throughput Sequence Data 
1. Galaxy is a scientific workflow system for high-throughput sequence data 
preprocessing, integration, and analysis. A free public server is available, but most 
users will need to download and install the open source Galaxy software locally 
due to the upload limitations and to preserve data privacy. UNIX/Linux and Mac 
OS X are supported and a recent version of Python must be installed (20-22). 
2. FastQC provides quality control checks for raw sequence data and generates 
summary graphs and basic statistics. FastQC is available through the Galaxy 
interface or for download and independent installation (23). 
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3. FASTX-Toolkit is a collection of scripts for manipulating raw sequence data. It 
includes conversion, trimming, and filtering tools and will generate some quality 
statistics. The FASTX-Toolkit is distributed with Galaxy or can be downloaded and 
installed independently (24). 
4. Mapping software: Bowtie, Bowtie 2, and BWA are popular short read aligners that 
distributed under the GPLv3 license. Bowtie and BWA are distributed with Galaxy. 
Memory requirements vary by algorithm and input data, but at least 2GB memory 
required and at least 4GB is recommended. Multiple processors can also improve 
alignment speed. It is critical to read the manual for mapping software because 
different parameters will generate different alignments. 
5. de novo assembly software: Velvet and ABySS (available for download and 
distributed under the GPLv3 license) are examples the many available de Buijn 
graph-based assemblers (25, 26). Other assemblers that use an 
overlap/layout/consensus approach are available, but take considerably longer to 
assemble short reads and are not considered for this protocol. While many 
assemblers support 32-bit platforms, a 64-bit machine is recommended and 
memory requirements vary by algorithm, short read data, and selected k-mer length. 
It is critical to read the assembler manuals because different parameters generate 
different contigs/scaffolds. 
6. Basic Local Alignment Search Tool (BLAST) is the most widely used sequence 
similarity tool. A web interface is available through NCBI, but a local installation 
of the BLAST+ open source applications provide a command line usage (27). 
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7. SAMtools is a collection of utilities for manipulating alignments. BCFtools, which 
is distributed with SAMtools, performs variant calling. SAMtools is distributed 
with Galaxy and can also be independently installed (14, 15). 
Mutation Verification 
1. Primer3 software (distributed under GPLv2) for primer design and primers (28). 
2. Plate Spinner Centrifuge. 
3. Commercial 10mM Tris-HCl, pH=8.5 buffer. 
4. 96-well PCR plates. 
5. Polymerase Chain Reaction (PCR) materials: QIAGEN® Taq PCR Master Mix Kit 
or QIAGEN® LongRange PCR Kit and Strain Genomic DNA (from material 
2.1.1). 
6. Gel loading materials: Blue (6X) Gel Loading Dye and ethidium bromide, 1% 
Solution/Molecular Biology, for visualization of PCR products and 1 Kb Plus DNA 
Ladder  for size determination. 
7. 50X TAE: 242g Tris base, 57.1ml Glacial Acetic Acid, 18.6g EDTA dissolved in 
900mL nanopure water. Add make up nanopure water to 1L. 
8. TAE DNA gel for separating DNA fragments: dissolve 1% W/V Agarose in 1X 
TAE. 
9. Gel electrophoresis equipment. 
10. PCR Purification Kit to purify PCR products. 
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11. DNA sequence finishing software Phred/Phrap/Consed or CodonCode Aligner (17, 
29, 30). 
12. Thermal Cycler for generating PCR products. 
Methods 
Obtaining the evolved strain and interpretation of mutation function is outside the 
scope of this paper. Here we restrict this protocol to DNA purification, genome 
sequencing, analysis and verification. 
Obtain Sequence Data 
1. After obtaining an evolved bacteria colony isolate, prepare to use the QIAGEN 
DNeasy® blood & tissue kit. Other commercial kits can also be used to isolate the 
genomic DNA. First, grow the parent strain (before the evolution experiment) and 
the evolved strain overnight in 25 mL LB. 
2. Follow the QIAGEN DNeasy® Blood & Tissue kit protocol for gram-negative 
bacteria. 
2.1 Harvest cells (maximum 2 x 109 cells) in 50mL centrifuge tube by centrifuging 
for 20 minutes at 4°C, ~5,000xg. Discard supernatant (see Note 1). 
2.2 Resuspend pellet in 180 µl Buffer ATL and transfer to a microcentrifuge tube. 
2.3 Add 20 µl proteinase K. Mix thoroughly by vortexing, and incubate at 56°C in a 
temperature controlled waterbath until the cells are completely lysed (3h). 
Vortex every hour. 
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2.4 Add 20 µl RNase A, briefly vortex, and incubate at room temperature for 2 
minutes. 
2.5  Add 200 µl Buffer AL, and mix thoroughly by vortexing. Then add 200 µl 100 
% ethanol and mix again thoroughly by vortexing (see Note 2). 
2.6 Pipet the sample into the DNeasy Mini spin column and centrifuge at maximum 
speed for 1 minute. Discard flow-through (see Note 3). 
2.7 Add 500 µl Buffer AW1 and centrifuge at maximum speed for 1 minute. 
2.8 Add 500 µl Buffer AW2, and centrifuge at maximum speed for 1 minute. 
Discard flow-through and centrifuge again at maximum speed for 1 minute to 
dry the column (see Note 4). 
2.9 Place the DNeasy Mini spin column in a clean 1.5 ml microfuge tube, and pipet 
100 µl Buffer AE directly onto the DNeasy membrane. Incubate at room 
temperature for 1 min, and then centrifuge at maximum speed for 1 min to 
elute. Add another 100 µl Buffer AE, incubate for 1 minute, and then centrifuge 
at maximum speed for 1 minute (see Note 5). Freeze DNA at -20°C or proceed 
directly to the next step. 
3. Check the quality of the genomic DNA on a nanodrop. First, blank the 
spectrophotometer with 1 µl nanopure water. Wipe away the water, then add the 
sample. One should see a smooth profile with a minimum at 230nm and a 
maximum at 260nm. Typical values should be ~20 µg genomic DNA, 280/260 
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value of ≥1.8, and a 260/230 value of ≥2. If the quality is too low, repeat the wash 
steps 2.7-2.9 with a new column. 
4. Submit ≥2 µg/sample genomic DNA (at least 1 parent strain sample and 1 evolved 
strain sample) to a core facility for whole genome sequencing. There are many 
options to choose which sequencing instrument and which sequencing method; 
currently the DNA core facility at Iowa State University has a GAII sequencer from 
Illumina, INC. 75-cycle paired-end sequencing is recommended as the researcher 
obtains more reads at a higher quality. To date, Illumina offers 150-cycle paired-
end data with the GAII sequencer and 100-cycle paired-end data on their HiSeq 
instrument. If submitting more than one sample, indexing is the best option as one 
pays only for one sequencing lane. Indexing allows to a maximum of 12 samples in 
a single lane. The workflow of the Illumina platform is shown in Figure 1. Refer to 
the Illumina website for their sequencing technology: 
http://www.illumina.com/technology/sequencing_technology.ilmn (see Note 6). 
Preprocess Sequence Data 
High throughput sequence data is most commonly stored in FASTQ format. 
FASTQ format represents each read as a set of lines: header, sequence, sequence ID 
(optional), and quality scores in ASCII encoding. These text files typically have a .fq, 
.fastq, or .txt extension. 1. Before beginning analysis, identify what quality scoring encoding is associated 
with the raw data. Different Illumina genome analyzer pipeline software versions 
use different scoring scheme variations (e.g., Illumina 1.3+, Illumina 1.5+, and 
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Illumina 1.8+). If there is difficulty identifying which encoding is used, FastQC 
includes this in its output. Software user manuals will specify if a particular scoring 
scheme is expected as input and it may be necessary to perform a conversion prior 
to analysis using Galaxy, the FASTX-Toolkit, or using a “Bio*” library in the 
language of your choice (e.g., BioPerl, BioPython, BioRuby, BioJava). 
2. Use FastQC to perform an initial quality assessment of raw data. Launch the 
FastQC GUI and open FASTQ data files to generate all FastQC reports at once. 
Reports and graphs are presented in HTML format and can be saved for reference. 
Examine per-base quality, per-sequence quality, per-base content, and 
length distributions (not applicable for Illumina reads). Also check for over-
representation of sequences and if they correspond to contaminants or PCR artifacts 
(in addition to common artifacts provided by FastQC users may supply sequences 
of potential contaminants to screen for). 
Use the summary icons (green: normal, orange: slightly abnormal, and red: 
very unusual) as guidelines in the following preprocessing steps. It is important to 
acknowledge that not all preprocessing steps will be necessary for all data and also 
that having small abnormalities may be acceptable in the context of the data and 
should not prevent a researcher from proceeding with analysis. 3. Perform read trimming using the FASTX-Toolkit if necessary. Read quality 
deteriorates with position and base calls near the end of a read are more prone to 
error. An appropriate length to trim may be determined from FastQC output. Use 
the fastx-trimmer	  command from the FASTX-Toolkit: 
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$ fastx_trimmer [-f N] [-l N] [-i INFILE] [-o 
OUTFILE] 
Where	   [-f N] specifies the first base to keep (default is 1),	   [-l N] 
specifies the last base to keep (default is entire read),	   INFILE specifies the 
FASTQ file and OUTFILE is the name to give the trimmed data file. More 
advanced techniques allow for adaptive read trimming, however reads of varied 
length may not be acceptable as input for all analysis software. 4. Filter reads by overall quality with the FASTX-Toolkit: 
$ fastq_quality_filter [-q N] [-p N] [-i INFILE] 
[-o OUTFILE] 
The minimum quality score to keep is	   [-q N] and [-p N]	   is the 
minimum percentage of bases that must have [-q] quality. 5. Remove sequencing artifacts, described as reads that are predominantly one base 
(e.g.,	  AAAAAAAAAAAAAAAACAAACA), using the FASTX-Toolkit:	  
$ fastx_artifacts_filter [-i INFILE] [-o OUTFILE] 
Where	  INFILE	  specifies the FASTQ file and	  OUTFILE is the name to give 
the filtered data file. 6. Remove adapters sequences (identified as overrepresented sequences in the FastQC 
report or defined in protocol) with the FASTX-Toolkit: 
$ fastx_clipper [-a ADAPTER] [-l N] [-i INFILE] [-
o OUTFILE] 
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Where [-a ADAPTER] is the adapter sequence that is to be removed from 
3'-end of sequences, [-l N] is the minimum length of reads to keep in the dataset 
(default is 5), INFILE specifies the FASTQ file, and OUTFILE is the name to 
give the filtered data file. 7. Resubmit filtered and trimmed data to FastQC to verify improved data quality and 
recalculate data summary statistics before proceeding with analysis. 
Map Short Reads to Reference Genome 
1. Build a reference index (using the reference genome in FASTA format) using the 
alignment algorithm of your choice, e.g., 
$ bwa index [-p prefix] [-a algoType] ref.fa # BWA 
$ bowtie-build [options]* ref.fa <prefix> # Bowtie 
$ bowtie2-build [options]* ref.fa <prefix> #Bowtie 2 
Where ref.fa	  is the reference genome in FASTA format, prefix is the 
prefix of the output database and also the database filename. Additional options are 
defined in the corresponding user manuals. 
Using the genome of the parent strain as the reference yields the best 
alignments. If the genome of the parent strain has not been sequenced, download 
the genome of the wild-type laboratory strain from a public online database such as 
NCBI RefSeq. One benefit of using the wildtype genome as reference is the ability 
to easily leverage existing annotation in publically available databases (e.g., 
BioCyc). 
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2. Align reads to the reference and generate a SAM file. The SAM file format is a 
TAB-delimited text file that contains information such as alignment position (or '*' 
for unaligned reads) and mapping quality for each read and is the common output 
format for aligners. SAMtools performs conversions between SAM and a 
compressed and indexed binary format called BAM. 
3. Assess overall alignment quality by reviewing the summary statistics generated by 
mapping software such as the percentage of reads that aligned to the reference 
genome. Use SAMtools to calculate read depths for each position of the genome: 
$ samtools depth aln.sorted.bam > depth.txt 
Where	   aln.sorted.bam	   is the sorted BAM file. The output file,	  
depth.txt, contains one line for each position in the reference genome. The 
second column is the coordinate and the third column is the number of reads that 
cover that position. The SAMtools depth utility does not report positions where 
read depth is zero, thus the number of lines in the file is equal to the number of 
bases where coverage is non-zero. Alternative, specify a depth cutoff to ignore very 
small read depths (i.e., do not consider depth = 1 as genome coverage). Calculate 
base coverage with one of the following: 
$ wc -l depth.txt     # depth > 0 
$ awk '$3 > $N {i++}END{print i}' depth.txt# depth > N 
Divide base coverage by genome size to obtain the percentage of the 
genome covered by reads. 
Map quality scores can also be examined by investigating column 5 
(MAPQ) of the SAM file. 
150 
 
De novo Assembly 
De novo assembly and mapping of short reads to a reference sequence are 
fundamentally different analysis procedures. Assembly of the genomes of evolved 
bacterial strains can be used to search for novel insertions and complex mutations that 
are difficult for mapping software to identify. Additionally, results from assembly 
methods can provide support for proposed alignments. 
Assembly of short read data does not use a reference sequence and instead tiles 
reads to generate sequences called contigs. Incorporating the average distance between 
paired-end reads (called the insert size) is used to join contigs into scaffolds. The most 
important parameter in de Bruijn graph based assembly algorithms is the hash length, 
which is also known as the k-mer length. Large k-mer values require longer overlap 
between reads in order for them to be assembled (therefore the k-mer value may not be 
larger than the read length). Conversely, small k-mer values require short overlap 
which results in increased sensitivity, but decreased specificity. The experimenter must 
provide the k-value parameter and there is no method to find the optimal value. 
Because of this, it is recommended that researchers test multiple k-mers and then 
compare several assemblies before proceeding. 
1. Assemble short read data with the assembler of your choice. Test multiple k-mer 
values and calculate the total number of contigs, N50, and N90 for each assembly 
(typically reported by assembly software). 
2. Proceed with the “best” assemblies such that the number of contigs is minimized 
and the N50 and N90 are maximized. 
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Identify Variations in Evolved Strains 
1. Identify single nucleotide polymorphisms (SNPs) and short insertions/deletions 
(indels) for an alignment using SAMtools/BCFtools: 
$ samtools mpileup -uf ref.fa aln.bam | bcftools 
view -bvcg - > var.raw.bcf 
Where ref.fa	   specifies the reference genome in FASTA format and 
aln.bam is a binary alignment file. The output is a binary file (BCF) for Variant 
Call Format (VCF) TAB-delimited files. VCF is standard for storing information 
about variants in alignment data. 
2. Find large deletions by inspecting of read depth (the number of reads mapped to a 
specific position on the reference genome). Calculate read depth values using 
SAMtools: 
$ samtools idxstats aln.bam 
Regions with zero or very low read depth may indicate deletions. 
Determining what qualifies as “low” read depth may be aided by examining the 
read depth distribution. 
3. Use assembly results to distinguish complex mutations such as large insertions, 
duplications, and inversions that are difficult for mapping algorithms to identify. 
Align contigs to a reference genome or an alignment consensus sequence. 
First, generate the consensus sequence from an alignment file with 
SAMtools: 
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$ samtools mpileup -uf ref.fa aln.bam | bcftools 
view -cg - | vcfutils.pl vcf2fq > cns.fq 
Where	  cns.fq is the output consensus sequence. Next, BLAST contigs 
against these sequences to reveal sequence variations. Syntenic dotplots can also be 
used to visually identify discontinuities. 
4. If possible, leverage reference genome annotation to form hypotheses about the 
effects of mutation. Verification by targeted sequencing can be used to confirm 
mutations. More advanced experimentation is necessary to confirm hypothesized 
effects. 
Verify Mutations 
1. Obtain a list of mutations from the above analysis and the sequences of the regions 
of interest. 
2. There are two approaches for obtaining primers for PCR: for genes and for non-
coding regions. 
2.1 For mutated regions containing open reading frames (ORFs or genes), first note 
how large the gene is and round up to the nearest 1,000. Add the additional 
sequences upstream and downstream of the gene equally. Then split the 
sequence into 1,000bp segments (see Note 7 and Note 8). This method will 
give you room to pick optimal primers to include the entire sequence of 
interest. Use the Primer3 program to design optimal primers whose PCR 
product size range is 851-1,000bp in length (see Note 9). Paste in the first 
1,000bp sequence, use the other default values, and click “Pick Primers”. Select 
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any of the suggested primers, noting where they bind to the template and the 
product size. Add the next 1,000bp block of sequence and repeat until 
complete. 
2.2 For mutated regions within a non-coding region (NCR), take a 1,000bp segment 
of DNA sequence and set the suspected mutation in the middle (~500bp from 
the first base). This ensures good sequencing data of this region. Use the 
Primer3 program for NCRs the same way for ORFs (see Note 10). 
3. For long sequencing regions (>1kb), the above method will have gaps in the total 
sequence. In order to fill in the gaps, repeat the process with a 500bp offset and 
choose the reverse complement primers that bind in the middle of the sequence. 
This will also increase the fidelity of the sequence data (see Figure 2). 
4. After choosing the primers, order them from an oligo synthesis company. If you 
have multiple primers, a 96-well plate format may be convenient. Resuspend them 
in either nanopure water or 10mM Tris-HCl, pH=8.5 at 100µM, vortex, and 
centrifuge briefly. 
5. Keep all PCR materials on ice and set up your PCR reaction in a 96-well plate 
according to Table 1. Reserve one well for a negative control PCR (no template, 
choose any primer pair) to check for contamination. Run PCR using a thermocycler 
according to Table 2. If the sequencing region is longer than 1kb, it is possible to 
make a long PCR product and then submit multiple sequencing primers for a single 
template (up to 5kb) (see Note 11). For higher fidelity, especially at longer 
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sequencing templates (>5kb) or difficult templates (high GC content), use the 
QIAGEN® LongRange PCR kit according to Table 3 and Table 4. 
6. Check the concentration of the PCR products using a nanodrop (see 3.1.3). Check 
the size of the PCR product on a 1% TAE agarose gel. 
6.1 Melt 1X TAE with 1% agarose gel in a standard microwave. Add 25mL with 2 
drops of ethidium bromide to a 8.5x10 cm gel casting tray in a gel casting tray 
holder with either an 8 or 15 sample comb (see Note 12). For more samples, 
use a 17x10 gel casting tray with a 26 sample comb. In this case, use 50mL of 
1% TAE agarose gel with a few drops of ethidium bromide. Allow 30 minutes 
for the gel to solidify. 
6.2 Remove the comb and the gel casting tray. Place the gel casting tray into the gel 
box. Add 1X TAE until the surface of the gel is covered evenly.  
6.3 Mix standard and samples according to Table 5. Mix the standard and load into 
the first well; perform the same with each sample. Set the voltage to 100, put 
the top on, and click “run” (see Note 13). Wait 45 minutes - 1 hour for the dye 
to reach the bottom. Turn the system off when finished. 
6.4 Use the UV camera to visualize the PCR products. Match the standard with the 
PCR product to determine the approximate size (see Note 14). 
7. If the PCR worked as expected, submit samples for sequencing by a core facility or 
company. The sample may need to be purified (use a standard PCR Purification Kit 
protocol) before submission (check the submission requirements). Use the 
155 
 
sequencing primers as described in Figure 2 (see Note 15). The sequencing data is 
returned as .ab1 trace files and .seq files. One can view the .seq files in any text 
editor program. More advanced analysis requires the use of .ab1 trace files and 
DNA sequence finishing software. 
8. In CodonCode Aligner (or any sequence finishing software), load the forward and 
reverse sequence of the samples. The first 20 bases and the last few bases (depends 
on the sequence length) have low quality scores. Highlight the samples and choose 
“clip ends” using the default parameters. Highlight the overlapping samples and 
assemble them into contigs (see Figure 3). The consensus sequence is shown at the 
bottom, where the base with the highest quality score is chosen. Here one can 
manually edit the sequence and call individual bases that are difficult. If there are 
discrepancies, open the trace files again to determine which is correct (see Note 
16). 
9. Use the BLASTn alignment tool (choose “Align two or more sequences” option) to 
align the consensus sequence to the parent strain and wildtype sequence. Sequences 
that are not matching or are unknown can be found using the NCBI nucleotide 
BLAST database. 
Notes 
1. The methods described here are developed in our lab, unless it is a published 
protocol from Illumina, INC. or commercial kit protocols. The steps using 
commercial kits are the published protocols of the kit manufacturer, where special 
deviations are in italics. Harvesting cells at 4°C, 4,000rpm prevents lysis and 
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increases DNA yields. Do not overload the DNA column. Overloading the column 
causes blockage of the membrane and decrease yields. To obtain the maximum cell 
count per DNA column, first obtain a correlation of OD (we use 550nm for E. coli) 
to C cells/mL (outside the scope of this protocol). Next, use     
to calculate the amount of cells you need: 
!!!"!!"##$!  !"##$ !"∗!"!" = 𝑥  𝑂𝐷!!"	    (1) 
For example, if C = 1.69x108, we have !!!"!!"##$!.!"!!"!  !"##$ !"∗!"!" = 1.18  𝑂𝐷!!". Therefore, 
10mL, OD550 1.18 is required to obtain 2x109 cells. 
2. The ethanol, sample and Buffer AL need to be mixed immediately and thoroughly 
by vortexing. Otherwise local precipitation may occur in the sample, which will 
decrease yields. 
3. Buffer AL and Buffer AW1 are not compatible with bleach and may form 
decomposition products. 
4. The column must be dried before eluting the DNA. Residual ethanol will decrease 
yields. 
5. Subsequent elution steps will increase DNA yields, but decrease concentration. Do 
not elute more than 200 µl into a single 1.5 ml microfuge tube. 
6. The insert sizes are less than 800bp. We typically use 400-500bp. 
7. Due to possible polar effects from upstream mutations, the researcher may want to 
include the complete sequence from the promoter to the stop codon of the gene of 
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interest. The sequencing length may be prohibitive and costly, so it is up to the 
researcher to include the upstream sequences along with the gene of interest. This 
is especially true if there are many genes in between the annotated promoter 
sequence and the gene of interest. 
8. For example, the E. coli gene carB is 3,222bp; therefore, round up to 4,000bp by 
using this formula: 4,000-3,222=778/2=389bp. Add 389bp upstream and 
downstream of the carB gene. The total sequence is therefore 4,000bp with the 
carB gene in the middle. This is enough to include a sequencing primer region and 
the promoter sequence 42bp from the translational start. 
9. The limit of good quality Sanger sequence reads is about 1,000bp. The Primer3 
program chooses optimal primers and performs in silico PCR to obtain PCR 
products in the desired range. This ensures that each primer has approximately the 
same length and melting temperature. It is good to also select alternate primers in 
case the primers weakly bind to the template. If the region is heavily mutated, it 
may be difficult choosing the correct primers. 
10. NCRs may include long blocks of A-T rich sequences and therefore optimal 
primers may not be available. In this case, adjust the target sequence, so that the 
mutated region is closer to either the 5’ end or 3’ end. This way one can obtain 
optimal primers that can be used for sequencing this region. 
11. QIAGEN® Taq DNA Polymerase is for general applications. For longer PCR 
products, the probability for incorporation of the incorrect base increases (false 
SNP); therefore, the use of a higher fidelity enzyme (i.e., QIAGEN® LongRange 
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PCR kit) is recommended. Higher fidelity PCR enzymes are recommended for SNP 
identification and resequencing applications. It depends on the researcher which 
option is best. For extremely long PCR (10kb-40kb), the researcher is referred to 
the QIAGEN® LongRange PCR Handbook for an alternate PCR protocol. 
12. Ethidium bromide is toxic and mutagenic. Always wear proper protection 
equipment. 
13. Make sure that the diode colors match (black with black and red with red) and that 
the black one is at the top. This ensures that the DNA samples will run through the 
gel in the correct direction. Also the dye should not run off the gel, otherwise one 
may lose the samples. 
14. If DNA bands are not visible, soak the gel for 1 hour in 1X TAE with ethidium 
bromide. 
15. Use the following formula to calculate the number of sequencing reactions: 
#𝑄𝑢𝑎𝑙𝑖𝑡𝑦  𝑠𝑒𝑞𝑢𝑒𝑛𝑐𝑒𝑠 = !"!""" ∗ 2− 1 (2) 
16. Common mismatches occur when the local sequence contains blocks of the same 
base (i.e., A block of 6 A’s in a row), or the ends are overlapping with one sample 
containing poor quality bases. This step may not be necessary as the consensus 
sequence is called according to quality. If SNPs or indels are discovered, this step 
becomes much more difficult, especially if there are duplication events. 
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Tables 
Table 1. A Typical 20µL PCR Reaction 
Material Stock Concentration 
Amount 
to add 
Final 
Concentration 
Nuclease-free water - Variable - 
Primer A 100µM 0.1µL 500nM 
Primer B 100µM 0.1µL 500nM 
Template Variable Variable 50-500ng 
2X QIAGEN® 
Taq PCR Master Mix 2X 10µL 
1X or 2.5U Taq 
+ 200µM dNTP 
 
Table 2. Typical PCR Reaction Conditions 
Step Time Temperature Comments 
1. Denaturation 4 min. 94°C Denaturation of template and primer-dimers 
2. Denaturation cycle 0.5 min. 94°C  
3. Annealing cycle 0.5 min. 55°C Or 5°C below the lowest primer melting temperature 
4. Extension cycle 1 min./kb 72°C  
5. Repeat  steps 2-4   Repeat 30 times 
6. Final extension 10 min. 72°C  
7. End infinite 4°C  	  
Table 3. 20µL QIAGEN® LongRange PCR Kit (up to 10kb) Setup 
Material Stock Concentration Amount to add Final Concentration 
Nuclease-free water - Variable - 
Primer A 10µM (diluted 10 fold) 0.8µL 400nM 
Primer B 10µM (diluted 10 fold) 0.8µL 400nM 
Template Variable (diluted 10 fold) Variable 0.1-10ng 
dNTP mix 10mM of each base 1µL 500µM of each base 
QIAGEN® LongRange 
PCR buffer 10X 2µL 1X or 2.5mM Mg
2+ 
QIAGEN® LongRange 
PCR enzyme mix 100U (total enzyme mix) 0.16µL 0.8U 
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Table 4. QIAGEN® LongRange PCR Reaction Conditions 
Step Time Temperature Comments 
1. Denaturation 3 min 93°C Denaturation of template and primer-dimers 
2. Denaturation cycle 15 s 93°C  
3. Annealing cycle 0.5 min 62°C Or 5°C below the lowest primer melting temperature 
4. Extension cycle 1 min/kb 68°C  
5. Repeat  steps 2-4   Repeat 35 times 
6. End infinite 4°C  
 
Table 5. Recipe for Mixing Standard and Samples 
Standard Samples 
Standard 1 µL PCR product 8 µL 
Dye 2 µL Dye 2 µL 
Nuclease-free water 7 µL Nuclease-free water - 
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Figures 
Figure 1. Illumina sample preparation Protocol 
 
Illumina sample preparation protocol, adapted from the Illumina guide Preparing Samples 
for Sequencing Genomic DNA. See the Illumina guidebooks for their detailed protocols. 
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Figure 2. Schematic for designing sequencing Primers for long sequencing Regions 
 
The average quality score is plotted for each individual base along the template. A quality 
score of 20 or greater is considered acceptable. Choose the forward primer binding to the 
lagging strand to cover the general area (top). To fill the gaps, use the reverse primer 
binding to the leading strand, with a 500bp offset. In this example, the forward sequencing 
primers will bind to bases 1, 1000, 2000, & 3,000. The reverse sequencing primer will bind 
to bases 3,500, 2,500, & 1,500. 
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Figure 3. Contig assembly in CodonCode Aligner 
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Summary 
Fermentative production of biorenewable fuels and chemicals is often limited by 
inhibition of the microbial biocatalyst, either by increasing concentrations of the product 
compound or by contaminant compounds in the biomass-derived sugars. This inhibition 
can interfere with economically viable production. Here we discuss typical mechanisms of 
inhibition and methods for improving biocatalyst robustness. Inhibition often takes the 
form of inhibition of enzyme activity, depletion of cofactor pools and membrane damage; 
methods are discussed for mitigating each of these types of inhibition. Various 
evolutionary schemes have been developed and implemented on a variety of inhibitory 
compounds, including butanol, acetic acid, furfural and ethanol. Reverse engineering of 
these improved strains can provide insight into new metabolic engineering strategies. 
Introduction 
The field of Metabolic Engineering has grown enormously since its definition in 
1991 (8, 112). Since then, enormous progress has been made in the use of engineered 
microbes for production of biorenewable fuels and chemicals. Two years after its initial 
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definition, Cameron and Tong classified five types of Metabolic Engineering: enhanced 
production of native metabolites; heterologous production of foreign metabolites; 
utilization of new substrates for metabolism; improved or new metabolic pathways for 
chemical degradation; and modification of cell properties that facilitate bioprocessing (14). 
Many landmark Metabolic Engineering projects have dealt with the first three strategies, 
including but not limited to (6, 54, 75, 88, 90, 110, 146), and can be thought of as relating 
mainly to metabolic functionality. Here we focus on the final of the five Metabolic 
Engineering types, modification of cell properties that facilitate bioprocessing. Such 
modifications have focused on a wide variety of biocatalyst properties; here we focus on 
the property of biocatalyst robustness, particularly in regards to inhibitor tolerance. This 
improved robustness can be geared towards increasing product tolerance, possibly enabling 
increased product titers, and increased ability to use “dirty” biomass-derived sugars. 
While industrial (18) and academic researchers (25, 49, 141, 145) have reported 
attainment of high titers, yields, and productivities, this is something that remains difficult 
to achieve, especially with next-generation biofuels and biochemicals. High product titers 
are desirable to make downstream separation steps cost-effective, but can be toxic to the 
microbial biocatalyst. Biocatalyst inhibition is also problematic when biomass-derived 
sugars are used as the fermentation substrate, as biomass hydrolysate or pyrolysate contain 
trace contaminants that are inhibitory to the microbe (53, 66, 83). This toxicity means that 
the amount of sugars that can be utilized by the organism, and thus the amount of product 
formed, is limited. One approach for dealing with this product or feedstock toxicity is to 
remove the inhibitory compounds (61, 66, 80). However, here we focus on the 
complementary approach of improving microbial robustness. Note that there are also 
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reports of inhibitory side products; these can often be addressed by re- distribution of the 
metabolic flux (1). 
Biocatalyst robustness as it relates to the economically viable fermentative 
production of fuels and chemicals have been previously discussed in a variety of reviews 
(27, 34, 52, 83, 89, 128). In this chapter, we highlight recent studies of biocatalyst 
robustness in the context of the production of biorenewable fuels and chemicals. The 
discussion also includes metabolic evolution coupled with reverse engineering, a valuable 
tool for gaining insight into the mechanism of inhibition and strategies for increasing 
tolerance. It is also important to note that cellular physiologically can be highly dependent 
upon growth condition. Engineering strategies may also change if rich or minimal growth 
media is used. In general, fermentative performance is enhanced and engineering strategies 
are more easily implemented in complex media compared to defined media; however, the 
analysis and any computational modeling is less complex in defined media as more 
information is available regarding the media composition. Most of our discussion involves 
either Escherichia coli or Saccharomyces cerevisiae, since they are the two most 
commonly-used organisms both for Metabolic Engineering and for understanding 
tolerance. 
Evolutionary strategies for increasing tolerance 
Evolution is essentially selection of random mutations that confer increased fitness 
(10, 26, 32, 58). These mutations can take a variety of forms and influence protein function 
via changes in amino acid sequence or increased, decreased or even total lack of gene 
expression. This evolutionary process has been leveraged in the development of strains 
with useful metabolic behaviors (99, 143, 147), but here we are more interested in its use 
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in the development of strains with increased robustness. While these robust strains are 
inherently useful, identifying and understanding the mutations that confer increased 
robustness can enable development of strain engineering strategies. The idea that we can 
distill Metabolic Engineering strategies from the evolved strains follows the proverb 
commonly known as Orgel’s Second Rule: “evolution is cleverer than you are”. The 
results of reverse engineering studies are included in our discussion below, though we do 
not go into detail about the methods of this reverse engineering. Table 1 lists selected 
reports of evolutionary studies for ethanol, acetate and butanol. The information in Table 1 
is for descriptive purposes and does not draw any conclusions about the relative merit of 
various evolutionary methods. The most basic evolutionary studies take advantage of the 
natural “background” mutation rate. For wild-type E. coli, the most recent estimate for the 
rate of point mutations is 8.9x10
-11 
events per base pair per generation (133). The 
mutation rate can be increased by the use of mutagens, such as ethyl methane sulfonate 
(EMS) (57), or deletion of proofreading enzymes, such as the methyl-directed mismatch 
repair system (108). A long-term study of E. coli evolution has been performed for more 
than 40,000 generations (9), though with a focus on metabolic behavior and not necessarily 
tolerance. Other studies have successfully evolved tolerance to inhibitory compounds, such 
as furfural (68, 82), isobutanol (7, 84), 2-butanol (37), acetic acid (111), biomass 
pyrolysate (67), biomass hydrolysate (36, 45, 83) and others. In this traditional 
evolutionary scheme cells are typically subdiluted in batch cultures on a regular basis (i.e. 
every 24 or 48 hours) or upon attainment of a certain cell density. Inhibitor concentration 
is typically increased in a stepwise fashion as cells gain tolerance. An interesting variation 
of this traditional approach is the Visualizing Evolution in Real Time (VERT) method, in 
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which fluorescence- based cell sorting is used to track distinct gains in fitness (100, 134, 
136); the utility of this method was demonstrated during evolution of n-butanol tolerance 
in E. coli (98). 
Other evolutionary-type studies rely on growth-based selection for improved 
tolerance, but do not only rely on the natural background mutation rate. Historically, 
transposon mutagenesis to randomly inactivate genes has been an effective method for 
identifying genes involved in a particular phenotype (113). The multi-SCalar Analysis of 
Library Enrichments (SCALES) method uses a plasmid library containing E. coli genomic 
fragments of various lengths to comprehensively increase expression of individual genes 
and gene clusters (13, 38, 76, 131). DNA fragments and genes conferring increased 
tolerance to the focal compound are identified and interpreted. This approach has been 
used with ethanol (137), acetate (105), 3- hydroxypropionic acid (3-HP) (129, 130), and 1-
naphthol (35). 
Global transcription machinery engineering uses a library of mutants within the 
transcription machinery, as the name implies (3, 59). For example, ethanol tolerance in E. 
coli has been addressed by enriching library of cAMP receptor protein mutants (17), 
Rhodococcus ruber tolerance of acrylamide and acrylonirtrile through mutation of sigma 
70 (78), ethanol and biomass hydrolysate tolerance in S. cerevisiae through mutation of the 
TATA-binding protein (70, 142). Global transcription machinery engineering can also be 
applied to a foreign regulator. Specifically, a mutation library of IrrE global regulator from 
radiation resistant Deinococcus radiodurans has been introduced into E. coli and screened 
for resistance to a variety of inhibitors, such as ethanol, butanol, acetate, osmotic stress, 
biomass hydrolysate and salt stress (16, 77, 91, 125, 149). 
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Some studies go even further in the search for genetic elements that will confer 
increased tolerance by randomly combining genomes with desired behaviors. For example, 
two distinct acid-tolerant Lactobacillus strains were subjected to a recombination-based 
genome shuffling; products of this shuffling process demonstrated improved acid tolerance 
and increased lactic acid production (94). Lactobacillus brevis and E. coli were hybridized 
through a protoplast fusion method to generate E. coli strains with increased butanol 
tolerance (135). In this manner, researchers were able to transfer traits conferred by 
unknown genes from one organism with the desired phenotype of butanol tolerance to an 
organism that has a demonstrated ability to produce butanol. 
Metagenomic screens, in which a plasmid library is generated from a mixture of 
various genomes and screened for the desired activity in an inhibitory condition, are most 
often used to find enzymes that are tolerant to specific stresses (73, 109). However, a 
search of a DNA library generated from the human gut microbioata not only identified 
multiple salt-tolerant Collinsella genes, they also found that expression of these genes in E. 
coli resulted in increased salt tolerance (22). These metagenomic screens provide the 
opportunity to discover and utilize tolerance-conferring genes from organisms or pathways 
that have not yet been characterized. 
Each of these different methods provides the opportunity to gain insight into 
mechanisms of inhibition and methods for increasing tolerance. Again, we will not go into 
the details of how this data is analyzed, but will focus on the insights gained by these 
studies. 
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Mechanisms of Inhibition 
The mechanism by which different compounds limit biocatalyst growth and 
metabolism vary according to the chemistry of the molecule. There are a variety of known 
pathogenesis-related inhibition mechanisms, such as antibiotics and reactive oxygen or 
reactive nitrogen species that are not discussed here (23, 30, 138). Cold shock and heat 
shock, though very well studied, are also not discussed here (5, 40). Omics analysis, such 
as transcriptome analysis, has often played a key role in identification of these mechanisms 
of inhibition. The contribution of omics analysis to understanding biocatalyst inhibition is 
reviewed elsewhere (52) and not discussed here. 
Given the necessity of amino acids and nucleotides for production of proteins, 
transcripts and genome replication, disturbance of their production can lead to biocatalyst 
inhibition. This can be especially problematic when the desired growth condition is defined 
minimal media, relative to metabolite-containing rich media. Depletion of essential 
metabolic building blocks can trigger the global “stringent response”, as reviewed 
elsewhere (29, 48). For example, it was shown that the biomass-derived inhibitor furfural 
indirectly inhibits cysteine production in E. coli by depleting the NADPH needed for 
conversion of sulfate to hydrogen sulfide (81). The accumulation of carboxylate ions in E. 
coli, such as during challenge with carboxylic acids, can increase the intracellular ionic 
strength to levels sufficient to inhibit homocysteine transmethylase (MetE), an enzyme 
required for methionine biosynthesis (102, 132). The feedback loop by which valine 
production is regulated in E. coli results in valine-mediated inhibition of production of 
leucine and isoleucine and thus, valine can be inhibitory to some E. coli strains when 
leucine and isoleucine are not exogenously supplied (79). 3-HP can limit amino acid 
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synthesis via inhibition of the chorismate and threonine superpathway (129). This 
limitation of biosynthesis pathways is distinct from situations where the product compound 
inhibits its own production; enzyme improvement for alleviating this problem has been 
reviewed elsewhere (51). 
Another commonly-noted mechanism of inhibition is membrane damage. This is 
especially problematic when dealing with hydrophobic compounds, such as carboxylic 
acids and butanol (50, 62, 71, 103). Overton’s Rule provides a general rule of thumb for 
predicting the membrane permeability of a compound, whereby compounds with increased 
lipid solubility (i.e. hydrophobicity) have greater membrane permeability (2). Membrane 
damage can manifest as a failure to maintain appropriate fluidity and/or leakage of 
valuable metabolites. Leakage is often monitored using Mg2+ as a reporter molecule (71, 
103, 144). Fluidity can be measured via the diffusivity of a fluorescent reporter molecule 
(11, 87). Recent studies have visualized membrane pores, and eventual disintegration, 
caused by an antimicrobial peptide (96), though such studies have not yet been performed 
with the type of inhibitors of interest here. This membrane damage can result in improper 
functioning of membrane-associated reactions, such as the electron transport chain, 
sometimes resulting in increased production of reactive oxygen species (19, 104, 114). 
Exogenous challenge with carboxylic acids, especially acetate, has been shown to 
disrupt intracellular pH (101, 123). Acetate has been the subject of numerous studied due 
to its abundance in biomass hydrolysate, while longer-chain carboxylic acids are of interest 
as biorenewable chemicals. This drop in intracellular pH is due to dissociation of the 
carboxylic acid in the cell interior. The acidification can inhibit cellular processes and 
impose a hefty ATP burden as ATPase is used to remove the excess protons (123). 
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Thus, biocatalyst inhibition can occur at a variety of levels and scales. Inhibition of 
a single biosynthesis-related enzyme can completely inhibit biosynthesis of the machinery 
needed for growth and metabolism. An increase in the harshness of the intracellular 
environment, such as increased osmotic stress or a drop in pH can stress multiple enzymes. 
Depletion of generic cofactors, such as NAD(P)H and ATP, can have a general slowing 
effect on metabolism. Membrane damage can impact membrane-associated process and 
result in leakage of valuable metabolites. A variety of Metabolic Engineering strategies 
have been demonstrated for dealing with these various types of inhibition. 
Mechanisms of Tolerance 
Strategies for increasing biocatalyst robustness have arisen both as a deliberate 
response to known mechanisms of inhibition and from analysis of evolved strains. Here we 
highlight a few of these known mechanisms. Note that it has been challenging to distill 
clear design strategies from some of the more advanced evolutionary schemes due to the 
large number of genes with perturbed expression. 
Problems with biosynthesis due to inhibition of enzyme activity can be addressed 
by replacing the sensitive enzyme with an isozyme or mutant enzyme that is resistant to the 
inhibitory effect. This approach has been successfully demonstrated with both valine and 
3-HP (92, 129). Depletion of generic cofactors, such as furfural-mediated depletion of 
NADPH, can be addressed by either deleting the enzyme responsible for this depletion 
(82) or implementing metabolic changes to increase cofactor availability (126, 127, 151). 
For instance, provision of an NADH- dependent furfural reductase enabled E. coli to 
reduce furfural to the less toxic furfuryl alcohol, while not depleting the NADPH needed 
for biosynthesis (126, 151). 
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A design scheme that has arisen somewhat independently of known inhibition 
mechanisms or analysis of evolved strains is the provision of appropriate transporter 
proteins. This strategy asserts that product toxicity can be alleviated, at least in part, by 
providing cells with the opportunity to expel the problematic compound. This strategy has 
proven effective in improving both tolerance and production of limonene (28) and valine 
(93) by E. coli, as well as alkane tolerance in S. cerevisiae (69), geraniol tolerance in E. 
coli (107) and decanoate tolerance in E. coli (64). 
One of the major benefits of reverse engineering evolved strains is the opportunity 
for biological discovery. For example, reverse engineering of furfural-tolerant E. coli 
identified YqhD as the major E. coli furfural reductase (82). However, not all reverse 
engineering results are so clear- cut. Analysis of the results of SCALES for 3-HP tolerance 
identified the 21-amino acid peptide IroK as important to 3-HP tolerance, independent of 
3-HP transport, but the biological function of this peptide remains unknown at this time 
(130). 
As mentioned above, membrane damage is a frequently-cited mechanism of 
inhibition and membrane-associated genes have been identified in the analysis of many 
strains evolved for various tolerance phenotypes (105, 137). For this reason, we have 
designated a distinct section for describing membrane engineering efforts. 
Membrane Engineering 
Modulation of the membrane composition enables microbes to respond to 
environmental challenges (148). The lipid-rich cell membrane is often targeted at the 
molecular level by hydrophobic compounds. As described above, this can result in 
decreased ability of the membrane to retain valuable metabolites and decreased function of 
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membrane-associated metabolic processes. For this reason, many of the most interesting 
recent breakthroughs in Metabolic Engineering for inhibitor tolerance are related to 
membrane engineering. We describe these results here, after a brief summary of the 
physiological role of the different bacterial membrane components. 
Bacterial membranes are a mixture of many different lipid entities. Each lipid 
species plays a distinct physiological role. The main lipid component of the E. coli 
membrane is the straight- chain, unsaturated palmitic acid (C16:0). Modifications can be 
made by either changing the length of the carbon backbone or adding a substituent such as 
a double bond or cyclopropane group (Table 2). An important note is that cyclopropanated 
lipids are formed as an intramembrane modification of a cis-unsaturated fatty acid and not 
from de novo fatty acid biosynthesis (148). The modifications and relative distribution are 
dependent on the species and the environment. For example, branched lipids are a major 
component in the membrane of gram- positive bacteria (21). Branched fatty acids can 
increase or decrease membrane fluidity, dependent upon the ante- or iso- conformation 
(148). The difference comes from the packing efficiency of the fatty acid within the lipid 
bilayer. The methyl group in the anteiso form is further away from the end, which 
increases the bulk. Another intriguing variable is the presence of cyclopropanated fatty 
acids. These occur when the double bond in unsaturated lipid is methylated, such as by the 
E. coli Cfa enzyme (39). Teichoic acid is a major component in the cell wall of gram 
positive bacteria and provides structural rigidity to the cell wall by cross- linking 
peptidoglycan layers (86). Sterols increase the membrane rigidity, decreasing passive 
transport of lactic acid and its resulting accumulation (121). Peptidoglycan is a three 
dimensional mesh outside the plasma membrane and can serve as a structural barrier 
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against osmotic pressure and toxic compounds (43, 117). LPS is the outer layer of 
polymers on the surface of a bacteria cell that can also be a protection against inhibitors. 
The hydrophobicity of the cell surface is attributed to LPS and may affect the interaction of 
the cell with inhibitors (4, 60). Typical metrics for describing membrane composition 
include average chain length and the unsaturated/saturated ratio. A variety of studies have 
reported changes in both of these metrics in response to challenge with inhibitory 
compounds (62, 71, 103, 139). 
Each lipid component has an overall effect on the fluidity of the membrane through 
hydrophobic interactions between the lipids and proteins in the membrane (148). 
Membrane fluidity is an important part of cellular physiology and affects the function of 
the membrane, including respiration, passive and active transport, and protein function. 
Typically, as the length of the fatty acid increases the membrane fluidity decreases due to a 
higher packing efficiency (87). Fatty acid length has also an effect on the membrane 
thickness (65, 122) and curvature (140). The membrane thickness is important for proper 
membrane function such as protein conformation and nutrient transport (33, 122). 
Moritella marina is found in deep, cold ocean waters (56). Membrane fluidity is 
temperature dependent; at low temperatures, bacterial membranes are generally less fluid 
(148). M. marina copes with this by producing polyunsaturated fatty acids that then 
increase the fluidity of the membrane. 
Membrane fluidity needs to be in an optimal range for proper membrane function. 
Solvents, such as alcohols and aromatics, have a fluidizing effect on the membrane (12, 
46) and thus a change in the membrane fluidity is needed to counter-balance fluidizing 
agents. Bacteria respond to solvent stress in a number of ways, most notably a change in 
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the membrane lipid composition. The ethanol producer Zymomonas mobilis contains 
relatively more octadecenoic fatty acid (C18:1) than E. coli (72). It has been shown that E. 
coli exposure to ethanol increases the relative amount of C18:1 compared to C16:0. This 
change is accompanied by altered growth rate and membrane fluidity (47, 72). This 
difference in membrane composition could explain why Z. mobilis has increased ethanol 
tolerance. Bacillus cereus predominantly uses branched lipids in the membrane; the 
relative abundance of saturated and iso-branched lipids increase during anaerobiosis, 
presumably in response to ethanol production (24). Biosynthesis of teichoic acid and 
capsular polysaccarides by Lactobacillus plantarum is stimulated by the presence of 
ethanol (120), leading to the suggestion that an increase in the cell wall thickness can act as 
a barrier against solvents. 
Cyclopropane fatty acids have been demonstrated as useful (15, 106), but not 
essential (115) for microbial acid tolerance. Motivated by an observed increase in both 
saturated and cyclopropane fatty acids in Clostridium acetobutylicum during butanol 
challenge (124), Zhao et al. overexpressed the native cfa gene in C. acetobutylicum. This 
increased Cfa expression did enable increased butanol tolerance, though it was 
unfortunately accompanied by decreased butanol production (150). It may be that a change 
in the membrane properties of C. acetobutylicum upon overexpression of cfa decreased 
solventogenesis. Liu et al. enabled cyclopropane fatty acid production in S. cerevisiae, an 
organism which does not inherently produce these compounds, in order to mitigate 
membrane leakage during octanoic acid challenge (71). While the cyclopropane fatty acids 
were successfully produced, there was no change in octanoic acid tolerance. 
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Luo et al. increased expression of the native fabA desaturase in E. coli with the goal 
of improving ethanol tolerance (74). This fabA overexpression increased the saturated lipid 
content and improved ethanol tolerance. The physiological effect of fabA overexpression is 
not clear at this time, but an increase in saturated fatty acids inherently decreases the 
fluidity of the membrane, possibly either affecting membrane functions or the transport of 
ethanol into the cell. Similarly, Lennen and Pfleger noted a decrease in saturated fatty acid 
content in the cell membrane during production of carboxylic acids and proposed that this 
change in membrane composition was actually a mechanism of carboxylic acid toxicity. 
They successfully engineered their strain to restore closer to normal saturated fatty acid 
content, though levels were still higher than that observed for the non-producing control 
strain (63). The viability of the modified carboxylic-acid producing strains was 
significantly increased in the strain engineered for increased saturated fatty acid content 
(63). 
Several analyses of E. coli strains evolved for isobutanol or n-butanol tolerance 
have noted possible changes in LPS content or composition (7, 85, 97). For example, one 
evolved isobutanol-tolerant mutant had an insertion mutation which essentially inactivated 
yhbJ, a mutation that can lead to increased production of glucosamine-6-phosphate, a 
major component of peptidoglycan and LPS synthesis (7). Another reverse engineering of 
isobutanol-tolerant E. coli found mutations in fepE and yjgQ, which contribute to LPS 
synthesis as well as eptB, which adds a phophoethanolamine group (a type of 
phospholipid) to LPS (85). 
Interestingly, accumulation of transcripts involved in glucosamine-6-phosphate 
synthesis in a ∆yhbJ mutant requires Hfq, a global stress response regulator (55). Hfq is an 
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RNA-binding protein that affects RNA processing and regulation. Minty et al. found that a 
mutated form, designated Hfq*, can increase isobutanol tolerance. The role of RNA 
processing in production of cellular components like glucosamine-6-phosphate is quite 
complicated and the reader is referred to other references (31, 44). The topic of how altered 
gene expression levels affect the global state of the microbe is complex and the reader is 
referred to other reviews (41, 116). 
Concluding Remarks 
Production of biorenewable fuels and chemicals from biomass is desirable as a 
means of potentially increasing energy security, stabilizing fuels costs and addressing 
climate change and increasing carbon dioxide levels. Microbes are an appealing biocatalyst 
for this production and we have developed excellent strategies and techniques for 
rationally and predictably engineering biocatalyst metabolism. However, biocatalyst 
inhibition by either the product compound or inhibitors in the cheap, “dirty”, biomass-
derived sugars remain problematic in the attainment of economically viable yields, titers 
and productivities. Here we have summarized representative mechanisms of inhibition and 
evolutionary and engineering strategies for increasing tolerance. Evolutionary strategies 
have proven quite adept at increasing tolerance (Table 1), but additional efforts on reverse 
engineering these improved strains can provide guidance for new design strategies. 
It is important to note that many mutations are synergistic in development of the 
final tolerance phenotype; rarely does one mutation dominate. It was suggested that global 
regulators at the transcriptional and post-transcriptional level may be key components in 
metabolic engineering for tolerance. Interestingly, stress responses may either overlap 
(120) or be antagonistic (97). This result is consistent with the idea that genes of 
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overlapping function have a negative epistasis (42). Epistasis can be quantified by a 
multiplicative fitness model (85) that can analyze how particular mutations are affected by 
subsequent mutations. Reversion of an evolved phenotype is always a possibility, though 
remote. In fact evolved E. coli with a frameshift mutation in rph-1, which represses the 
downstream nucleotide biosynthesis gene pyrE, are often subject to reversion in order to 
derepress pyrE (20, 85). 
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Tables 
Table 1. Evolution for inhibitor Tolerance 
It is important to note that many mutations are synergistic in development of the final 
tolerance phenotype. 
Organism Evolutionary Method Result Reference 
Inhibitor: Ethanol 
E. coli 
SCALES 
Enriched populations 
in 15 and 30 g/L 
ethanol in minimal 
media 
(137) 
Transcription 
Machinery 
Engineering of Sigma 
70 
Final strain showed 
growth (6-hr doubling 
time) in the presence 
of 60 g/L ethanol in 
rich media; control 
strain had no growth. 
(3) 
Transcription 
Machinery 
Engineering of CRP 
Final strain had a 
growth rate of 0.08 hr-
1 in the presence of 
62 g/L ethanol, 
relative to 0.06 hr-1 of 
original strain 
(17) 
Transcription 
Machinery 
Engineering of IrrE 
Best strain showed a 
10-fold increase in the 
number of cells 
surviving 1-hr shock 
with 12.5% ethanol 
(16) 
S. cerevisiae 
Transcription 
Machinery 
Engineering of Spt15 
Significantly improved 
viability during 30 
hours of culturing with 
20% ethanol. 
(3) 
Transcription 
Machinery 
Engineering of Spt15 
Evolved strains grew 
in the presence of 
15% ethanol; control 
strain did not 
tolerance 
concentrations above 
10% 
(142) 
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Table 1 Continued 
Organism Evolutionary Method Result Reference 
Inhibitor: Acetate 
E. coli 
SCALES 
Enriched population in 
1.75 g/L acetate in 
minimal media at 
neutral pH 
(105) 
Transcription 
Machinery 
Engineering of IrrE 
Best strain showed 
increased growth in 
the presence of 
0.05% acetate in rich 
medium 
(16) 
Inhibitor: Butanol 
E. coli 
Sequential transfers 
Increased growth and 
viability in the 
presence of 6 and 8 
g/L isobutanol in rich 
medium 
(7) 
Sequential transfers 
Increased growth in 
the presence of 1% 
(w/v) isobutanol 
(84) 
VERT 
At least 10-fold 
increased survival to 
shock with 2 vol% n-
butanol for 1 hr in 
minimal medium 
(98) 
Transcription 
Machinery 
Engineering of IrrE 
Best strain showed a 
100-fold increase in 
the number of cells 
surviving 1-hr shock 
with 2.1% butanol 
(16) 
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Table 2. Physiological Significance of selected Types of bacterial membrane Lipids 
 
E. coli membranes contain minor 
amounts of these lipids. E. coli 
incorporates C14:0 into lipid A 
(95). Fluidity is dependent on 
chain length and degree of 
saturation; short lipids increase 
fluidity and long lipids decrease 
fluidity. 
Saturated C14:0 
C12:0, C18:0 (not shown) 
 
Lipid A comprises also of 3-
hydroxy-C14:0 in E. coli. This 
fatty acid binds other C14:0 or 
C12:0 fatty acids to the hydroxyl 
group in lipid A. 
3-hydroxy-C14:0 
 
Odd-chain fatty acids are 
unusual, but generally present in 
gram-positive bacterium (eg. 
clostridium butylicum.) C15:0 
 
E. coli bacteria membranes are 
predominantly C16:0. Palmitic acid C16:0 
 
Gram-negative bacteria 
incorporate more cyclopropane 
during the stationary phase as a 
stress response (15). C17cyc 
helps mediate acid stress. 
Cyclopropane C17cyc 
C19cyc (not shown) 
 
An increase in unsaturated lipids 
increases membrane fluidity. 
Monounsaturated Cis-C16:1 
C18:1 (not shown) 
 
Trans fatty acids occur naturally 
in Pseudomonas putida, which is 
solvent-tolerant. The trans species 
acts like saturated fatty acids by 
decreasing membrane fluidity 
(148). 
Trans C18:1 
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Table 2 Continued 
 
Generally present in gram-
positive bacteria (eg. 
Lactobacillus plantarum). Polyunsaturated C18:3 
C18:2 (not shown) 
 
Membrane fluidity depends on 
iso or anteiso forms. These lipids 
are usually observed in gram-
positive bacteria. Combined 
substituents are also possible- 
iso-C17:1 and anteiso-C17:1. 
Branched iso-C17:0 
 
Branched anteiso-C17:0 
 
DHA and other long chain 
polyunsaturated fatty acids are 
unique to marine bacteria. PUFA 
increase membrane fluidity in 
environments that are cold 
(<15ºC), under high pressure (up 
to ~1,000bar), and high osmotic 
pressure (~35 ppt salinity) 
(118,119). 
Docosahexaenoic acid (DHA) 22:6(n-3) 
EPA 20:5(n-3) (not shown) 
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Figures 
Figure 1. Reported Mechanisms of inhibition 
 
Reported mechanisms of inhibition often take the form of (1) inhibition reactions that 
produce metabolic precursors, limiting the formation of biomass and/or the enzymes 
needed for metabolism; (2) depletion of general metabolic precursors, such as ATP and 
NADPH; (3) damage to the cell membrane, interfering with membrane-associated 
reactions and retention of valuable metabolites. 
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APPENDIX C 
Figures 
Figure 1. Accumulation of Acetate in the log Phase is indicative of a change in Physiology. 
 
250mL Shake flasks of MG1655 in 50mL M9 + 1.0 % dextrose, 37 °C, 200 rpm pH=7.0 a: 
control b: +25mM octanoic acid. 
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Figure 2. Additional Mutations investigated in LAR1 for Carboxylic Acid Tolerance 
included disruptions by IS1 Sequences. 
 
The yeaJ and yebB genes were fully disrupted by IS1. YeaI, an inner membrane protein, is 
predicted to be a diguanylate cyclase, which is a secondary messenger molecule in E. coli 
(1). Diguanylate cyclases are important for motiliy regulation and stress response. It is 
known that deletion of yeaJ increases motility. Motility and curli have an inverse 
correlation, for which the regulatory control is complex. Previously, motility was shown to 
be down regulated in response to C8 stress (3). Therefore, the LAR1 strain may be 
activating motility in order to negate the adverse effects of octanoic acid on motility. The 
downstream gene yeaK may be involved in trans-editing mischarged tRNAs during protein 
translation (4). The IS1 has flanking inward promoters that may increase expression of the 
neighboring genes (5). Promoters pointing towards genes that are transcribed on the 
opposite strand of DNA do not affect the transcription of those genes since the translated 
protein would be nonsense. In the case of yeaJ::IS1, the pinsL promoter may increase the 
expression of a truncated yeaJ gene product as well as the downstream gene yeaK. If C8 
causes protein translation inhibition, it is possible that increased yeaK expression may help 
correctly translate tRNAs into the appropriate protein. Note that the yeaJ promoter uses the 
sigma factor σ70. 
 
yeaI yeaJ yeaK 
MLC115 genome 
•IMP with predicted 
diguanylate cyclase 
activity 
(stress response) 
•! yields increased 
biofilm and motility 
•IMP with predicted 
diguanylate cyclase activity 
(stress response) 
•! yields increased motility 
•Uncharacterized 
•Predicted trans-editing of 
mischarged tRNAs 
yeaJ 
yeaJ 
InsAB-1 
"24 
"70 "70 
"70 pinsL pinsR 
LAR1 genome 
a) 
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Figure 2 Continued 
 
YebB is an uncharacterized protein; the effect of a ∆yebB mutation is unknown. The IS1 
pinsL promoter may increase expression of the uncharacterized protein YobI and the 
helicase subunits RuvAB. Increased expression of ruvAB promote DNA damage repair that 
may be caused by C8 oxidative damage (6). RuvABC are subunits that form a DNA 
helicase, promoting recombination-mediated DNA damage repair. LexA is a 
transcriptional repressor of genes involved with DNA damage repair. Enhanced expression 
of ruvAB may be overcome any transcriptional repression by lexA. Also note that yebB and 
ruvC have σ70 promoters. RNA helicases are a class of proteins that regulate mRNA 
metabolism including maintenance, translation, and degradation (7). Overexpression of ruv 
genes may increase the ability of LAR1 to mutate and adapt to stressful environments, also 
known as evolutionary potential (8). 
  
b) 
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Figure 3. yeaJ aligned with leuB showing the likelihood of an AT-rich gene disrupted by 
IS sequences. 
 
The leuB gene is displayed only as a comparison for a GC-rich gene. 
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Figure 4. Gene knockout mutants ∆yebB and ∆yeaJ are more tolerant to C8 at higher 
concentrations compared to the wild type strain MG1655. 
 
∆yebB and ∆yeaJ mutations in MG1655 have confirmed their effect on C8 tolerance 
(Figure 5). The gene yebB is uncharacterized and therefore how it confers C8 tolerance is 
unknown. It is known that a ∆yeaJ mutation increases motility. It is unknown whether the 
yeaJ deletion mutation affects C8 tolerance specifically because of an increase in motility 
or by the lack of regulatory control of flagella motor activity. How the control of motility 
or curli affects C8 tolerance is not clear. 
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 Figure 5. The Magnesium Leakage is not different between LAR1 and ML115 Strains 
 
Experiment by Ping Liu in the stationary phase shows that there is no difference in 
magnesium leakage caused by octanoic acid addition in ML115 and LAR1 strains. 
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Figure 6. Membrane fluidity and magnesium Leakage of unadapted and adapted E. coli 
cells to 2 % ethanol.  
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Tables 
Table 1. Percent Microbial Adhesion To Hydrocarbons for Strains Unadapted or Adapted 
to 30 mM Octanoic Acid. 
% MATH test was performed in 0.8 % saline (sodium chloride) buffer instead of 
Phosphate Buffer Saline in order to reduce complexities associated with high ionic strength 
buffers. Note that the majority of the ML115 cells lysed in the C8 sample. 
Strain Condition % MATH 
ML115 MOPS 12.0±3.5 
+ 30 mM C8 19.3±6.0 
LAR1 MOPS 10.1±1.6 
+ 30 mM C8 13.6±3.4 
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